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Abstract 
Dental tissue conditioners are compliant, viscoelastic gels used primarily to form a 
soft cushion between the oral mucosa and the hard denture base.  Their uses 
include the treatment of inflamed mucosa resulting from ill-fitting dentures and in 
treatment of denture related stomatitis.  They are presented in powder/liquid format 
where the powder is usually poly(ethyl methacrylate) (PEMA) and the liquid is a mix 
of an aromatic ester (plasticiser, usually a phthalate) with ethanol. In use, the 
ethanol and plasticiser leach out with time causing the material to harden.  In recent 
years there has been concern about possible toxic effects of the leached phthalate.  
Preliminary work has shown citrate plasticisers to be acceptable replacements for 
phthalates.   
Another disadvantage of the powder/liquid format is the porosity produced on mixing 
which can lead to microbial ingress and contamination.  One possible solution would 
be to use a pre-gelled material which would have the advantages of easy application 
and reduced porosity. 
Candidal infections are a common etiological factor in denture related stomatitis. 
Earlier studies have shown it possible to release chlorhexidine diacetate (a broad 
spectrum antibacterial/antifungal agent) from powder/liquid tissue conditioners to 
treat these infections  
The aim of this study is to develop citrate-based pre-gelled and powder/liquid tissue 
conditioners and explore its use as potential drug delivery vehicle for chlorhexidine 
diacetate.  
The experimental pre-gelled system (EPGS) containing PEMA and acetyl tributyl 
citrate (ATBC) only showed stable Shore A hardness values over an 18 month time 
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period when stored at 7oC. The Shore A hardness and creep compliance ratio (flow) 
of EPGS indicated that it could be used as both a tissue conditioner and a 
temporary denture lining material, whereas experimental powder liquid system 
(EPLS), which contained 16 hours ball-milled PEMA powder and ATBC plus 5% 
ethanol, had more suitable properties for use as a tissue conditioner. Addition of 
chlorhexidine diacetate alone or with sodium fluoride did have an effect on the 
hardness and creep compliance ratio of the materials but these were within 
acceptable range. Both EPGS and EPLS containing 1% chlorhexidine had a higher 
percent release than those containing 9% chlorhexidine. The addition of sodium 
fluoride increased the release of chlorhexidine in all formulations.  
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1 Introduction 
Dental tissue conditioners are viscoelastic gels which are mainly used to form a soft 
cushion between the tissue surface of the hard denture base and oral mucosa. They 
are used when there is an underlying problem with the oral mucosa due to poor oral 
hygiene, ill-fitting dentures, resorption of the alveolar ridge that can lead to 
inflammation, ulcerations and sometimes to treat fungal infection caused by Candida 
albicans. They help to redistribute the forces evenly on the oral mucosa to promote 
healing. In short they are used as temporary relining materials for immediate 
dentures, in the treatment of denture related stomatitis where candidal infection is a 
common etiological factor, as a functional impression material and in some 
prosthetic devices e.g. obturators. 
 
They are presented as a powder/liquid system ready to be mixed and used. The 
powder is most commonly poly(ethyl methacrylate), or a related copolymer; whereas 
the liquid consists of a mixture of a plasticiser, usually an aromatic ester, and 
ethanol as solvent. After mixing, the ethanol swells the polymer powder allowing 
penetration of the plasticiser. The polymer chains become more mobile and a gel is 
formed by polymer chain entanglement, which is a physical reaction not a chemical 
one. The rate of gelation depends upon a number different aspects of composition; 
molecular weight and particle size of polymer powder, molar volume of plasticiser, 
amount of ethanol and powder/liquid ratio. 
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The problems associated with current tissue conditioners available on the market 
are described subsequently. Tissue conditioners become hard in the oral cavity 
initially due to the leaching of ethanol and then plasticiser. The rate of plasticiser 
leaching is affected by its molecular weight, molar volume, water solubility and the 
amount of ethanol in the formulation. Methods used to reduce plasticiser leaching 
such as using higher molecular weight plasticiser, reducing ethanol amount etc., 
also increase the gelation time to an unacceptable level to be used as a chair side 
material in the clinics (Jones et al., 1986; Parker and Braden, 1990). 
 
In recent years there has been concern about possible toxic effects of the leached 
phthalate plasticisers, commonly used in tissue conditioners. They are believed to 
have possible cytotoxic, carcinogenic and oestrogenic activity (Okita and Hensten-
Pettersen, 1991; Hashimoto et al., 2003). Hence, citrate-based plasticisers have 
been used as suitable replacements. 
 
Tissue conditioners are most commonly available as powder to liquid systems with 
different compositions. Practically, altering the powder to liquid ratio (factor 
controlled by the clinicians) affects the properties of these materials. Another 
disadvantage of the powder/liquid systems is the resulting porosity produced, which 
can lead to microbial ingress and contamination (Wright, 1980). 
 
One possible solution to overcome the problems associated with tissue conditioners 
is to develop a citrate based pre-gelled tissue conditioner formulation. This will result 
in a standardised gel with optimal properties, ease of use at the chairside, a 
reduction or elimination of air bubbles thus improving the hygiene of the dentures 
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and as a controlled drug delivery vehicle for treatment of Candidal infections, which 
is commonly seen in denture wearers.  
 
Hence one of the aims of this research was to develop a pre-gelled tissue 
conditioner incorporating a citrate plasticiser and no ethanol. Furthermore, the 
physical properties of an experimental pre-gelled formulation were compared with 
experimental and commercial powder/liquid formulations. Viscogel and Coe-Comfort 
were selected as commercial materials for this study due to represent the range of 
commercial tissue conditioners available, where Viscogel is recommended for 
general applications and Coe-Comfort mainly as a tissue conditioner. 
 
When developing a new tissue conditioner formulation, it is important to have 
knowledge of its basic properties that are required for its clinical use. These 
properties include gelation time, water uptake behaviour, hardness and creep 
compliance (flow properties). Gelation time is important as these materials are used 
at the chairside and therefore a short gelation time is desirable. However with a pre-
gelled system this is not important. Due to these materials being used in an aqueous 
environment it is essential to study their water uptake behaviour and their interaction 
with the environment in which they are used. Similarly hardness and creep define 
the materials usage in a particular clinical situation. 
 
Viscogel as commercial control together with experimental P/L and pre-gelled 
formulations could be investigated further as drug delivery vehicles for the potential 
treatment of Candidal infections. Therefore it was decided to add chlorhexidine 
diacetate, as an anti-fungal drug, with and without the addition of 0.5% NaF to these 
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materials and study their water uptake and chlorhexidine diacetate/fluoride release. 
The effect of incorporating chlorhexidine and NaF on the physical properties of the 
formulations, e.g. Shore A hardness, creep compliance ratio and gelation time (for 
powder/liquid formulations), were also studied. 
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2 Literature Review 
2.1 Denture Lining Materials 
The alveolar ridge changes with the use of dentures and sometimes it is necessary 
to make changes to the fit surface of the acrylic dentures in order to improve 
adaptation to the oral tissues. So either the whole of the denture base is replaced 
with heat-cured acrylic resin or a self-cured resin is applied to the fitting surface of 
the existing base. Occasionally it is necessary to apply a very soft material to the 
tissue surface of the denture, to provide a cushioning effect to traumatized soft 
tissue, to allow recovery before recording an impression for a new denture. Some 
denture wearers cannot tolerate a hard denture base so a long term soft cushion is 
applied on the fitting surface of the dentures. These materials can be classified into 
three groups (McCabe and Walls, 2008; Parker and Braden, 1982; Braden et al., 
1997) 
1. Hard reline materials 
2. Soft lining materials 
a. Long-term soft lining material 
b. Temporary soft lining material 
3. Tissue Conditioners  
 
Hard reline materials are used to replace the tissue surface of an existing denture. 
This requires taking an impression of the soft tissues using the denture as an 
impression tray and the relining is carried out in a laboratory with a heat cured 
material (McCabe and Walls, 2008). 
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Soft lining materials are much softer than the conventional denture base acrylics, as 
the name indicates. They are divided into two types based on their usage. Long-
term soft lining materials are meant for those patients who cannot tolerate a hard 
denture base. This is mostly because of the irregular alveolar ridge (usually 
mandibular) which is covered by non-resilient and thin mucosa. Long-term soft lining 
materials provide relief to the pain caused by the masticatory loads (through a hard 
base) in these patients; they are intended to last for the life time of the dentures. 
They are normally applied at the time of production of a new denture in a laboratory 
(McCabe and Walls, 2008).  
 
The temporary soft lining materials are intended to be used for a few months as they 
have a limited life. They are room temperature cured chair side materials that are 
directly applied on the denture base by the dentist (McCabe and Walls, 2008). 
Currently available soft lining materials can be classified according to the types of 
materials as shown in Figure  2.1 (Qudah et al., 1990; McCabe and Walls, 2008): 
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Figure  2.1: Different types of Soft Lining Materials 
 
Tissue conditioners and temporary soft relining materials have similar properties and 
are often referred to as similar materials in literature. The difference between the 
two is that temporary soft lining materials are set by a polymerisation reaction and 
will last several weeks in the mouth whereas tissue conditioners gel by polymer 
chain entanglement only and require replacement after two to three days (Braden et 
al., 1997).  
 
2.2 Tissue Conditioners 
Tissue conditioners were first proposed by Chase in 1961 and described by Smith in 
1962, as temporary variants of the permanent liners that were already in use at that 
time (Chase, 1961; Smith, 1962). Tissue conditioners are commonly composed of 
an acrylic polymer e.g. poly(ethyl methacrylate) (PEMA) or a copolymer powder e.g. 
n-butyl methacrylate/ethyl methacrylate (BMA/EMA) and a liquid consisting of 
Denture Soft 
Lining Material
Acrylics
cold cure heat cure
Silicone
heat cure cold cure
condensation addition
Poly phosphazine
(heat cure)
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plasticiser (commonly a phthalate) and ethanol as a solvent. Table  2.1 shows typical 
compositions of some commercially available tissue conditioners.   
 
Table  2.1 Composition of some commercial tissue conditioners (Jepson et al., 
2000) 
Materials Polymer Plasticiser Solvent 
Coe-Comfort PEMA 
Benzyl Benzoate (87.3%) 
Di-n-butyl phthalate (4.5%) 
Ethanol 
(8.2%) 
Coe Soft PEMA 
Benzyl salicylate (35.1%) 
Di-n-butyl phthalate (49.7%) 
Ethanol 
(15.2%) 
Soft-Liner 
 
PEMA 
Butyl phthalyl butyl glycollate 
(80.9%) 
Di-n-butyl phthalate (4.3%) 
Ethanol 
(14.8%) 
Viscogel 
(VG) 
PEMA (86.2%) 
Poly(methyl 
methacrylate)(13.8%) 
Butyl phthalyl butyl glycollate 
(86.9%) 
Di-n-butyl phthalate (8.2%) 
Ethanol 
(4.9%) 
Coe-Comfort (Coe lab Inc.), Coe Soft (GC America), Soft-Liner (GC Dental 
Industry), Viscogel (Dentsply) 
  
They are usually available in a powder and liquid (P/L) form, however similar 
materials are also available as over-the-counter products in the form of sheets or as 
a gel in tubes. Some common brand names are Snug (Mentholatam®) and 
Dinabase (Medident Lab.). 
 
Tissue conditioners are temporary materials used in denture wearers. When the 
powder and liquid are mixed a gel is formed. This gel is viscoelastic in nature 
responding elastically to the rapid dynamic loading of masticatory forces, but will 
flow under constant masticatory loads (Braden et al., 1997).  Tissue conditioners 
harden with time in the oral cavity due to the leaching of ethanol initially and 
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subsequently as a result of loss of plasticiser (Braden and Causton, 1971). They 
should be replaced after every 2-3 days when used as tissue conditioners by the 
dentist, up to 3 months usage as a temporary relining material and after 24 hours as 
a functional impression material (Graham et al., 1991b).  
 
Home reliners are supplied in pharmacies as a paste packed into a tube to be used 
by the patients. They are often used to provide cushioning effect from ill-fitting 
dentures (Hirayama et al., 2015). They are soft materials and mainly comprised of 
polyvinyl acetate containing varying amounts of ethanol (Takahashi, 2003). The 
polyvinyl acetate is amorphous polymer and in addition they also include calcium 
carbonate, polypropylene glycol, white bees wax and alkyl methacrylate copolymers 
(Murata et al., 2010; Prasad et al., 2014). Home reliners are not very popular among 
the dentists because of their poor properties (Woelfel and Kreider, 1968; Means, 
1964). In a recent study on the physical properties of denture home reliners by 
Murata et al. (2010) it was found that they lack the cushioning effect and their 
softness is lost very quickly, usually within a day. This is because of the presence of 
large amounts of ethanol they contain, which can be as high as 40%. The authors 
believed that ethanol leaches out very quickly and is responsible for the quick loss of 
softness and large water uptake in these materials. In contrast to this study Udo‐
Yamakawa and Kawai (2010) suggested that home reliners can be temporarily used 
effectively under  professional care. Home reliners are generally abused by the 
patients and are not recommended by the dentists (Hirayama et al., 2015) however; 
there are few scientific studies that have been conducted on the properties and 
effects of the home reliners. 
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2.3 Uses of Tissue Conditioners 
2.3.1 Mechanical Trauma 
Stresses produced in the mouth are transferred to the supporting underline bone 
through oral mucosa which acts as a cushion. If the denture does not fit properly 
then the soft tissues can experience excessive forces, resulting in tissue damage 
that ranges from slight displacement to gross deformation. In severe cases there is 
generalized redness and swelling. Tissue conditioners can be applied to the fitting 
surface of the denture to equalize distribution of occlusal forces by providing a 
cushion on the mucosa thus permitting the healing of the inflamed tissue. The tissue 
should recover sufficiently in a week so that a new denture can be made, but in 
severe cases further application may be required (Harrison, 1981). 
 
2.3.2 After Care of Immediate Dentures 
Tissue conditioners can be used as a temporary soft lining on the fitting surfaces of 
immediate dentures following extraction. This results in reduction of both post-
operative pain and denture problems because of their compliant viscoelastic nature 
(Hopkins, 1979). 
 
2.3.3 In Treatment of Denture Stomatitis 
Tissue Conditioners are commonly used for the treatment of denture related 
stomatitis (Prasad et al., 2014). Denture stomatitis is also known as denture sore 
mouth and chronic atrophic candidiasis. It consists of a mild inflammation and 
erythema of the mucosa beneath the denture that occurs mostly in a complete upper 
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denture (Scully, 2008). It is usually asymptomatic but patients may complain of 
mucosal bleeding, swelling, burning sensation, halitosis, unpleasant taste and 
dryness of the mouth. About 70% of the denture wearers suffer from this condition 
(Arendorf and Walker, 1987). It is slightly more prevalent in females than males 
(Mikkonen et al., 1984).  
 
2.3.3.1 Predisposing Factors of Denture Stomatitis 
Denture stomatitis is caused by multiple factors. These factors include denture 
trauma, poor oral and denture hygiene, denture wearing especially throughout night 
or with a dry mouth, fungal infection, hypersensitivity to denture base material, 
smoking, diabetes or high carbohydrate diet and HIV (rare factor) (Wilson, 1998; 
Figueiral et al., 2007) 
 
2.3.3.2  Clinical Features and Classification of Denture 
Stomatitis 
Denture stomatitis is presented with chronic erythema and oedema of the mucosa 
that comes in contact with the fitting surface of the denture (mostly upper complete 
denture), which is restricted to the denture bearing area. It is usually asymptomatic 
and uncommon complications include angular stomatitis and papillary hyperplasia in 
the vault of the palate (Figueiral et al., 2007).  
 
Diagnosis is usually made on the clinical symptoms. It is classified into three 
different types increasing in severity (Newton, 1962): 
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• Type 1: a localised simple inflammation or a pinpoint hyperaemia 
• Type 2: an erythematous or generalized simple type, presented as a more 
diffuse erythema, involving a part of, or the entire, denture covered mucosa 
• Type 3: a granular type (inflammatory papillary hyperplasia) commonly 
involving the central part of the hard palate and the alveolar ridge. 
 
2.3.3.3  Treatment of Denture Stomatitis 
Treatment of denture stomatitis includes improvement in oral and denture hygiene, 
correction of denture faults, relieving of stresses on the mucosa by tissue 
conditioners and prescription of antifungal drugs. Although several methods are 
used for treatment, there are three major approaches used widely which are 
(Wilson, 1998; Chow et al., 1999; Uludamar et al., 2010): 
1. Effective cleaning of dentures using denture cleansers. 
2. Concentration of the treatment with antifungal drugs on the palate. 
3. Replacing the dentures with new ones or using tissue conditioners to reduce 
the trauma. 
Tissue conditioners have been studied as potential drug delivery vehicles, to deliver 
anti-fungal drugs directly at the site of infection (Sample, 2001; Geerts et al., 2008; 
Radnai et al., 2009; Falah-Tafti et al., 2010; Urban et al., 2014). This role is further 
discussed in the drug delivery section  2.7.3. 
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2.3.4 As Functional Impression 
According to Razek (1979) “a functional impression material is one which is applied 
to the basal surface of a denture to make an impression under functional stress”. It 
has been found that tissue conditioners are useful in taking a functional impression 
of the edentulous arch where they are kept in the mouth for 24 hours (Razek, 1979; 
Harrison, 1981; McCarthy and Moser, 1978). 
 
2.3.5 Other Uses 
Tissue conditioners have also been used in a variety of different applications due to 
their compliant viscoelastic properties. They include (Frisch et al., 1968; McCarthy 
and Moser, 1978; Loh and Tan, 1986): 
• As immediate surgical splints 
• As stents for haemophiliacs 
• As post-surgical periodontal packs 
• As obturators for surgical defects resulting from oral cancer removals 
• In cleft palate defects to aid in the speech 
 
2.4 Requirements of Tissue Conditioners 
International Organisation for Standardisation (ISO) defines some minimum and 
desirable requirements for the long term and temporary lining materials (ISO 10139-
1, 2005 and ISO 10139-2, 2009 respectively; ISO, 2009) . 
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The requirements for a tissue conditioner are as follows: 
1. It should be biocompatible i.e. nontoxic and non-irritant to both patient and 
dental staff. 
2. It should be tasteless and odourless. 
3. It should be quickly and easily processable using conventional dental 
techniques. 
4. It should be easy to clean and should be stable in the oral environment, 
especially in the presence of food, drinks or tobacco. Also denture cleansers 
should not have an effect on the lining as it has been found that these can 
have a dramatic effect on the mechanical properties of the materials leading 
to clinical failure (Braden et al., 1995). 
5. There should be no voids or porosity as these may be potential sites for 
microbial growth. 
6. The material should be dimensionally stable during its processing and use in 
the mouth. The water absorption should be low as high water absorption 
leads to swelling of the material resulting in dimensional change. This may 
lead to straining of the denture base interface, increase distortion and reduce 
bonding (Braden and Causton, 1971). Swelling also allows the ingrowth of 
microbial organisms. 
7. The material should not support the growth of microbial organisms especially 
C. albicans (Wright, 1980). C. albicans is part of the natural flora of the 
mouth and is a common etiological factor for denture related stomatitis 
(Arendorf and Walker, 1987).  
8. There should not be any leaching of constituents from the material, however 
if it does occur, it should be minimal. 
9.  The material should have adequate mechanical properties so that it can 
perform its purpose adequately and effectively i.e. it should have appropriate 
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viscoelastic properties and a low modulus but sufficient to withstand the 
masticatory forces. It should also maintain good adaptability to the contours 
of the ridges in the mouth so that its cushioning effect is maintained. 
10. The material should adhere well to the denture base to provide good 
stability. If there is weak bonding between the two materials then there may 
be separation of the two which may lead to poor hygiene due to difficulties in 
cleaning the denture. 
11. It should have good wettability so that a thin layer of saliva is formed 
between alveolar ridges and polymer base. This helps in lubrication of the 
surfaces resulting in better comfort and retention of the denture. Poor 
wettability may lead to increase in friction and thus tissue damage  (Wright, 
1981). 
 
Every material has some short comings and this is also true of current tissue 
conditioners currently available on the market when comparing their properties 
with the ideal properties. There are concerns regarding the biocompatibility of 
the constituents leached out of the materials. Most of the materials are in 
powder liquid format and mixing is done by a dentist or dental assistant.  
Although some manufacturers include measuring cups for dispensing powder 
and liquid, however the standardization of the correct ratio for mixing is difficult 
to achieve due to human errors which can lead to a material which does not 
have optimal properties. Mixing produces air bubbles which can be a potential 
site of growth for microbial organisms. Tissue conditioners are used in a moist 
environment so water absorption occurs in different amounts as each 
commercial material has different composition. The effects of these on different 
properties are discussed further in the literature review. 
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ISO 10139-2:2009 has classified the soft lining materials as “soft” if Shore A 
hardness is 25-50 and “extra soft” if the Shore A hardness is ≤ 25. Similarly the 
penetration ratio (R) i.e. the penetration at 30sec and 5sec determines the 
resistance to flow. Class I is high resistance to flow if R ≤ 1.1 and class II is low 
resistance to flow if 1.1 < R ≤1.75 (McCabe and Walls, 2008). Clinically tissue 
conditioners are used as temporary denture lining materials, as tissue 
conditioning materials and as functional impression materials. The optimal 
properties required in each clinical situation are summarized in Table  2.2 
(Murata et al., 1996; Craig, 1997; Gonzalez, 1977; McCabe and Walls, 2008). 
 
Table  2.2: Properties of tissue conditioners required in clinical uses 
Clinical 
Use 
Tissue 
Conditioning 
Temporary Denture 
Lining 
Functional Impression 
Properties 
Required 
Hardness 13-49 
 Penetration (R) 
Ratio: 1.1<R<1.75 
Hardness 20-25 
Penetration (R) 
Ratio: R≤1.1 
Relatively low hardness* 
Relatively high flow* 
*There are no specific values recommended for tissue conditioners as functional 
impression in the literature  
 
 
2.5 Composition of Tissue Conditioners 
As mentioned in section  2.2 tissue conditioners are composed of polymer powder 
and a liquid that contains plasticiser and ethanol.   
Literature Review 
45 
 
2.5.1 Polymer Powder 
Poly(ethyl methacrylate) PEMA (Figure  2.2) (Braden, 1970a) or a copolymer (e.g. n-
butyl methacrylate/ethyl methacrylate, BMA/EMA) (Parker and Braden, 1990), are 
the most common polymers used in  tissue conditioners. The type and class of 
polymer powder, its molecular weight, size and shape of polymer particles, affects 
the gelation process of tissue conditioners.  
 
 
Figure  2.2: Chemical Structure of PEMA polymer 
 
Glass transition temperature (Tg) of polymer powders can indicate which types of 
polymer powders are suitable for use in tissue conditioner formulations. Tg is the 
temperature where there is a sudden change in the physical properties especially 
elastic modulus of the polymer. At the Tg there is a clear change from brittle to 
ductile behaviour (Anusavice et al., 2012), where the material is brittle below its Tg 
and rubbery or ductile above it. It is necessary for a tissue conditioner to possess a 
Tg below mouth temperature so that it is sufficiently compliant for its intended 
purpose. Plasticisers are added to the monomers/polymers to lower the Tg of the 
resulting polymers. Therefore, a large amount of plasticiser would be required to 
lower the Tg of poly(methacrylates) to below mouth temperature compared to PEMA 
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(Jones et al., 1991), as seen by the Tg values of some poly alkyl methacrylates 
listed in Table  2.3  (McCabe, 1976). For use as tissue conditioners, polymers that 
have lower Tg values than ethyl methacrylate, are so soft at room temperature that 
their fine particles coalesce, and are therefore not conveniently dispensed in powder 
form (Table  2.3). So the choice of using a polymer powder is limited to those which 
form free running powders at room temperature (Tg above room temperature), but 
do not require too much of plasticiser for lowering the Tg to below mouth 
temperature. PEMA or a copolymer would be the best choice to use (McCabe, 1976; 
Braden et al., 1997). 
 
Table  2.3: Glass transition temperature of some methacrylate polymers and 
copolymers (McCabe, 1976; Parker and Braden, 1990) 
Polymers (methacrylates) Tg (
oC) 
Methyl  
Ethyl 
Propyl 
n-Butyl  
Isobutyl 
80/20 n-butyl/ethyl 
60/40 n-butyl/ethyl 
50/50 n-butyl/ethyl 
105 
65 
35 
20 
70 
37.3 
40 
46.3 
 
Solubility parameters (δ) are also an important factor in the use of PEMA in tissue 
conditioners. PEMA has δ values in the range of the alcohols listed in Table  2.4. The 
latter swell the polymer beads whereas they are unlikely to do so in PMMA. Poly (n-
butyl methacrylate) has a similar δ to PEMA but it’s very low Tg limits its use as it 
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does not form a free-running powder. Also from the δ values for the plasticisers, 
PEMA is a much better choice as its δ value is in a similar range (Table  2.4).    
 
Table  2.4: Solubility parameters of Tissue Conditioner components (Jones et 
al., 1986; Parker and Braden, 1990; Murata et al., 2005)  
Polymer 
δ 
(J/m3)½ 
Plasticiser 
δ 
(J/m3)½ 
Poly (methyl methacrylate) 0  Benzyl salicylate (BS) 22.54 
Poly (ethyl methacrylate) 19.4-
23.3 
Acetyl tributyl citrate (ATBC) 18.74 
Poly (n-butyl methacrylate) 15.1-
22.7 
Acetyl trihexyl citrate (ATHC) 18.21 
Alcohol  Acetyl triethyl citrate (ATEC) 19.19 
Ethanol 26.0 Tributyl citrate (TBC) 19.01 
n-Hexanol 21.9 Triethyl citrate (TEC) 19.32 
n-Octanol 21.1 Dibutyl sebacate (DBS) 17.8 
Cetyl alcohol 16.2 Dibutyl phthalate (DBP) 19.2 
  Benzyl benzoate (BB) 21.98 
  Butyl benzyl phthalate (BBP) 18.67 
  Butyl phthalyl butyl glycollate 
(BPBG) 
21.56 
 
The choice of the type of polymer or copolymer used depends not only upon the Tg 
but also on the rate of absorption of the solvent. PEMA (or copolymers based on this 
polymer) give reasonable products because of the speed of dissolution in ethanol; 
poly (methyl methacrylate) (PMMA) is not suitable because it is only swollen (not 
dissolved) slowly by ethanol. So PEMA or related copolymers are the most suitable 
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materials in producing tissue conditioners (Braden, 1970a). The role of polymer 
powder in tissue conditioners is further discussed in section  2.6. 
 
2.5.2 Plasticisers 
Plasticisers are generally described as substances added into a material to increase 
the flexibility, workability and softness of the material. Plasticisers are typically high 
boiling, oily organic liquids which are usually colourless and odourless (ECPI, 1999). 
 
Plasticisers penetrate between polymer chains, reducing the intermolecular forces, 
so that the individual chains can slip past one another more easily. Their use in 
tissue conditioners allow gelation to occur by polymer chain entanglement producing 
a soft gel that is able to provide a cushioning effect (Braden, 1970a; Jones et al., 
1986).  
 
As plasticisers are not bound chemically to the polymer, they leach out of the tissue 
conditioner during usage in the mouth (Wilson, 1995).  As a result of this, they 
gradually become hard and need to be replaced regularly and so have a limited 
lifetime in the mouth (Jones et al., 1988). 
 
Plasticisers currently commonly used in tissue conditioners can generally be divided 
into two different groups i.e. phthalates and citrates, which will be discussed below. 
Other plasticisers are also used including benzyl salicylate (BS), benzyl benzoate 
(BB), and dibutyl sebecate (DBS) (Murata et al., 1997; Murata et al., 1993). 
Literature Review 
49 
 
 
2.5.2.1 Phthalate Plasticisers 
Phthalates are esters of phthalic acid and are commonly used in the plastic industry. 
They are used in many daily products ranging from footwear, electric cables, 
stationary, toys to life saving medical devices e.g. medical tubing and blood bags 
(ECPI, 1999).  Many commercial tissue conditioners contain di-n-butyl phthalate 
(DBP), butyl phthalyl butyl glycollate (BPBG) (Figure  2.3), and butyl benzyl phthalate 
(BBP) as plasticisers (Jones et al., 1988; Murata et al., 1997). Table  2.5 shows 
some commonly used plasticisers in commercial tissue conditioner formulations.  
 
 
 
 
Figure  2.3: Chemical Structure of Butyl phthalyl butyl glycollate  
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Table  2.5: Some commonly used plasticisers in tissue conditioners (Jones et 
al., 1986; Takamata et al., 2007; Jepson et al., 2000) 
Plasticisers Abbreviation 
Commercial 
Tissue 
Conditioners 
Molecular 
Weight (g/mol) 
butyl phthalyl butyl glycolate BPBG 
VG, FS, DS, GC 
and CL 
336 
butyl benzyl phthalate  BBP HC and TC 312 
di butyl phthalate DBP CC, CS, GC,VG 278 
benzyl salicylate BS CS 228 
Benzyl benzoate BB CC 212 
Viscogel (VG; Dentsply), Fit Softer (FS; Dentsply-Sankin), Denture Soft II (DS; 
Chem. Ins Co), GC-Soft Liner (GC; GC Dental Industry), Caulk Lynal (CL; L.D. 
Coulk), Hydro Cast (HC; K.C Dental Mfg Co), Tissue conditioner (TC; GC Co), Coe-
Comfort (CC; Coe lab Inc), Coe-Soft (CS; GC America) 
 
One of the main issues is the leaching of phthalates from the material which is 
further discussed in section  2.6.4.2, giving rise to concerns with the biocompatibility 
which is discussed further in section  2.5.2.3.  
 
2.5.2.2 Citrate Plasticisers 
Citrate esters are all derived from citric acid, a tribasic monohydroxy acid that is 
found naturally in citrus fruits. Citric acid is commonly used as a flavouring agent, in 
several food and beverage products like pudding, cake mixes and soft drinks (Frank, 
2005). They are made by esterification and acetylation of long chains of esters 
where the hydroxyl group is reacted to form acetyl or butyryl derivatives (Wilson, 
1995). Generic formula for the citrate esters is shown in Figure  2.4 and some 
commonly used citrates are given in Table  2.6. 
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Figure  2.4: Generic formula for the citrate esters (R and R' are defined in 
Table  2.6) 
 
Table  2.6: Some commonly used Citrate plasticisers (Morflex, 1996) 
Generic Name Abbreviation R' R 
Molecular 
Weight (g/mol) 
Triethyl Citrate TEC H Ethyl 276 
Acetyltriethyl Citrate ATEC OAc* Ethyl 318 
Tri-n-butyl Citrate TBC H n-Butyl 360 
Acetyltri-n-butyl Citrate ATBC OAc* n-Butyl 402 
Acetyltri-n-hexyl Citrate ATHC OAc* n-Hexyl 486 
n-Butyrltri-n-hexyl Citrate BTHC OBu** n-Hexyl 514 
* OAc = Acetate (CH3COO
-), ** OBu = Butyrate (C4H7O2
-) 
 
Among other citrate plasticisers, acetyltri-n-butyl citrate (ATBC) has been shown to 
be safe by the U.S. Food and Drug Administration (Lehman, 1951). ATBC, Acetyltri-
n-hexyl citrate (ATHC) and n-Butyryltri-n-hexyl citrate (BTHC) are used in medical 
devices (Morflex, 1996). ATBC is specifically recommended for medical devices and 
other sensitive applications whereas ATHC and BTHC are intended primarily for use 
as plasticisers for medical plastics (Morflex, 1996). Examples of these citrates 
R' — O — C —COOR 
CH2COOR 
CH
2
COOR 
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include aqueous-based pharmaceutical coatings, extra corporeal tubing, blood bags, 
I.V. solution containers and catheters (Morflex, 1996).  
 
Among the citrates ATBC is one of the leading alternatives to phthalates currently 
being investigated. Recently, in late 2010, the manufacturers of VG introduced a 
new formulation to the market where they have substituted BPBG with a citrate 
plasticiser (Dentsply, 2014). 
 
In a comprehensive study by Dhiman (2004), a range of citrate based plasticisers 
were used, with increasing molecular weights, as potential replacements for the 
traditional phthalate plasticisers. Mechanical properties, water absorption, 
solubilities and gelation characteristics were studied compared to three commercial 
materials namely VG, CC and GC. From the results Dhiman recommended high 
molecular weight citrate plasticisers as good substitutes for conventional phthalates 
used in commercial tissue conditioners. 
 
2.5.2.3 Biocompatibility of Plasticisers 
The biocompatibility of phthalates is questionable as from different studies it has 
been shown that they have toxic effects; they may be cytotoxic (Okita and Hensten-
Pettersen, 1991), or in some cases, like butyl benzyl phthalate, they may be 
carcinogenic (Ellis et al., 1979). In addition, the European Union Regulation 793/93 
(2006) has also limited the use of certain phthalate plasticisers including BPBG 
because of its toxic effects. 
 
Literature Review 
53 
 
According to a study by Okita and Hensten-Pettersen (1991), all four phthalate 
containing commercial tissue conditioners studied, namely VG, CC, KF and GC, 
showed cytotoxicity. However CC and KF were more cytotoxic than GC and VG. 
Mouse fibroblasts were used to check the cytotoxicity up to 15 days according to the 
ISO technical report 7405-1984. CC contains BB (87%) and DBP (4.5%), KF 
contains DBP (85%), GC contains BPBG (80.9%) and DBP (8.9%) and VG contains 
BPBG (94.6%) as listed in Table  2.1 (page 36) and Table  2.5 (page 50). 
 
Some phthalate plasticisers such as DBP and BBP have shown estrogenic activity 
in the human body. These plasticisers have an effect on estrogen receptors due to 
their chemical structure, especially the phenolic rings (Jobling et al., 1995). An in 
vitro study conducted by Hashimoto et al. (2003), on four commercial tissue 
conditioners, namely CC, TC, HC and Denture Soft, tested estrogenic activity using 
E-screen test and MCF-7 estrogenic tests. The number of cells was assessed by 
measuring total protein content using sulforhodamine B assay. Cell proliferation 
indicated estrogenic activity. Results showed estrogenic activity in all four 
commercial materials containing phthalate plasticisers, as shown in Table  2.1 (page 
36) and Table  2.5 (page 50).  
 
Tay et al. (2012) studied the effect of water storage and heat treatment on 
cytotoxicity of different denture liners including a tissue conditioner (Dentusoft) 
containing DBP. The cytotoxicity was measured by immersion of specimens in 
distilled water at 37°C for 24 and 48 hours. A quantitative method was used to 
measure the number of viable cells of mouse fibroblasts. The study concluded that 
Dentusoft alternated between slight cytotoxic to non-cytotoxic materials with 75% 
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cell viability in average over 48 hours. Storage in water and heat treatment had no 
effect on the cytotoxicity. 
 
Cytocompatibility of the citrate plasticisers is well established in the literature 
(Morflex, 1996). In general the citrates have an image of being non-toxic due to the 
fact that citric acid is a naturally occurring product in citrus fruits and also as 
carbohydrates of human metabolites (Wilson, 1995). Among the citrates ATBC is a 
prime candidate currently being investigated as substitute for phthalates.  
 
Nishijima et al. (2002) conducted a study to examine the estrogenic activity of ATBC 
compared with conventional phthalates using three estrogenicity assays (i.e. yeast 
two hybrid system assay, competition binding assay and E-screen assay), and 
cytotoxicity on human gingival fibroblast and living skin equivalent. They looked at 
the acute toxicity, mutagenicity, carcinogenicity and reproductive toxicity, and found 
that ATBC was more cytocompatible than the other plasticisers used in commercial 
tissue conditioners and it also had no estrogenic activity. Estrogenicity is related to 
the phenolic compounds (presence of benzene ring) (Jobling et al., 1995; 
Hashimoto and Nakamura, 2000). Phthalate plasticisers, such as BPBG, have a 
benzene ring in their structure as shown in Figure  2.3 and citrate plasticisers are 
aliphatic as shown in Figure  2.4 hence they show no estrogenic effect. The authors 
also suggested ATBC as a candidate for replacement of phthalates plasticisers in 
tissue conditioners (Nishijima et al., 2002), since they found no estrogenic effect 
with it. 
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Meyers et al. (1964) studied the toxicity of TEC, ATEC, TBC, and ATBC in rats, 
mice, frogs, and rabbits for 2 weeks. Histopathological examinations revealed no 
damage to the liver, kidney, lungs, and spinal cord in the animals. Johnson Jr (2002) 
assessed the safety of ATEC, ATBC, ATEC and acetyl trioctyl citrate in cosmetic 
products. He reviewed different studies on acute, short-term, sub-chronic and 
chronic oral toxicity, neurotoxicity, cytotoxicity, genotoxicity and carcinotoxicity of 
these materials and concluded that they were safe for use. Similarly Hirata-Koizumi 
et al. (2011) focused on the effects of 6 different plasticisers, including ATBC and 
TBC, on the oral exposure, and ATBC was found to be least toxic among all 
plasticisers.   
 
Thus it can be said that citrate plasticisers, especially ATBC, are safe to use as an 
alternative to the phthalate plasticisers. 
 
2.5.3 Ethanol 
The physical properties of a tissue conditioner do not only depend on the choice of 
the plasticiser used, but also on the amount of ethanol used. Ethanol, a highly polar 
molecule, is a necessary additive as it rapidly swells the polymer powder and 
facilitates its dissolution in the plasticiser. The amount of ethanol required to 
produce a clinically acceptable gelation time depends upon the particle size and 
molecular weight of the polymer (Braden, 1970a). Takamata et al. (2007) showed 
that ethanol content in various commercial tissue conditioners varied from 13.9% to 
0.4%. 
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The ethanol can also influence water absorption where a high ethanol content will 
result in higher absorption (Braden and Causton, 1971; Jones et al., 1988). A high 
ethanol content will also result in greater weight loss and shrinkage of the material 
because the plasticiser leaches more readily, thus leading to more rapid hardening 
of the material, in water or in the oral environment (Harrison, 1981).  Furthermore, 
the leached ethanol can irritate the oral mucosa, whereas some patients find the 
taste and sensation of the ethanol objectionable. Also use of ethanol (alcohol) is 
also forbidden in many religions like Islam (Quran 5: 90-91). Hence Braden (1970b) 
considered reducing the ethanol content in the material; however lowering the 
ethanol content increased the gelation time (Murata et al., 1994; Murata et al., 
2001a). The effect of ethanol on the properties of tissue conditioners is further 
discussed in section  2.6. 
 
There had been some concerns about ethanol as a risk factor for carcinogenicity 
and in February 2007, the WHO’s International Agency for Research on Cancers 
classified that ethanol in alcoholic beverages was carcinogenic to humans. 
However, ethanol containing products such as mouthwashes and dental products 
are safe to use when intended for a short period of time (Braden, 1968; 
Lachenmeier, 2008; Lachenmeier et al., 2009). Tissue conditioners are only used as 
temporary denture lining materials, up to 3 months in the mouth (Graham et al., 
1991b) and as there is complete leaching of ethanol in the first 24 hours (Jones et 
al., 1988), they are considered to be safe to use (Nishijima et al., 2002). 
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2.6 Properties of Tissue Conditioners 
2.6.1 Gelation 
The gelation of tissue conditioners is important in determining the handling 
characteristics of the material indicating how much time the dentist has to apply it to 
the denture and to adapt to the oral contours.  
 
The gelation of tissue conditioners has previously been characterized by using a 
reciprocating rheometer (Jones et al., 1986) and oscillating rheometer (Murata et al., 
1993; Murata et al., 1998b; Li, 2007; Hassan, 2007). Gelation is rheologically 
described by three stages i.e. pre-gelation (sol), sol-gel transition and post-gelation 
(gel) (Murata et al., 2005). Gelation begins when the powder is mixed with the liquid. 
Initially ethanol swells the polymer beads allowing penetration of the plasticiser. The 
result is polymer chain entanglement and the formation of a physical gel (Parker and 
Braden, 1990).  
 
There are many factors that affect the gelation time. These include the amount of 
ethanol, molecular weight of the polymer powder, ball milling the polymer powder, 
the class of the plasticiser, powder to liquid ratio and temperature. These are 
discussed subsequently. 
 
Ethanol content plays an important part in gelation process. Increasing the amount 
of ethanol decreases the gelation time. In a study conducted by Parker and Braden 
(1990) it was shown that by using 60/40 BMA/EMA copolymer powder with BPBG 
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the gelation time was decreased from 63 min to 31.5 min when the ethanol content 
was increased from 2% to 4%. Similarly, in 2001, the same authors showed that the 
gelation time of VG was decreased from 16 min to 6 min when the ethanol amount 
in the liquid containing BPBG was increased from 4% to 8% (Parker and Braden, 
2001). The effect of ethanol on gelation time has also been reported by other 
authors and all are in agreement that increasing the ethanol content decreases the 
gelation time (Dhiman, 2004; Li, 2007; Parker and Braden, 1996; Jones et al., 
1986). 
 
Braden (1970a) showed that a smaller particle size of polymer powder needed less 
ethanol than a larger particle size polymer powder in order to achieve a similar 
gelation rate. One simple way of altering the particle size and surface morphology 
was by ball milling the polymer powder. It has been shown that the gelation rate was 
increased by using ball milled polymer powder that produces finer and more 
irregular powder particles (Parker and Braden, 2001). In addition, ball milling had a 
larger effect on PEMA, on both size and regularity of shape of powder particles, as it 
has a higher Tg than the BMA/EMA copolymer. Heat will be generated during ball 
milling and the copolymer powder particles, having a lower Tg may have been 
distorted rather than be ground (Parker and Braden, 1996). Ball milling polymer 
powder increased the surface area thus facilitating gelation.  
 
Using Scanning Electron Microscopy Dhiman (2004) showed that the ball milled 
powder had more irregular shaped particles and additional sites of agglomeration. 
Irregular particles have higher surface area compared to the surface area of 
spherical particles. The 4 hours and 16 hours ball milled powders had a lower 
particle size diameter than the un-ball milled powder. All these modifications led to a 
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shorter gelation time for a tissue conditioner (Dhiman, 2004). Ball milling of the 
polymer powder not only increased the surface area of polymer particles but it was 
shown by Parker and Braden (1996) to also decrease the activation energy of the 
gelation process. This can be very useful in making formulations with reduced 
ethanol content that will  gel in an acceptable time (Parker and Braden, 1996).  Ball 
milling can reduce the gelation time from 82 min to 9.5 min when the PEMA powder 
was ball milled for 1 hour and 56 hours (Parker and Braden, 1990). 
 
The molecular weight of the polymer powder also affects the gelation time. Use of a 
higher molecular weight polymer powder will lead to slower penetration of ethanol 
and plasticiser. Thus more ethanol is needed to control the appropriate gelation time 
for clinical use (Braden, 1970a). Murata et al. (1993) used different weight average 
molecular weight (Mw) PEMA polymer powders and mixed them with BPBG. Their 
results showed that the polymer powder with Mw between 9.4x10
4 and 56.1x104 
provided appropriate gelation times and gel strength. It was shown that using Mw of 
9.4 x 104 to 56.1 x 104 could reduce the gelation time from 1.57 min to 0.67min 
using 70%BPBG and 30% ethanol in 1.5 P/L ratio.  
 
Copolymerisation of ethyl methacrylate with n-butyl methacrylate would change the 
Tg of the polymer. Parker and Braden (1996) showed a reduction in gelation time 
using copolymer of BMA/EMA. When 50/50, 60/40and 80/20 BMA/EMA copolymer 
were mixed with 4% ethanol and BPBG, the gelation times of these formulations 
were found to be ~58 min, ~32 min and ~4 min respectively.  
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Jones et al. (1986) reported that molecular weight or molar volume of plasticisers 
influenced the gelation. The formulations of tissue conditioners that contain 
plasticisers of higher molar volume were found to give longer gelation times.  
(Parker and Braden, 1990; Li, 2007). A higher powder to liquid ratio resulted in a 
shorter gelation time and increased gel strength (Murata et al., 2001a; Li, 2007; 
Dhiman, 2004). 
 
The gelation time can be affected by changing the temperature of the tissue 
conditioner, especially in the range of 20 – 40oC. This property is important in 
clinical use of the tissue conditioner as the material has shorter gelation time at 
mouth temperature than at room temperature (Parker and Braden, 1996). 
 
Gelation time is a critical property for the clinical use and a number of factors play a 
vital role in giving a clinically acceptable gelation time. Some of them are controlled 
by the user like powder to liquid ratio, which can eventually alter the ethanol amount. 
Dentists, dental assistants/nurse usually alter the recommended powder liquid ratios 
to suit their need (quick gelation) but don’t realize that the properties of the materials 
are also changed. One alternate could be a pre-gelled material which can save the 
dentist time and the resulting material will have consistent properties. 
 
2.6.2 Hardness and Compliance  
Softness is a major factor in the clinical efficacy of the tissue conditioner. During use 
in the mouth the material should be soft enough not to harm the underlying soft 
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tissues. The softness of a material can be represented by its compliance or 
hardness value. 
 
Compliance is a measurement associated with the depth of deformation. The higher 
the value of compliance the softer is the material. Hardness, on the other hand is the 
resistance to deformation. The lower the value of hardness the softer is the material.  
 
Compliance can be measured using the formula (Graham et al., 1990): 
stressth
compliance
1
×
∆
=        Eq 2.1  
where ∆ = depth of penetration of indentor 
th = the total thickness of the specimen  
stress is defined as “force per unit area” (Graham et al., 1990). 
The standard methods for measuring the hardness of elastomers and polymers use 
either Shore A and D, or the International Rubber Hardness Degree (IRHD) 
methods N, H, L and M; these test methods are specified in ISO 868 (ISO, 2003) 
and BS 903/ISO 48 (BS, 1995) respectively. 
   
Shore hardness specifies procedures for measuring the hardness of materials by 
means of a durometer of two types: type A for softer materials and type D for harder 
materials (ISO, 2003). The method allows measurements at variable times for 
penetration of indentation. The hardness is inversely related to the penetration and 
is dependent on the modulus of elasticity and the viscoelastic properties of the 
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material (Mohamed and Aggag, 2003). The shape of the indenter, the force applied 
and the duration of test affects the outcome of the results. The Shore durometer is 
made up of a reference presser foot, an indenter, an indicating device and a 
calibrated spring that produces force on to the indenter (Basfar, 1997). The units of 
hardness range from 0 for full penetration of the indenter to 100 for no penetration. 
The Shore A hardness test is a popular test for elastomeric biomaterials, such as 
impression materials, soft lining materials, and tissue conditioners. 
  
Measuring Shore A hardness of specimens is affected by the thickness of the 
specimens (Siddiqui et al., 2010). In a study by Canay et al. (1999) Shore A 
hardness was measured and it was acknowledged that the thickness of the 
specimens would affect the hardness results. Yahya (2003), Ali (2010) and Siddiqui 
(2010) showed that increasing the thickness from 1 to 6 mm of the material 
decreased the hardness values, and that there was not much change in the 
hardness values when the thickness was increased further. This is because the 
depth of penetration of the indenter into the material is restricted by the hardness of 
the underlying material when there is insufficient thickness. However in a clinical 
situation 2 to 3 mm thickness of tissue conditioner was recommended by Wright 
(1976) for its optimal use. On the other hand Murata et al. (2009) suggested that 
tissue conditioners are optimally compliant at a thickness of 1.5 to 2 mm.  When 
comparing different studies the thickness should be taken into account as higher 
values may not be true values when using smaller thickness specimens in order to 
simulate the clinical conditions.  
 
Starcke and his team (1972) used Shore A durometer as part of a study to evaluate 
the physical properties of a  tissue conditioning material to be used as a functional 
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impression. It was shown that the Shore A hardness of commercial materials (HC, 
CC, Tempo and Treatment Liners) increased gradually from 30 min to 24 hours, 
which is the recommended duration for functional impression materials. The Shore 
A hardness values of HC were 5.0 and 12.8, for CC 3.6 and 6.4, for Tempo 14.0 to 
25.2 and for Treatment liners 18.4 and 49.2 at 30 min & at 24 hours respectively. In 
this study specimens use only 2.4 mm thick, which will not give the exact hardness 
value as thickness has more effect on lower Shore A hardness values and also at 
30 min the gel formation might not be completed leading to lower Shore A hardness 
values. 
 
Murata et al. (1996) studied the effect of change in compliance of different tissue 
conditioners namely CC, CS, GC and VG, in a number of solvents, over a period of 
28 days at 37°C. The immersion solutions were distilled water (DW), 
10%acetone/90%water, 20%acetone/80%water and hexane. The highest reduction 
in compliance (~50%) was seen in hexane compared with other solutions and the 
majority of the changes in compliance were seen in first week. Hence there is a 
need to change the material within a few days of use in mouth.  
 
Yahaya (2003) reported the effect of storage in DW, artificial saliva (AS) and olive oil 
on Shore A hardness, over a period of 5 weeks, using VG and experimental tissue 
conditioner formulations containing 50/50 BMA/EMA copolymer with 2% ethanol and 
ATBC. The Shore A hardness increased the most in VG specimens immersed in 
olive oil followed by DW and then AS. The experimental tissue conditioner 
specimens showed an increase in Shore A hardness in olive oil followed by DW but 
Shore A hardness decreased in AS. This was because the plasticisers used, had 
higher solubility in olive oil compared to other immersion solutions.  
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Ali (2010) used two experimental tissue conditioners containing PEMA powder with 
5% ethanol and BPBG, or 5% ethanol and ATBC. Shore A hardness of these 
formulations was studied for 84 days at 37°C when immersed in DW, AS, 25% 
ethanol/75% water, 3% citric acid and coconut oil. The results showed that Shore A 
hardness increased with time in all solutions, with the highest increase in coconut oil 
for both materials, whereas the lowest changes were found in AS. The increase in 
Shore A hardness was more rapid during the first week followed by a gradual 
increase. Both studies by (Yahaya, 2003) and (Ali, 2010) are in agreement that 
Shore A hardness is effected most by oil based immersion solutions and lowest 
changes were found in AS.  
 
Shanmuganathan et al. (2012) studied the compliance of VG, CS and GC for 4 
week in vivo using a penetrometer. Compliance was measured at 2 hour, 24 hours, 
1 week and 4 weeks. They found significant changes in compliance during the test 
period for all materials. The reduction in compliance depends upon the base line 
value of the material. CS showed lowest change in compliance (4.783 to 1.781) 
whereas GC showed the greatest change (4.608 to 0.592) followed by VG (3.785 to 
0.489), at 2 hours to 4 weeks. These changes were linked to the leaching out of 
ethanol and plasticiser from the material which were measured using HPLC in vitro. 
They concluded that the loss of compliance was due to loss of plasticiser rather than 
ethanol and that using a large molecular weight plasticiser will result in lower 
change. 
 
The effect of addition of antifungal drugs on Shore A hardness has been reported in 
a number of studies. Urban et al. (2014) used Softone, a tissue conditioner and 
Truesoft, a resilient liner and added Nystatin (500000 Unit, 1000000 Unit), 
Literature Review 
65 
 
Miconazole (125mg, 250mg), Ketoconazole (100mg, 200mg), CHD (5%, 10%) and 
Itaconazole (100mg, 200mg) respectively, as antifungal agents. The Shore A 
hardness of these formulations was measured at 24 hours, 1 week and 2 weeks 
when immersed in DW at 37°C. The hardness of both materials increased with time 
and when the amount of incorporated drugs was increased.  
 
Bertolini et al. (2014) incorporated 0.5%, 1% and 2% CHD in two commercial 
materials namely CS and Truesoft. The Shore A hardness was measured over 7 
days when immersed in water at 37°C. The Shore A hardness increased with time in 
both materials. The increase in amount incorporated did not have an effect on CS 
where the Shore A hardness of the formulations with different CHD percentages 
was ~10 and, after 7 days, the increase was ~20. Truesoft had an increase in Shore 
A hardness from ~7 in 0%CHD to ~12.5 in 2% CHD and after 7 days all formulations 
had hardness of about 22. The authors attributed the difference in Shore A hardness 
between the two materials to the difference in polymer powders used in them but 
failed to explain the effect of CHD 
 
 In an in vivo study by Graham et al. (1990) compliance of CC, a tissue conditioner 
and Veltec, a soft lining material was measured. Ten patients with complete 
dentures were included in this study. Denture liners were applied and 
measurements were taken at 1 hour, 24 hours, 48 hours, 7 days 14, days and 30 
days. There was a significant reduction in the compliance of the two materials at 24 
hours from 1 hour measurements, and there was no significant difference between 
the two materials for up to 14 days of clinical use. The compliance of CC was 
measured on day 30 only and no explanation was given why the measurement for 
Veltec was not taken on day 30. 
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Hardness measurements can be used to calculate Young’s modulus values. The 
indentation produced in the case of elastomers is elastic in nature. Depending upon 
the type of test, the indentation is either flat-ended for Shore or spherical for ISO 
hardness testing (Meththananda et al., 2009). So the appropriate equation for the 
relation between force (F), young’s modulus (E), radius of indenter (a), depth of 
indentation (w) and Poisson’s ratio (v), for a flat-ended indenter is (Timoshenko and 
Gudi, 1951): 
2
1
2
v
aEw
F
−
=        Eq 2.2 
Eq 2.2, and the following equations derived from it are for a semi-infinite solid. In 
practice it means the dimensions of an actual test piece need to be sufficient that 
the stress field produced by the indentation has decayed to zero at the bounding 
surfaces.  
Since elastomers are incompressible (Love, 1927), v= 0.5, and Eq. 2.2 becomes: 
aEw
F
3
8
=        Eq 2.3  
In the case of a spherical indenter the equation will be (Braden, 1968): 
( )2
2321
13
4
v
wEa
F
−
=        Eq 2.4 
for a rubber like material v=0.5 (Treloar, 1958), so Eq 2.4 becomes 
23
16
9
Eaw
F =        Eq 2.5 
Eqs 2.2 and 2.4 were originally derived by Hertz (1881). In these two cases the 
depth of indentation (w) against a constant force (F) is a direct function of E; there is 
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a direct relationship between Shore or ISO hardness and Young’s modulus 
(Meththananda et al., 2009). 
 
Gent (1958) investigated the relationship between Shore hardness and Young’s 
Modulus in detail and derived equation 2.6: 
( )
( )
( )s
s
MPaE
54.2254137505.0
66.7560981.0
−
+
=     Eq 2.6 
where s = Shore hardness 
Ideally, the hardness scale should convert a modulus range of 0 to ∞ into a 
hardness scale of 0-100. Eq 2.6 is valid for s=100 but not for s=0, and there are 
small deviations at s values under 40, given in Gent’s paper, based on BS 903 
(1950) (Meththananda et al., 2009). However Eq 2.7 does meet the criteria using 
error functions to generate a hardness scale as it is more accurate at lower levels of 
hardness. 
 
 Apparent Young’s Modulus can be calculated using the following equation based on 
BS 903 (1950) (Meththananda et al., 2009; Siddiqui et al., 2010) : 
( ) erfzkEerfH 100100 21 ==      Eq 2.7 
Where k= 3.186x 10-4 Pa-½.. Now z=kE½, hence: 
2
82
186.3
10×
=





=
z
k
z
E       Eq 2.8 
Where z is the value form erfz statistical table corresponding to H/100. 
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From the values of Young’s modulus compliance values can be calculated as 
ModulussYoung
compliance
'
1
=     Eq 2.9 
 
2.6.3 Viscoelasticity 
Many materials show a complicated behaviour that cannot be described as either 
being Hookean solids (where stress is directly proportional to strain) or Newtonian 
liquids (where stress is directly proportional to strain rate); these are termed 
viscoelastic. They can be modelled in order to determine their stress or strain 
interactions as linear combinations of springs (elastic component) and dashpots 
(viscous component). These models are used to predict the response of a material 
under various loading conditions and time. The elastic modulus of the spring 
represents the energy stored and the viscosity of dashpot as energy dissipated. The 
Maxwell model can be represented by a dashpot and spring connected in series. 
This model postulates that strain will increase linearly from t0 (when the load is 
applied) to t1 time (when load is removed) (Figure  2.5). A drawback of this model is 
that it does not predict creep accurately (Darvell, 2000).   
Literature Review 
69 
 
 
Figure  2.5: The strain response of a Maxwell model to a stress pulse (redrawn 
from Darvell, 2000) 
 
The Kelvin-Voigt Model is represented by a dashpot and spring connected in parallel 
and it postulates that when a constant load is applied at t0, the material deforms at a 
decreasing rate, asymptotically approaching the steady-state strain. When the load 
is released at time t1, the material gradually relaxes to its original state. Thus this 
model is extremely good at modelling creep in materials but is less accurate with 
regards to relaxation when the stress (load) is removed (Figure  2.6) (Darvell, 2000).  
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Figure  2.6: The strain response of a Kelvin-Voigt model to a stress pulse 
(redrawn from Darvell, 2000) 
 
A combination of Maxwell and the Kelvin-Voigt models gives a more accurate result 
in predicting material responses to applied force. This behaviour, where there is a 
combination of an instantaneous elastic deformation, a time dependent reversible 
deformation, and irreversible flow, all superimposed is called viscoelastic. The plot 
of strain against time when a load applied at t0 and removed at t1 in Figure  2.7 
shows all of these components present in a viscoelastic materials. When 
viscoelastic materials are subjected to a constant load, they experience a time-
dependent increase in strain. This phenomenon is known as viscoelastic creep. As 
shown in Figure  2.7, when the force (load) is applied at t0, the instantaneous elastic 
deformation is followed by an increase in strain with time. The Newtonian 
deformation continues until the load is removed at t1. On removing this load, the 
elastic strain is immediately recovered, followed by an exponential recovery of the 
strain. The Newtonian deformation cannot be recovered resulting in permanent 
strain (Figure  2.7) (Darvell, 2000). 
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Figure  2.7: The strain response of a viscoelastic model to the stress pulse 
(redrawn from Darvell, 2000) 
 
Viscoelastic behaviour of tissue conditioners is important in clinical use as it 
characterizes the ability of the material (see Table  2.2) to recondition abused tissues 
underlying ill-fitting dentures. Tissue conditioners flow viscously over a long period in 
response to the changes in the oral mucosa during resting, and behave elastically in 
response to rapid dynamic forces produced during chewing (Murata et al., 2002). 
 
Creep compliance is defined as “the change in strain as a function of time under 
instantaneous application of a constant stress” (Tweedie and Van Vliet, 2006). 
During creep test when strain is divided by stress, due to applied load, the creep 
compliance over time will characterize both elastic and viscous properties (Duran et 
al., 1979). 
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Viscoelasticity of materials is generally measured by either applying strain and 
measuring the stress or by applying stress and by measuring strain (Saitoh et al., 
2010). Viscoelastic properties have been measured in tissue conditioners in a 
variety of ways such as creep test (Wilson et al., 1966), stress relaxation test 
(Murata et al., 1998a),  Shore A hardness test (Dootz et al., 1993) and dynamic test 
(Murata et al., 2009). 
 
The viscoelastic properties of a tissue conditioner are influenced by number of 
factors. In a study by Murata et al. (1994), influence of ethanol and type of 
plasticiser on the viscoelastic properties of different tissue conditioner formulations 
was investigated. In the first part of the study 0, 10, 20 and 30% by weight of ethanol 
with BPBG to evaluate the influence of ethanol, then BPBG, DBP and BB with 10% 
ethanol were also mixed with PEMA powder to evaluate the influence of type of 
plasticiser. Using a stress relaxation test, measurements were taken at 8 and 24 
hours, 2, 4, 7, 21 and 28 days after mixing. A 10% strain was used to measure the 
changes in stress over a 30 min time period, where a reduction in stress indicated 
flow of the material. Materials with more ethanol showed more flow after gelation, 
but flow reduced rapidly with time of storage and with increasing the ethanol 
content. The formulation containing BB produced highest flow after gelation followed 
by DBP and then BPBG. This reflects the difference in molecular weight of the 
plasticisers where BB has the lowest molecular weight (212 g/mol) and BPBG the 
highest (336 g/mol). However the type of plasticiser used did not have any effect on 
the changes in viscoelastic properties with time.  
 
Murata et al. (1998c) then studied the influence of molecular weight of polymer 
powder and the effect of powder liquid ratio on the viscoelastic properties using the 
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same technique. In this study liquids contained either BPBG or BPBG with 10% by 
weight ethanol. PEMA powder with average Molecular weights (Mw), which varied 
from 9.4 x 104 to 56.1 x 104, and the P/L ratios varied from 0.6 to 1.5 g/ml. The lower 
Mw powder produced the highest flow, especially after long time periods, whereas 
the lower P/L ratios produced greater flow, both after short and long time periods. 
However no effects were seen on the viscoelastic properties between either the 
different Mw of the polymer, or the P/L ratios. Thus the authors suggested that the 
viscoelastic properties can be controlled for different clinical purposes by varying the 
composition of the tissue conditioners (Murata et al., 1998c).    
 
Jepson et al. (2000) studied the influence of dietary simulation solutions on the 
viscoelastic behaviour of CC, VG, Coe-Soft and GC soft-liner. The study was 
conducted for 4 week where the specimens were immersed in DW, 8% ethanol, 
50% ethanol and corn oil at 37°C. Creep compliance was measured using a 
pentrometer. The creep compliance reduced with time in all immersion solution 
however there was no consistency in pattern of reduction between the materials in 
different immersion solutions. The authors attributed the early reduction to the 
ethanol content and later changes to the loss of plasticiser. 
 
Saitoh et al. (2010) studied the viscoelasticity of three commercial tissue 
conditioners, namely Tissue Conditioner II, TC and Tissue Care. It was concluded 
that all three materials had different viscoelastic properties. Tissue Conditioner II 
showed the highest hardness and Young’s modulus followed by Tissue Care and 
then TC. Immersion in water showed increase in hardness and modulus of elasticity 
for all three materials. It was also concluded that among these three materials 
Tissue Care was best for use as a tissue conditioner as it showed the highest stress 
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relaxation, i.e. more flow, whereas the other two products were best suited as a 
functional impression materials. In this study a rheometer was used and equations 
reported by Kanie et al. (1992) were applied to calculate the hardness, modulus of 
elasticity and stress relaxation These results cannot be compared to the studies that 
used the standard methods for testing the hardness like Shore A or IRHD, which are 
the direct method of measurements.  
 
The required viscoelastic properties are different for different applications however 
tissue conditioners can be used in all three clinical situations i.e. for tissue 
conditioning, temporary soft lining and for functional impressions. The Shore A 
hardness and flow (creep) properties are shown in Table  2.2 (page 44). 
 
2.6.4 Water Absorption Characteristics 
Many materials absorb water by the process of diffusion when they are placed in an 
aqueous environment (Braden and Wright, 1983). Similarly the constituents of the 
material can also leach out by the same process of diffusion. Thus it is important to 
determine the water uptake characteristics so that long-term durability of the 
material can be assessed, not only in terms of its biocompatibility, but also in terms 
of its functionality (Parker et al., 1997b). Ideally tissue conditioners should have 
water uptake similar to PMMA denture base materials (~2%) (Stafford and Braden, 
1968). 
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2.6.4.1 Diffusion Processes in Polymers 
Diffusion into polymers, including the uptake of water generally obeys Fick's Laws 
(In, 1975). 
 
Fick's First Law states that the flux (F) (amount of material flowing per unit area at a 
given point) is proportional to the concentration (C) gradient: 
 
x
CD
F
∂
∂
−=        Eq 2.10 
 
where x is length of sample, and D is the diffusion coefficient. This latter property 
measures the speed at which the diffusing material moves through the medium and 
increases with temperature. 
 
Eq 2.10 is developed mathematically to give equations for concentration at various 
points throughout the material at given times. Finally, it can be used to predict how 
much material is absorbed or desorbed as a function of time, which is highly 
relevant to the work in this project. 
 
For a thin sheet of polymer the following equation applies for the earlier parts of the 
uptake experiment (Braden and Wright, 1983): 
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Mt is the mass absorbed (or desorbed) at time t, M∞  the final mass absorbed (or 
desorbed) when the process has equilibrated, and the thickness of the sample is 2L 
(i.e. L is half the thickness). This equation predicts that the mass change, when 
plotted against t½ will be a straight line. If so, the slope (s) of the line will be: 
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There are some diffusion processes that do not obey the above laws, and such 
behaviour is referred to as non-Fickian. The most important of these is termed Case 
II (Case I is Fickian diffusion), where mass change varies linearly with time. This 
occurs when the uptake is accompanied by relaxation of polymer chains. (Thomas 
and Windle, 1982). 
 
Some cases exhibit a combination of Case I and Case II; these are generally 
represented by the equation (Peppas, 1984): 
btatM
t
+=
21                   Eq 2.14 
Polymers can absorb water by different diffusion processes and it is possible for 
more than one process to be involved at a time (Kalachandra and Kusy, 1991). 
There are number of factors that may influence the water uptake of the polymers, 
which are described subsequently. The presence of hydrophilic groups in the 
polymers which can increase water uptake because of polar attraction (Fedors, 
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1980). Crosslinking also limits the water uptake of polymers. This is because the 
material is more rigid so it will resist swelling as chains will be less mobile (Baddour 
et al., 1965). Molecular weight of the polymer is another factor that affects the water 
uptake. It was shown by Turner (1987) that materials having higher molecular 
weight are packed less efficiently compared to the materials with lower molar weight 
polymers thus creating greater free volume which absorbs more water. Presence of 
water soluble components or impurities in the material will also lead to a higher 
water uptake (Fedors, 1980; Parker et al., 1997a). 
 
Muniandy and Thomas (1984) proposed that water uptake of elastomers is 
governed by water-soluble components within the polymer matrix that leads to a 
chemical potential gradient. When water molecules diffuse in (Parker and Braden, 
1989) they are attracted to any hydrophilic groups or water soluble impurities 
present in the material (CHD and NaF if added will act as impurities) (Sample, 
2001). A solution droplet starts growing around the hydrophilic group/impurity and 
creates an osmotic pressure gradient between the droplet and external solution 
which causes the material to expand or swell (Braden and Wright, 1983). The 
droplets continue to grow (Figure  2.8) and distort the material in the surrounding 
area until restrained by the material or the osmotic pressure gradient equalises 
(Muniandy and Thomas, 1984; Muniandy and Thomast, 1985; Braden and Wright, 
1983).  In tissue conditioners it is most probably the later due to their viscoelastic 
properties. 
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Figure  2.8: Representation of water uptake mechanism (Braden et al., 1997) 
 
2.6.4.2 Water uptake of tissue conditioners 
Water uptake study of tissue conditioners will give information on their behaviour in 
an aqueous environment. It also helps to study the leaching of ethanol and 
plasticiser from the material, thus giving a better understanding of the properties 
involved.  
 
When tissue conditioners are immersed in water, water is absorbed by the polymeric 
phase of the gel and ethanol and plasticiser leach out into the water (Braden, 1970a; 
Jones et al., 1988; Parker and Braden, 1990; Liao et al., 2012). In a study by Braden 
and Causton (1971), the material with a high ethanol content showed greater and 
more rapid weight loss from the gel, resulting in shrinkage. This was denoted by a 
steady loss in weight due to ethanol diffusion when the material was immersed in 
water. Thus the material with a low ethanol content exhibits less change in weight 
when immersed in water. These latter materials are more dimensionally stable and 
they remain compliant for longer periods of time. 
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The effect of ethanol content was studied by Dhiman (2004) in DW and AS. PEMA 
powder was mixed with ATBC containing 2% and 5% ethanol. Results showed that 
increasing the ethanol increased the weight change in both immersion media. 
However the effect was greater in AS compared to DW. The % real uptake in DW 
was ~4% and 4.5% respectively, whereas in AS it was ~1% and ~1.3 respectively. 
 
Murata et al. (2001b) studied the absorption, solubility and linear dimensional 
changes with time in DW, for a period of 21 days, of six tissue conditioner 
formulations including CC, VG, KF, GC, HC and SR-Ivoseal. The results showed 
that all materials, except SR-Ivoseal, had weight loss and shrinkage. The 
percentage solubility of all materials, except SR-Ivoseal, was higher than the 
percentage absorption. They also found that the dimensional changes were 
associated to the absorption and solubility, and there was a linear relationship 
between percentage changes in linear dimension and weight. The weight loss in the 
materials resulted from leaching of the ethanol and plasticiser. in SR-Ivoseal, the 
presence of a higher percentage of ethanol and a linear plasticiser (dibutyl 
sebacate) was attributed to its higher absorption and solubility. 
 
Liao et al. (2012) studied the effect of immersion of Eversoft and Vertex in DW and 
50% ethanol/DW solutions for a period of 52 weeks. Eversoft is a tissue conditioner 
containing DBP as plasticiser, whereas Vertex is a heat cured soft lining material 
containing ATBC as plasticiser. Results showed that Vertex and Eversoft had weight 
changes of ~2.7% and ~3.8% respectively in DW, whereas weight changes of 
~2.9% and ~5.7% respectively were recorded in 50% ethanol/DW. The authors also 
reported that the uptake plots of both materials in 50% ethanol/DW showed very 
similar characteristics with three distinct stages. First a rapid increase in uptake 
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followed by weight loss and finally weight gain. The rapid weight increase was 
thought to be due to absorption of ethanol from the solution whereas the weight loss 
was indicative of plasticiser leaching along with ethanol and, the last stage is 
indicative of the uptake process. 
 
Water absorption also encourages leaching of additives. Currently the main issue 
about the plasticisers used in dental tissue conditioners is their leachability, leading 
to concerns about potential toxicity (Okita and Hensten-Pettersen, 1991)  and 
gradual hardening of these gels (Yahaya, 2003). The leaching rate of plasticisers 
was dependent on the composition of the tissue conditioner; the amount leached 
was proportional to the original content of the different plasticisers (Munksgaard, 
2004). Currently there is more focus on using citrates as substitutes for the 
phthalate plasticisers of which ATBC is a prime candidate. This is due to the 
possible biocompatibility issues associated with phthalates as discussed in 
section  2.5.2.3 (page 52). 
 
 A commonly used method to measure the leachability of a plasticiser is by 
determining the weight loss of these materials, after immersing in different solutions, 
such as water, olive oil or artificial saliva, for a period of time (Ali, 2010; Ellis et al., 
1979; Braden and Wright, 1983). However, it is very difficult to determine the exact 
amount of plasticiser leached due to the complicated two-way exchange process 
between fluids and the tissue conditioner (i.e. the leaching of plasticiser and ethanol 
from the gel and the water uptake by the gel) (Jones et al., 1988; Braden and 
Causton, 1971; Liao et al., 2012). 
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The leaching behaviour of these plasticisers is assumed to be the opposite of the 
gelation process where they diffuse into the polymer structure when the gel forms. 
The data from the research of Jones et al. (1988) showed the amount of plasticiser 
leaching from soft lining materials was about 10-40 times more than the level of 
ester that would normally be obtained from food and environmental sources. It was 
also estimated that the maximum amount of phthalate ester leaching from a tissue 
conditioner was ~12mg/14 days, which is only one tenth of the most stringent ADI 
specified value for safety. It was also shown in the same study that the plasticisers 
with a low molecular weight, such as benzyl salicylate and benzyl benzoate, 
presented with higher leaching and that the leaching of phthalate esters was 
facilitated by ethanol (Jones et al., 1988). 
 
The leaching behaviour of a plasticiser has been shown by Graham et al. (1991b) to 
be higher in vivo than in vitro (immersed in DW) tests for two commercial materials, 
which used poly (ethyl methacrylate) polymer powder, gelled with ethanol and a 
phthalate ester. In this study, Coe-Comfort lost 31.1±12.4% mg/g average plasticiser 
in vivo compared to 13.41±1.11 mg/g in vitro, in 14 days. Veltec lost 11.8±3.3% 
mg/g average plasticiser in vivo compared to 8.47±0.73 mg/g in vitro at 30 days 
(Graham et al., 1991b). The in vitro tests were carried out in distilled water whereas 
in vivo the material would be exposed to saliva and various food stuffs. In vitro 
measurements, by Ali (2010), in food simulating fluids have shown plasticisers are 
more readily leached in fatty food substitutes such as coconut oil when compared to 
artificial saliva (AS), 3% citric acid and 25% ethanol/water mix.  
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Effect of additives on water uptake 
Tissue conditioners are widely studied as vehicles for delivery of anti-fungal drugs 
(Thomas and Nutt, 1978; Parker et al., 1997a; Chow et al., 1999; Radnai et al., 
2009; Urban et al., 2014) so the effect of incorporation of these drugs on the water 
uptake is also important. As explained in section  2.6.4.1 (page 75) when antifungal 
drugs are added they act as impurities which attracts more water molecules thus 
leading to an increased water uptake (Fedors, 1980; Parker et al., 1997a).  
 
Parker et al. (1997a) studied the effect of incorporation of 0.9% and 9% 
chlorhexidine diacetate (CHD) on the water uptake of two tissue conditioner 
formulations for a period of 4 weeks in DW at 37°C.  PEMA and an 80/20 BMA/EMA 
copolymer were used. The PEMA powder was mixed with a solution of 90% BPBG 
plasticiser and 10% ethanol, while the BMA/EMA powder was mixed with BPBG 
only.  The formulation containing PEMA powder showed water uptake of -0.49% in 4 
weeks, which increased to 2.55% and 9.6% when CHD was added at 0.9% and 9% 
respectively. Similarly BMA/EMA formulation had a water uptake of 2.3% which 
increased to 3.8% and 7.4% when CHD was added at 0.9% and 9% respectively. 
The authors concluded that addition of water soluble additives increased the water 
uptake and, the higher uptake in the case of the PEMA based material, was 
attributed to the presence of ethanol. 
 
Sample, in 2001, investigated ATBC as a substitute for phthalates in different tissue 
conditioners and as a potential drug delivery vehicle. ATBC was used with 2% 
ethanol and a 80/20 BMA/EMA copolymer powder with and without the addition of 
0.9% & 9% CHD.  He found that the ATBC containing tissue conditioner showed 
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lower water absorption compared to the two commercial tissue conditioners VG and 
CC, both containing phthalate plasticiser. The addition of CHD increased the water 
uptake of the material from 2.13% to 7.93% (for 0.9% CHD) and 72.39% (for 9% 
CHD) in 140 days of immersion in distilled water. CHD release shown in this study is 
much higher compared to the study reported by Parker et al. (1997a), however the 
difference between two can be attributed to the difference in ethanol content, 
plasticiser and time scale. 
 
Hassan (2007) studied the use of an ATBC based  tissue conditioner as a potential 
drug delivery system. The effect of incorporating CHD alone and in combination with 
sodium fluoride (NaF) on water absorption characteristics was compared to a 
conventional BPBG based tissue conditioner. Both formulations contained PEMA 
powder with 5% ethanol. Water uptake by tissue conditioners was increased with 
the addition of CHD, and when NaF was also added along with CHD, the water 
uptake increased further from ~5-7% (CHD only) to ~30-35% (CHD and NaF). 
 
The effect of additives (CHD and NaF) on water uptake in room temperature cured 
rigid lining materials has also been investigated. Sawtell et al. (1997) added 0.9% 
CHD into PEM/ tetra hydrofurfuryl methacrylate (THFM) system and showed that the 
equilibrium % uptake increased to ~2.8% compared to the control (~1.5%). Patel et 
al. (1998) showed that when 0.5% NaF was added to PEM/THFM polymer systems 
the % uptake of the polymers increased to ~65% in 250 days compared to control 
which was ~46%.  All these studies are in agreement that addition of additives 
increases the water uptake because of the increase in osmotic gradient between the 
immersion solution and the liquid within the polymer (Patel et al., 1998; Anusavice et 
al., 2006; Patel et al., 2001; Sawtell et al., 1997). 
Literature Review 
84 
 
2.7 Controlled Drug Delivery (CDD) 
The pharmaceutical industry has primarily consisted of simple, fast-acting chemical 
compounds that are dispensed orally (as solid pills and liquids) or as injections. 
However during the past three decades, time release medications that control the 
rate and period of drug delivery have been developed. These specifically target an 
area of the body for its treatment (Vogelson, 2001).  
 
There are many shortcomings in the current methods of drug delivery e.g. partial 
degradation of the drug in the body before it reaches its target site thus limiting its 
potency and therapeutic effect. Another shortcoming is patient compliance e.g. if the 
prescribed course is interrupted or discontinued, resulting in reoccurrence of the 
disease or there might be development of resistance for that drug. Thus there is a 
need for research into methods of drug delivery to administer pharmaceutical 
therapies. The safety and efficacy of current treatments may be improved if their 
delivery rate, biodegradation, and site-specific targeting can be predicted, 
monitored, and controlled. Therefore finding ways to administer medications by 
delivering costly, multiple-dose, long-term therapies in an inexpensive effective 
method of releasing them is also needed from both a financial and a global health 
care perspective. Administration methods that allow patients to safely treat 
themselves is as important as any other health care development (Vogelson, 2001; 
Vilar et al., 2012). 
 
Possible advantages of drug delivery vehicles over conventional systems are the 
ability to deliver a drug more selectively to a precise site; easier, more accurate, less 
frequent dosing; reduced variability in systemic drug concentrations; absorption that 
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is more reliable with the site and mechanism of action; and reductions in toxic 
metabolites (Okita and Hensten-Pettersen, 1991). 
 
2.7.1 Mechanism of CDD 
Polymeric controlled drug delivery systems can be divided into two methods i.e. 
temporal control and distribution control (Uhrich et al., 1999). 
 
2.7.1.1 Temporal Control 
In this method the drug is delivered over a period of time or at specific times during 
the treatment. This type of drug delivery is advantageous for drugs which have quick 
metabolism and elimination from the body as shown in Figure  2.9. The drug given 
by injection or orally metabolises and its concentration remains in the therapeutic 
window only for a short time until another dose is given. In contrast, the controlled 
drug release system, releases the drug such that the rate of release remains the 
same as the rate of drug elimination thus the concentration of the drug remains 
within the therapeutic concentration window and gives maximum benefits (Uhrich et 
al., 1999; Vilar et al., 2012). 
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Figure  2.9 Drug concentrations in conventional injection system against 
temporal control release system (Uhrich et al., 1999) 
 
The polymeric matrix protects the drug molecules until they can be released from 
the device. This can be achieved by three mechanisms (Langer, 1990; Uhrich et al., 
1999): 
• Diffusion controlled 
• Chemically Controlled 
• Drug solution flow control 
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 Diffusion controlled 2.7.1.1.1
It is the most simple and cheapest method of controlled drug release. The drug can 
either be stored in a polymer sac or distributed evenly within the polymer matrix.  
 
In the former method, a core of drug may be held in a polymer sac thus controlling 
release of the drug via the permeability of the polymer sac wall as shown in 
Figure  2.10. The release rate of the drug depends upon the thickness of the sac 
wall, solubility of the drug in the sac material and the concentration of the drug in the 
core (Langer, 1990). 
 
Figure  2.10: Reservoir System for Drug Delivery 
 
In the latter method, the drug is simply incorporated into the polymer matrix from 
where it diffuses out through the material into the surrounding environment 
(Figure  2.11). The rate of release of drug is dependent on the drug solubility (in the 
polymer and outside the medium), its concentration and the drug diffusion coefficient 
(Langer, 1990). 
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Figure  2.11: A matrix based diffusion controlled drug delivery system 
 
  Chemically Controlled  2.7.1.1.2
It is possible to design a drug delivery vehicle in which the drug is released when the 
vehicle encounters a specific trigger like a certain enzyme or a pH (Liechty et al., 
2010). One method is to bond the drug to the polymer backbone as a pendant 
molecule where the bond breaks by the action of water or a specific enzyme, thus 
releasing the drug. Another method is the use of biodegradable polymers, where the 
chemistry of the local environment can be used to deliver the drug. The drug is 
released as the polymer degrades (Figure  2.12). Several polymers, like poly 
lactic/glycolic acid copolymer, poly caprolactone, are used as biodegradable 
polymers to deliver drugs (Langer, 1990; Uhrich et al., 1999; Liechty et al., 2010). 
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Figure  2.12: Drug release by polymer degradation (Uhrich et al., 1999) 
 
  Drug Solution Flow Control 2.7.1.1.3
There are two types of mechanisms according to the type of flow control. One, 
where the drug is released when the polymer swells which is controlled by a solvent 
and the other, where drug is delivered due to the osmotic pressure gradient between 
the polymer and the solvent (Uhrich et al., 1999). 
 
In swelling systems, the drug is incorporated into the polymer matrix and when this 
polymer interacts with the environmental solvent (e.g. water based physiological 
fluids present in body), it swells and the polymer chains separate resulting in the 
release of the drug (Langer, 1990; Uhrich et al., 1999).  
 
Osmotic processes drive the later mechanism of a solvent controlled system 
(Figure  2.13). The water molecules cross the semipermeable membrane due to high 
osmotic gradient into the polymer. The drug is dissolved in the water and the 
pressure created by the water is relieved by the flow of the drug solution out of the 
polymer. The flow of the drug dissolved solution is restricted by fluid transport via 
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the size of the pores in the polymer thus controlling the rate of flow (Langer, 1990; 
Uhrich et al., 1999; Vilar et al., 2012). 
 
 
2.7.1.2 Distribution controlled 
In a distribution controlled system the drug is released where treatment is requird in 
the body (i.e. topical delivery). The advantage of this system is shown schematically 
in Figure  2.14, where a drug, when given by conventional methods like orally or by 
injection can only be used within the systemic window safely. To get the therapeutic 
effects the dose of the drug must be increased to the therapeutic window which is 
above the level where side effects occur so doing more harm in the body compared 
to the benefits. Thus by using distribution controlled system the therapeutic dose is 
administered at the required site of action thus the systemic side effect are avoided.  
Chemotherapeutic agents are a good example that can benefit from this system. 
Another advantage of this system is its uses for those drugs which cannot reach the 
site of action when delivered systemically due to natural barriers of the body e.g. a 
drug that cannot cross the blood brain barrier when distributed through blood, but 
acts on brain receptors, would be a good example (Uhrich et al., 1999). 
Figure  2.13: Drug molecules flow into environment through pore present in 
polymer (Uhrich et al., 1999) 
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Figure  2.14 Distribution controlled drug delivery system: drug concentration 
level at site of action vs systemic drug concentration level (Uhrich et al., 1999) 
 
2.7.2 Tissue Conditioners as a CDD System 
Tissue conditioners are ideal for controlled drug delivery systems because there is 
no chemical reaction during gel formation (Braden, 1970a). Any drug incorporated in 
the powder or liquid will remain unaffected as there will be no chance of change in 
the chemical structure, which may result from a chemically set material e.g. CHD 
decomposes when heated above 70oC, so in a heat cured material where the curing 
of polymer is carried out above 100oC the CHD will not be stable.  
 
In this system the drug is released by a simple diffusion process as shown in 
Figure  2.11. Release is governed by concentration gradient in the polymer matrix 
and its solubility in the solvent (Sample, 2001). 
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Tissue conditioners were used for the first time as a CDD by Douglas and Walker 
(1973) when nystatin was incorporated into commercial tissue conditioners as 
antifungal CDD systems. Since then they have been used as potential drug delivery 
vehicles for the treatment of fungal infections associated with denture stomatitis 
(Parker et al., 1997a; Eduardo et al., 2001; Sample, 2001; Hassan, 2007; Geerts et 
al., 2008; Dar-Odeh et al., 2012) as further discussed in section  2.7.3.  
 
2.7.3 CDD System in Treatment of Denture Stomatitis 
As tissue conditioners are commonly used in the treatment of denture stomatitis, 
their matrices can be used for controlled delivery of a therapeutic agent. This idea of 
combining of a therapeutic agent into the tissue conditioner was first examined by 
Douglas and Walker (1973). According to their studies, two commercial tissue 
conditioners, namely Tempo and CC had fungicidal properties. When a common 
antifungal drug, nystatin, was incorporated in the tissue conditioner matrix, they 
were able to prolong the time of the fungicidal effect of the materials. 
 
In one study by Thomas and Nutt (1978), nystatin and amphotericin B were 
incorporated into VG. Their results showed that VG containing amphotericin B 
produced a minor fungicidal effect whereas VG containing nystatin had a far greater 
effect. The authors concluded that tissue conditioners containing nystatin are useful 
for treating denture stomatitis accompanied by Candidal infection. 
 
Two methacrylate-based tissue conditioner materials were developed as potential 
vehicles for intra- oral drug delivery (Parker et al., 1997a). PEMA and 80/20 
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BMA/EMA copolymer were used in this study. CHD was mixed into the PEMA 
polymer powder to give 0.9% and 9% w/w formulations. The PEMA powder was 
mixed with a solution of 90% BPBG plasticiser and 10% ethanol, while the 
BMA/EMA powder was mixed with BPBG only. CHD release into distilled water was 
measured using UV/Vis spectrophotometry. PEMA containing formulation showed 
that 0.9% and 9% CHD formulations released 1.14mg and 10mg respectively after 4 
weeks; similarly BMA/EMA containing formulations showed that 0.9% and 9% CHD 
materials released 4.7mg and 11.58mg respectively. Parker et al. (1997a) 
concluded that the results were encouraging for the experimental materials to be 
used as intra-oral drug delivery systems for additives such as CHD for the treatment 
of denture stomatitis.  
 
Sample (2001) conducted a study in 2001 where he added CHD and NaF into 
experimental tissue conditioner formulations and found that adding NaF increased 
the CHD release. The CHD release in one of his experimental formulations 
containing 0.9% CHD with PEMA and BPBG/10% ethanol was 0.33 mg after 7 days 
and 1.25 mg after 140 days. The CHD release increased to 1.56 mg after 7 days 
and 3.84 mg after 140 days when 0.5% NaF was added into the same formulation. 
In the same study, Sample also experimented with ATBC as a substitute for BPBG 
containing tissue conditioners and as a potential drug delivery vehicle. The two 
different formulations containing 80/20 BMA/EMA polymer powder with BPBG or 
ATBC and 2% ethanol were shown to release similar levels of CHD when 
incorporated with 0.9% CHD. The release was 0.39 mg after 7 days and 0.7mg after 
140 days for BPBG; and 0.4 mg after 7 days and 0.64 mg after 140 days for ATBC 
respectively. 
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In an in vitro study by Geerts et al. (2008) involving patients with denture stomatitis, 
nystatin was incorporated into VG powder by pulverization. Its effect as an 
antifungal denture liner was examined, comparing tissue conditioner with and 
without the drug in 40 patients for 14 days. Total yeast counts were performed and it 
was found that in the control group the total yeast count decreased for the first 4 
days and then increased until the end of the test period but remained higher than 
the pre-treatment count. The test group showed only decreased levels till day 7 but 
increased after that, remaining significantly lower than the control group at the end 
of the test period, thus showing the advantage of adding anti-fungal drugs in tissue 
conditioners (Geerts et al., 2008).    
 
In a study by Radnai et al. (2009) CHD and miconazole gels were incorporated into 
VG in concentrations of 5, 10, 15 20 and 25 by volume. Sample discs were placed 
on Sabouraud Dextrose Agar plates which, were inoculated with Candida albicans 
prior to the experiment. CHD containing discs failed to show any antifungal activity 
so CHD was not investigated further. The authors suggested that either the CHD did 
not diffuse out of the gel or it was deactivated when mixed with VG. However VG 
discs containing 20% v/v miconazole were further investigated for antifungal activity 
over time, by immersing in water at different time periods and then placing on SDA 
plates. Miconazole gave a dose related antifungal effect, increasing from 10.29±1.09 
mm diameter for 5% drug to 23.39±.47 diameter of inhibition zone for 25% v/v of the 
drug; the discs immersed in water gave an inverse relationship between immersion 
time and degree of inhibition (Radnai et al., 2009). 
 
In an in vitro study the antifungal activity of copper sulphate, borax and CHD mixed 
with GC was evaluated. The GC was mixed with 0.5 w/v% copper sulphate, 0.5 
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w/v% of equal volumes of copper sulphate and borax or 2 w/v% of CHD. The 
materials were placed in the wells and incubated at 37oC. The mean inhibitory zone 
(MIZ) was measured at 24 and 72 hours. The material with copper sulphate showed 
maximum MIZ (26.39, 27.61) while the material with CHD showed the least MIZ 
(5.44, 6.33) at 24 and 72 hours (Rathore et al., 2009). It should be noted that tissue 
conditioners are usually replaced after one week and the study does not give any 
antifungal activity data for that period of time. 
 
Use of nystatin and fluconazole was investigated by Falah-Tafti et al. (2010) who 
incorporated them into tissue conditioner discs (Acrosoft) in concentrations of 1%, 
3%, 5% and 10% wt/wt. All concentrations of nystatin showed complete inhibition of 
attachment and colonization of Candida albicans after 48 hours, whereas only the 
10% fluconazole discs showed complete inhibition. 
 
The release of ketoconazole and itraconazole was studied by Gupta et al. (2011) 
where two commercial materials VG and GC were used. The antifungal effect 
against C albicans was assessed after 24 hours of incubation. Inhibition of growth 
was significant in all drug containing materials. However itraconazole containing 
tissue conditioners were found to be the least effective because of the drugs 
interaction with the tissue conditioner. Ketaconazole in GC was found to be 
significantly more inhibiting than in VG, having a mean inhibition diameter of 29.45 
mm and 17.95mm respectively. The authors failed to explain how the interaction 
between the drug and tissue conditioners affected the efficacy of the drugs. 
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Recently Srivatstava et al (2013) evaluated use of origanum oil as an antifungal 
agent when it is mixed with the liquid component of VG in concentrations of 10 to 
65% by volume. They concluded that 65 vol% oil content was an optimum 
concentration for antifungal activity. They further tested this concentration to look at 
the effect of oil on tensile strength and surface roughness of the tissue conditioner 
and found that both reduced with the addition of the oil. Although these properties 
are important, perhaps the effect of addition of the oil on compliance and gelation 
time would have been more appropriate as it is more critical in the clinical use of 
tissue conditioners.  
 
So far the studies in the literature are mostly focused on using different antifungal 
drugs as a means of treating candidal infections, but the effects of these additives 
on their properties such as compliance/creep compliance, gelation time etc. has not 
been widely reported in the literature. There arises a question as to whether tissue 
conditioners retain their physical properties and handling characteristics with the 
addition of antifungal drugs.  
 
2.7.4 Anti-Fungal Agents Used in Dentistry 
Some common anti-fungal drugs used in dentistry are briefly discussed in this 
section however main focus is on chlorhexidine’s as an anti-fungal and anti-
microbial use in dentistry. 
2.7.4.1 Chlorhexidine  
Chlorhexidine (Figure  2.15) is a bisbiguanide compound and is one of the most 
effective anti-plaque agent available (Walton et al., 1989).  
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Figure  2.15 Chemical structure of chlorhexidine 
 
It has broad antibacterial and antifungal activity and is mostly used in the form of the 
digluconate, diacetate and dichloride. Digluconate and diacetate are more suitable 
for drug delivery purposes in the oral cavity, because saliva contains chloride ions 
and chlorhexidine dichloride may precipitate out resulting in a reduced concentration 
of chlorhexidine. (Hamers et al., 1996).  
 
In vitro studies provided evidence that growth of C albicans, a common etiological 
factor in denture stomatitis, can be inhibited by CHD (Schneid, 1992; Hamers et al., 
1996). The mode of action of chlorhexidine as antifungal agent is not clear but it is 
believed to inhibit the formation of cell wall by binding to negatively charged  groups 
in cell wall of the candida that results in intracellular material leakage and cell death 
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(Salim et al., 2013b). The role of CHD and other antifungal agents in the treatment 
of denture stomatitis has been discussed in section  2.7.3 (page 92). 
 
Chlorhexidine’s use in dentistry is not solely because of its bactericidal and 
fungicidal properties, but also due to its retention in the oral cavity. It binds 
electrostatically to acidic protein groups (phosphatase, sulphates and carboxyl ions) 
present in the oral tissues. This increase in retention in the oral fluid means that 
more drug remains active for a longer period of time. In the oral environment, 
chlorhexidine is considered to be active above a concentration of 2x10-4mg/100ml 
(Rölla and Melsen, 1975).  
 
Chlorhexidine has many applications in dentistry where, along with other 
antibacterial drugs they can also be used to reduce the incidence of caries (Emilson, 
1994). Schaeken and De Haan (1989) studied the release of drugs from controlled 
release varnishes, which contained chlorhexidine and fluoride separately and a 
combination of both. The effectiveness of each varnish was investigated against 
Streptococcus mutans. The varnish containing fluoride had no effect on the microbe 
while varnish with chlorhexidine showed a marked reduction in the Streptococcus 
mutans level. There was an even greater inhibitory effect of the varnish containing 
both chlorhexidine and fluoride, which might suggest that fluoride may have 
increased the delivery of CHD. A similar effect of fluoride on release of CHD is seen 
in tissue conditioners as discussed in section  2.7.3 (page 92). 
 
Guiliana et al. (1997) studied seven commercial mouthwashes  containing 
cetylpyridinium chloride, chlorhexidine digluconate, hexetidine, sanguinarine, and 
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triclosan as active ingredients. The minimum fungicidal concentration (MFC) against 
six species of yeasts was determined by a broth macrodilution method and the kill-
time at half the concentration of the commercial mouthwashes was also determined. 
MFCs were achieved with all mouthwashes, except the sanguinarine containing 
mouthwash. No kill-times were achieved with the sanguinarine containing 
mouthwash, whereas mouthwshes containing either cetylpyridinium or CHD had 
less than, or equal to 180 seconds, kill-time with all the species of yeasts. 
 
There have been a few studies in the literature investigating the release of CHD 
from soft polymers but their release has also been investigated in rigid polymers for 
different dental applications. For the potential treatment of periodontal disease a 
study was performed by Addy and his co-workers in (1982). CHD, metronidazole 
and tetracycline were incorporated, into the powder component of various dental 
acrylics (e.g. PMMA).The release characteristics of these materials were compared. 
The results showed that drug release was greater when the drug concentration in 
the polymer was high. Furthermore, metronidazole and tetracycline leached from the 
material more quickly than CHD due to different properties of these drugs, but they 
were clinically effective in the management of chronic periodontal diseases (Addy et 
al., 1982). 
 
The use of CHD as an anti-fungal drug has also been studied from acrylic polymer 
systems besides tissue conditioners. In a recent study by Cao et al. (2010) discs 
were prepared by copolymerization of methacrylic acid and diurethane 
dimethacrylate. These discs were immersed in 5% miconazole or 10% CHD 
solutions for 24 hours. The amount of drug bound to the discs was measured using 
Soxhlet extraction and UV measurement techniques. The results showed 59.8±2.5 
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µg/cm2 of miconazole and 45.7±2.1 µg/cm2 of CHD bound to the discs. Their 
antifungal activity was then assessed using Kirby-Bauer technique at pH 5 and 7. 
The discs with miconazole produced a inhibition zone of 5.0±0.4 mm and CHD 
containing discs produced a 2.0±0.2 mm inhibitory zone showing miconazole to be 
more effective than CHD. The antifungal activity of the discs was sustained for up to 
60 days and the drug release was faster at pH5 than at pH 7. Additionally, the 
bound drug was washed out with EDTA and the discs recharged with the same or a 
different drug. The recharge level and also the inhibition zones were found to be at a 
similar level to the original changed discs. This demonstrated the possible reuse of 
these discs. 
 
CHD release was studied from light curable filled resins containing urethane 
dimethacrylate (UDMA) and triethylleneglycol dimethacrylate (TEGDMA). Leung et 
al. (2005) reported a release of ~50% CHD from a composite resin containing 
hydroxyethylmethacrylate (HEMA), TEGDMA, UDMA and 10w% CHD in DW for 2 
weeks.  Anusavice et al. (2006) used CHD at 9.1%, 23.1% and 33.3 wt% in a 
UDMA/TEGDMA filled resin and studied the release for 4 months in solutions of 
different pH. They showed 3.5%, 29.1% and 50.5% CHD release respectively in pH 
4 compared to 1.4%, 9.8% and 11.6% release respectively at pH 6. This study 
showed that CHD release was increased in an acidic environment.   
 
A study by Ryalat et al. (2011) used 10% w/w CHD in room temperature PMMA 
acrylic resin. 58.4 mg of CHD was release after 28 days. Similarly Salim et al. 
(2012) used 10% w/w CHD in poly ethyl methacrylate/tetrahydrofurfuryl 
methacrylate (PEM/THFM) copolymer system and measured the release for 28 days 
and found ~ 50% of the CHD released in DW. Salim et al. (2013a) also studied the 
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antifungal effects of fluconazole and CHD using a PEM/THFM copolymer where 
each sample contained 100mg of active drug. The drug release was studied for 28 
days in water using UV/Vis spectrophotometer and a time kill method was used for 
antifungal activity against fluconazole susceptible and fluconazole resistant candida 
species. They found that both drugs showed antifungal properties for the first seven 
days, however CHD showed a more rapid (100%) kill and continued to be effective 
upto 28 days. 
 
2.7.4.2 Other Anti-fungal Drugs 
Anti-fungal drugs used commonly for treatment of fungal infections are nystatin, 
amphotericine B and imdazoles. These are usually used to treat systemic diseases 
(Requa-Clark, 2000). A brief description about their use in dental treatments is 
discussed below. 
 Nystatin 
Nystatin is a topical antifungal drug used to treat infections such as thrush and 
denture stomatitis. The drug is active against yeast and fungi only but does not 
show any antibacterial effect. Due to the toxic effects of this drug it is not used for 
treating systemic disorders (Blomgren et al., 1998).  
 
Amphotericin B  
Amphotericin B is effective against a number of fungi including C albicans but it is 
ineffective against bacteria. It can be used to treat systemic diseases but is mostly 
combined into lozenges or a suspension for use in dental applications. 
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Imidazoles 
Imidazoles are another group of anti-fungal drugs which includes clotrimazole, 
miconazole, econazole, fluconazole and ketoconazole. Clotrimazole and miconazole 
are commonly used in dentistry. Miconazole is often used as topical application by 
dissolving 250 mg pill in water, it is also available in gel from which it can directly be 
applied on the infectious site and also to the tissue surface of the dentures. 
Fluconazole is another common systemic antifungal drug. It is well tolerated and has 
low toxicity and mild side effects but in elderly patients, who often have reduced 
salivary production. There is a chance of low levels reaching the oral cavity thus 
leading to the resistance against these drugs so limiting its use in dentistry 
(Samaranayake et al., 2009; Siikala et al., 2010). 
 
The effect of release of some of these drugs has been studied in tissue conditioners 
for the treatment of denture stomatitis as discussed in section  2.7.3 (page 92) but 
their usefulness is limited to patients with active candida infection whereas CHD can 
be used not only to treat the fungal infection but also to prevent it and to improve the 
oral hygiene of the patients without any fear of undesirable effects of the drugs. 
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2.8 Aims and Objectives 
Aims of this study are 
• To develop an ethanol-free, citrate-based, pre-gelled system to overcome 
the problems associated with commercial P/L tissue conditioners. 
• To investigate the release of CHD from both pre-gelled experimental and 
P/L commercial/experimental citrate-based tissue conditioners.  
• To investigate the potential of a novel method to assess flow properties of 
both commercial and experimental tissue conditioners which uses Shore A 
hardness measurements at different dwell times. 
 
The objectives of this study are 
• To investigate the shelf life (stability on storage) of the pre-gelled tissue 
conditioner system over a period of 18 months using Shore A hardness 
measurement. 
• To evaluate the physical properties of the experimental pre-gelled system 
and the commercial/experimental P/L formulations, which included weight 
changes in DW, Shore A hardness and creep compliance ratio with time 
when stored dry, DW and AS, and the gelation time for 
commercial/experimental P/L formulations. 
• To evaluate the effect of addition of CHD with or without NaF on the same 
physical properties (described above) of both experimental pre-gelled and 
the commercial/experimental P/L formulations. 
• To investigate the release of CHD from both pre-gelled and the P/L 
experimental/commercial formulations in DW. 
• To study the processes involved in water uptake and CHD/F release. 
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3 Materials and Methods 
3.1 Materials  
The materials used in this study are listed in Table  3.1 along with their supplier’s 
name. 
 
Table  3.1: List of materials used 
Name Supplier 
Poly (ethyl methacrylate) (PEMA) - 
powder 
Lucite International, UK. Batch No. 
B3/17180 
Acetyl tributyl citrate (ATBC) - plasticiser 
Vertellus Performance Materials Inc. 
USA. Batch No. 0000070477 
n-Butyrltri-n-hexyl Citrate (BTHC) - 
plasticiser 
Morflex Inc. USA 
Viscogel (VG Old) (Old formulation) Dentsply International, UK 
Viscogel (VG) (New formulation) Dentsply International, UK 
Coe-Comfort (CC) GC Europe 
Ethanol BDH Chemical Ltd, UK 
Chlorhexidine diacetate (CHD) - powder 
Sigma-Aldrich Co., UK. Batch No. 
19H0417 
Sodium Fluoride (NaF) - powder Sigma-Aldrich Co., UK 
Distilled water (DW)  
Artificial saliva (AS) A S Saliva Orthana by A.S Pharma, UK 
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The constituents of AS (A S orthana) is listed in Table  3.2 
Table  3.2: Constituents of Saliva Orthana 
Each 50ml of Aqueous Solution Contains 
Component Amount 
Mucin Gastric 1.75g 
Methylparaben 50mg 
Benzalkonium Chloride 1.0mg 
EDTA 25mg 
Xylitol 1.0g 
Peppermint Oil 2.5mg 
Spearmint Oil 2.5mg 
Potassium Fluoride 0.21mg 
Mineral Salts - 
 
In this study two commercial materials Viscogel (VG) and Coe Comfort (CC) were 
used as commercial controls. Both materials were used in two powder/liquid (P/L) 
ratios; a manufacturer’s recommended P/L and a higher P/L ratio of 1.8g/ml. The 
recommended P/L ratio for VG is 1.5g/ml, for VG Old is 1.3g/ml and for CC is 1.2 
g/ml. CC was included in the study as well as VG to represent the range of 
commercial tissue conditioners available where VG is recommended for general 
application and CC more for use as a tissue conditioner. 
VG was used as a commercial control in all experimental procedures. VG using P/L 
ratio of 1.8 was used with 1% chlorhexidine diacetate (CHD) and 9%CHD with and 
without 0.5% sodium fluoride (NaF).  
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VG containing butyl phthalyl butyl glycolate (BPBG) in liquid (VG Old) was also used 
to compare the effect of change of plasticiser, (the new VG contains a citrate based 
plasticiser but it does not state which one) and the results are presented in Appendix 
A2. 
Two different experimental materials were used; an experimental powder liquid 
system (EPLS) and an experimental pre-gelled system (EPGS). The composition of 
EPLS consisted of 16 hours ball milled poly (ethyl methacrylate) (PEMA) powder 
mixed with 95% Acetyl tributyl citrate (ATBC) and 5% ethanol using a P/L ratio of 
1.8g/ml. The composition of EPGS was PEMA powder mixed with ATBC in a P/L 
ratio of 1.2 g/ml. This ratio was finalised as appropriate after the pilot study.  Both 
materials were also used with 1% or 9% with and without 0.5% NaF. A summary of 
formulations and their P/L ratios used are listed in Table  3.3. 
Table  3.3: P/L ratios of different materials 
Materials / Formulations P/L ratio (g/ml) 
VG Old 1.3, 1.8 
VG  1.5, 1.8 
CC 1.2, 1.8 
VG 1% CHD, VG 9%CHD 1.8 
VG 1% CHD+0.5%NaF, VG 9%CHD+0.5%NaF 1.8 
EPLS, EPLS 1% CHD, EPLS 9%CHD 1.8 
EPLS 1% CHD+0.5%NaF, EPLS 9%CHD+0.5%NaF 1.8 
PEMA + ATBC (pre-gelled system) 1.2, 1.4, 1.6, 1.8, 2.0 
PEMA + BTHC (pre-gelled system) 1.2, 2.0 
PEMA + ATBC:BTHC (70:30, 50:50, 30:70) (pre-gelled 
system) 
1.2 
EPGS, EPGS 1% CHD, EPGS 9%CHD 1.2 
EPGS 1% CHD+0.5%NaF, EPGS 9%CHD+0.5%NaF 1.2 
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3.2 Methods 
3.2.1 Development of Experimental Pre-gelled System (EPGS) 
For development of the pre-gelled system PEMA powder was used with two 
different plasticisers, namely ATBC and BTHC. 
 
For the ATBC containing pre-gelled system, powder and liquid were mixed together 
using 1.2, 1.4, 1.6, 1.8 and 2.0 g/ml P/L ratios in order to select the most appropriate 
formulation. Shore A hardness specimens were prepared as described in 
section  3.2.3 and were left to gel for 16 hours at 37±2°C in an incubator wrapped in 
foil. After 16 hours the gelled specimens were removed from the mould. Shore A 
hardness and CCR were measured using the procedure described in section  3.2.4 
and  3.2.6.  
 
For the BTHC pre-gelled system 1.2 and 2.0 P/L ratios were tried using the same 
procedure as described above. Initially 1.2 g/ml P/L ratio was selected based on the 
results of the ATBC containing formulation and later 2.0 g/ml ratio was used when 
the formulation failed to gel in 16 hours. However the 2.0 g/ml also failed to form a 
coherent gel after 16 hours. To speed up gelation, 16 hours ball-milled PEMA 
powder was then used instead of un-milled PEMA powder. It was shown by Parker 
and Braden (2001) that ball-milling the PEMA powder for 16 hours decreased the 
gelation time from 58 min to 19 min when mixed with BPBG.  
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The 16 hours ball-milled PEMA powder was then mixed with BTHC using 2.0 g/ml 
P/L ratio only, in order to accelerate gelation, with the same procedure as described 
above for the ATBC pre-gelled system. After 16 hours the material again failed to 
form a coherent gel for hardness testing. Again using 2.0 P/L ratio the oven 
temperature was raised to 75±2°C, which is above the Tg of PEMA, to accelerate 
the gelation and to form a coherent gel. The mix again failed to form a gel so no 
further work was carried out with BTHC as plasticiser. 
 
Further mixtures of ATBC and BTHC were also tried in three ratios of 70:30, 50:50 
and 30:70 respectively. These liquids were mixed with PEMA powder using the 
same procedure as described above (section  3.2.1) for ATBC materials and the 
same selected P/L ratio of 1.2 was used. After 16 hours of mixing only the 30:70 
ATBC-BTHC containing material failed to form a gel. Shore A hardness and CCR 
were measured for all the formulations that formed a gel. 
 
The final formulation selected (based on Shore A hardness and CCR results) for 
further development was PEMA powder and ATBC liquid mixed in P/L ratio of 1.2 
g/ml. This formulation was named as experimental pre-gelled system (EPGS).  
 
The next stage was to evaluate the shelf life of EPGS over a period of 18 months 
using Shore A hardness measurements. Specimens were prepared as mentioned in 
section  3.2.3 and stored in an oven at 23±2°C. Shore A hardness measurements 
were taken at regular intervals over 18 months as shown in Table  3.4; the shore A 
hardness increased gradually with time so new EPGS specimens were prepared 
and stored in 7±2°C in refrigerator (many medical products/drugs are required to 
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store in a cool environment). Shore A hardness was measured at regular intervals 
over 18 months as shown in Table  3.4.  
 
Table  3.4: Shelf life - time periods for hardness testing 
Storage temperature Time period for testing 
23±2°C 1, 2, 4 days, 1, 5 weeks, 6, 9, 12 and 18 months 
7±2°C 1, 2, 4 days, 1, 5 weeks, 4, 6, 9, 12 and 18 months 
 
3.2.2 Preparation of Powder and Liquid 
3.2.2.1 Powder 
The PEMA powder was ball milled for 16 hours for EPLS formulations. A roller mill 
(GEC Machines LTD, Newcastle, UK) was used to ball mill the powder (Figure  3.1).  
 
 
Figure  3.1: Ball milling apparatus with ball mill rollers 
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A ceramic container (Figure  3.1) from Pascall Engineering, Sussex, UK of 500ml 
capacity was used with a charge of alumina balls with two different diameters: 7 
balls with an average diameter of 26.1mm and 20 small balls, with an average 
diameter of 18.9mm. The total weight of the balls was 500.5g. 50g of PEMA powder 
was placed in the jar along with the alumina balls and the jar was securely clamped 
by using a metal clamp on the ceramic lid and placed on the rollers of the machine 
for the required time (see below). 
 
For drug delivery formulations CHD was added to the PEMA powder as 1% and 9% 
weight percentage with and without 0.5% NaF in EPGS, EPLS and VG. The 
percentage of the drug was calculated as percentage of the total powder and liquid 
(P/L) ratio. CHD with and without NaF was added to PEMA to give 50g of powder in 
total and was ball milled for 3 hours, for distributing the additives evenly. The 
formulations prepared with the additives used are shown in Table  3.5. 
 Particle Size Analysis 3.2.2.1.1
Particle size analysis is used mostly for the controlled production of powders (with 
appropriate particle size) used in ceramics, foodstuff and chemistry. Usually a laser 
technique is used to determine the particle size distribution of powders (Mishchenko 
et al., 1999).  
Theory 
When an incident beam strikes a spherical particle it has a specific intensity (I1) and 
wavelength. The intensity (Is) of the scattered light is a function the scattered angle, 
particle size, wavelength and optical properties of the particle and the medium 
represented by: 
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Where ɵ is the angle of scatter, d is diameter of particle, λ is the wavelength and n is 
refractive index of the medium. 
 
Two scattering theories, depending on the size range of the particles, are typically 
used to interpret the pattern of scattering of light and then converting it into a size 
distribution. These are Fraunhofer theory for particle size greater than 10µm and 
Mie theory for both less than and greater than 10µm particle size (Rawle, 2003). 
Modern light scattering instruments use Mie theory to measure the particle size 
distributions assuming the particles are perfect spheres. Irregularly shaped particles 
are very difficult to size because of involvement of multiple parameters. 
Method 
A Malven MastersizerTM Type E particle size analyser  (Malvern Instruments, 
Worcestershire, UK; Mie theory), connected to Malvern® PowerMate 286 Plus3 
personal computer was used to measure the particle size of the powders of VG old, 
VG, PEMA and PEMA 16 hours ball milled powders. 
 
A suspension was prepared of 2g of powder in 20ml of DW containing 6 drops of 
dispersant, Teepol L (Teepol Products Ltd, Surreys, UK) to keep the powder in 
suspension during the measurements procedure. A 100 mm focal length lens was 
used. The reservoir tank was filled with 900ml of DW and 3 drops of Teepol L. The 
laser beam intensity was checked for optimised values and a back-ground 
measurement was taken to set it to zero. The powder suspension solution was 
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added to the reservoir using a syringe (to minimize bubbles forming) with the end 
under the water surface until the obscuration level was 0.2 – 0.25 (recommended 
level), a measurement was taken. Ultrasonics were applied at a maximum level for 1 
min, followed by a quick burst of stirrer to level 10, then back to level 2 and 
measured. This cycle of ultrasonics was repeated until D[v,0.5] which is the average 
particle size reached a minimum or when D[3,2] which is surface volume/mean 
diameter, increased indicating complete dispersion. Cumulative frequency plots of 
volume were obtained which were then used to calculate the mean particle diameter 
(D[4,3]) (Parker and Braden, 2001).   
 
3.2.2.2 Liquid 
190ml of ATBC was mixed with 10ml of ethanol to prepare a liquid of 200ml in total, 
with 5% ethanol and 95% ATBC concentration. This liquid was used for making 
specimens for all EPLS formulations as mentioned in Table  3.5  
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Table  3.5: Powder compositions containing CHD with and without and NaF 
Formulation Powder (50g) 
VG 1%CHD VG Powder (49.23g) + CHD (0.77g)  
VG 9%CHD VG Powder (43.1g) + CHD (6.9g) 
VG 1%CHD+0.5%NaF 
VG Powder (48.85g) + CHD (0.77g) + NaF 
(0.38g) 
VG 9%CHD+0.5%NaF VG Powder (42.72g) + CHD (6.9g) + NaF (0.38g) 
EPLS 16hrs ball-milled PEMA (50g) 
EPLS 1%CHD 16hrs ball-milled PEMA (49.23g) + CHD (0.77g) 
EPLS 9%CHD 16hrs ball-milled PEMA (43.1g) + CHD (6.9g) 
EPLS 1%CHD+0.5%NaF 
16hrs ball-milled PEMA (48.85g) + CHD (0.77g) + 
NaF (0.38g) 
EPLS 9%CHD+0.5%NaF 
16hrs ball-milled PEMA (42.72g) + CHD (6.9g) + 
NaF (0.38g) 
EPGS 1%CHD PEMA (49.08g) + CHD (0.92g) 
EPGS 9%CHD PEMA (41.75g) + CHD (8.25g) 
EPGS 1%CHD+0.5%NaF PEMA (48.63g) + CHD (0.92g) + NaF (0.46g) 
EPGS 9%CHD+0.5%NaF PEMA (41.29g)+ CHD (8.25g) + NaF (0.46g) 
 
3.2.3 General Sample Preparation procedure 
Powder and liquid (for both P/L and pre-gelled systems) were mixed in a glass jar 
for 1min. The mixture was transferred to the appropriate mould (100x20x10 mm3 
polytetrafluoroethylene [PTFE] mould for Shore A hardness testing and 40x10x1 
mm3 steel mould for water absorption). The mould was placed on top of a metal 
plate lined with an acetate sheet. The mixture was placed in the mould which was 
then covered with an acetate sheet and topped with another metal plate as shown in 
Figure  3.2. The assembly was then wrapped in aluminium foil and clamped with 
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bulldog clamps and placed in an oven at 37±2°C. Before testing the mould was 
opened and the strips of material were taken out and any excess was removed.  
 
 
Figure  3.2: Mould assembly for specimen preparation 
 
 
3.2.4 Hardness Testing 
P/L ratios of all the formulations of different materials for Shore A hardness testing 
are shown in Table  3.3. 
Specimens (100x20x10 mm3) were prepared according to the procedure described 
in section  0 3.2.3. Shore A hardness of materials were measured after 1hr, 24hrs 
and 1 week after mixing for the P/L materials, whereas EPGS formulations were first 
tested 16 hours after mixing then after 24hrs and 1 week. After the first Shore A 
hardness measurements the specimens were stored either dry (always wrapped in 
aluminum foil until testing), in 100ml distilled water (DW) (to study the effects with 
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minimum factors affecting the hardness) or in 100ml artificial saliva (AS) (to mimic 
the oral fluids/environment), in an oven at 37±2°C for the rest of the study period.  
 
The Shore A hardness tester (H17A, Congenix Wallace, Kingston, England) 
(Figure  3.3) was used to measure Shore A hardness. The indenter of the instrument 
is made up of a blunt-point truncated cone with indenter of 0.79mm in diameter, 
truncated from a cylinder of 1.1 – 1.4 mm. If the indenter totally penetrates the 
sample a reading of 0 is indicating a very soft material and 100 if there is no 
penetration thus indicating a harder material. To minimize the effect of creep, 1 sec 
dwell time was used to take six readings on each sample at different places, 
according to ASTM D 2240-05 (2010), such that the indenter was 10mm away from 
the edges and 10 mm apart from each reading .  
 
Figure  3.3: Shore A hardness tester 
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3.2.5 Young’s Modulus  
As described in section  2.6.2 (page 60) Young’s Modulus can be calculated from 
Shore A hardness. Young’s Moduli of all formulations were calculated using 
equation 2.8 (page 68).   
 
3.2.6 Creep and Creep Compliance Ratio 
To measure creep and creep compliance ratio (CCR), the same specimens as 
described in section  3.2.4 (used for Shore A hardness measurements) were used 
with dwell time of the indenter at 1, 5, 10, 15, 20, 25, 30 sec. Dwell time is the 
amount of time the indenter penetrates the specimen. Six readings 10 mm apart and 
10mm away from the edges were taken according to ASTM D 2240-05 (2010). 
 
Young’s modulus and compliance were calculated using Eq 2.8 and 2.9 as 
discussed in section  2.6.2.  From the values of compliance, CCR was calculated as 
 
sec1atcompliance
ttimeatcompliance
ratiocompliance =    Eq 4.1 
Where t = dwell time.  
Penetration ratio (R) was also calculated by taking the ratio of Shore A hardness at 
30 and 5 sec dwell time in accordance with the ISO 10139-2. 
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3.2.7 Gelation Time 
The gelation times of the different P/L formulations of the tissue conditioners were 
determined by using an oscillating rheometer (Figure  3.4). The rheometer consists 
of two cylindrical plates (upper and lower plate). The upper plate is removable and it 
remains stationary during testing with respect to the lower. The gap between the 
upper plate and the lower plate was approximately 1.8mm. The lower plate is 
connected to a rotating cam, which is attached by an iron core that moves to and fro 
via a wire spring allowing the lower plate to oscillate. The transducer measures this 
movement and is connected to a chart recorder (Linseis GmbH, 95100 Selb, 
Germany) which produces a trace.  
The baseline trace was recorded at a chart speed of 5mm/min. A water bath (low 
temperature bath/circulator R series, Camlab limited, Cambridge) was used to 
circulate water through the upper plate to maintain the temperature, during the 
procedure. 
 
Figure  3.4: Oscillating Rheometer 
 
Lower oscillating 
plate 
Upper fixed 
plate 
Chart recorder The powder liquid mixture is placed 
between upper and lower plate 
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The powder and liquid were mixed according to the formulations and P/L ratios 
shown in Table  3.3; the mixing time was approximately one minute. The mixture was 
transferred to the lower oscillating plate and the upper plate was then placed on top 
of the mixture and clamped tightly. As the material sets it resists the oscillations of 
the lower plate which results in a change in the amplitude of the oscillations. This 
was recorded on the chart recorder and a trace was produced. Gelation time was 
recorded from the start of mixing of material to the point when the oscillation 
reached a minimum value. Each formulation was repeated 5 times at 37˚± 2°C. 
Gelation time was taken when the rheometer trace length reached a 60% reduction 
(Figure  3.5) (Parker and Braden, 1996). 
 
Figure  3.5: Determination of gelation time of tissue conditioner  
 
3.2.8 Water Absorption 
The powder and liquid components were mixed in the ratios shown in Table  3.3. VG 
old and VG were mixed according to the manufacturer’s recommended ratios (1.3 
for VG Old and 1.5 for VG) and 1.8 g/ml ratio. EPLS and EPGS were mixed with P/L 
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ratios of 1.8 and 1.2 g/ml respectively. Specimens (40x10x1 mm3) were prepared as 
described in section  3.2.3. 
 
The prepared specimens (5 specimens for each formulation) were weighed using an 
AE Mettler balance (Metler – Toledo Ltd, Leicester, UK) accurate to four decimal 
places, and then transferred to preheated glass bottles (37°C) containing 100ml of 
distilled water (DW). The materials containing NaF were immersed in polypropylene 
bottles instead of glass bottles. The bottles were stored in an incubator (Labheat 
Model RLCH0400, Boro Labs Ltd, Berkshire, UK) at 37±2°C.  Each sample was 
periodically removed from the bottle, blotted dry to remove excess water, weighed 
and then placed back in the incubator in its’ respective bottle. The specimens were 
weighed according to the time intervals shown in Table  3.6. The whole procedure 
was performed for a 12 week period because recommended time for their use in 
mouth as temporary lining material is 1-3 months (Graham et al., 1991b). 
 
Table  3.6: Time intervals used for the water absorption characterization 
Time Period Measurements 
Week 1:Day 1 0, 5, 10, 15, 30, 60, 120, 240, 480 min 
Week 1:Day 2 24 and 36 hours 
Week 1: Day 3-7 48, 72, 96a.336 hours (After every 24 hours)  
Week 2: After every 48 hours 
Week 3-4: Three readings a week 
Week 5-9: Two readings a week 
Week 10-12 One reading a week 
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The water absorption for formulations containing CHD with and without NaF was 
carried out for 4 weeks, where the initial intervals were the same as in Table  3.6, 
with the exception of readings from day 3 to 14, which were taken every 24 hours, 
and then every 48 hours until week 4. At each time interval, starting from 60 
minutes, a 5ml aliquot of immersion liquid was taken after weighing and then 5ml of 
fresh DW at 37°C was added so that the volume of the liquid was maintained at 
100ml. These aliquots were stored in a refrigerator - Lec+ IST47 (Glen Dimplex 
Professional Appliances, UK) at 7±2°C until they were analysed using 
Ultraviolet/visual (UV/Vis) spectrophotometry, for detection of CHD (see 
section  3.2.11) and using fluoride ion spectrometry for fluoride detection (see 
section  3.2.12). The immersion liquid was also changed at week 1 and 2 to avoid 
saturation of CHD and fluoride. 
 
3.2.9 Water Desorption 
After completing the water absorption studies, the specimens were desorbed. They 
were removed from the respective liquids, blotted dry, weighed and stored in an 
incubator (Carbolite Model No. PIF120) at 37±2°C. The specimens were weighed at 
regular intervals using the same timing regime as described in Table  3.6 until they 
reached a minimum weight (equilibrium). 
 
3.2.10 Solubility & Diffusion coefficient 
Percentage weight change and solubility were calculated as a percentage of initial 
weight using eqs 4.3 and 4.4 
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SolubilityWUptakeReal %%% +∆=   Eq 4.5 
where %∆W is the percentage weight change, Wo is the initial weight of the sample 
before absorption, Wt is weight at time t, and W1 is the final minimum desorbed 
weight. 
 
The desorption diffusion coefficient was calculated using equation 4.6 which is 
appropriate for early stages of diffusion, where Mt/M∞ ≤ 0.5. Mt/M∞ should be linear 
to t1/2 (Patel and Braden, 1991). The equation is given by 
16
4
22
lS
D
pi
=      Eq 4.6 
where D is the diffusion coefficient, S is the slope of the Mt/M∞ against t
1/2 plot and 2l 
is the thickness of the sample. 
   
3.2.11 The Ultraviolet/Visual Spectrophotometer 
Spectroscopy is a technique which measures electromagnetic radiation that 
interacts with molecules. A range of near ultraviolet (UV) and visible (vis) light has 
an energy of about 150-400 kJmol-1 in the electromagnetic spectrum which is used 
to promote electrons from ground state to an excited state. A spectrum is formed 
when light absorbed is measured as a function of its wavelength. The wavelength of 
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the light absorbed ranges from 150-400 nm for near UV and 400-800 nm for visible 
light. 
 
Absorption spectroscopy is usually performed by dissolving a solute in a transparent 
solvent, where absorbance is linearly dependant on the solute concentration. So, for 
quantitative measurements, spectroscopic absorbance is ideal. The wavelength and 
strength of absorbance depends on the chemical nature and the environment of 
chromophores.  Spectroscopy is non-destructive and very sensitive, needing only a 
small amount of material for analysis. 
Theory 
Spectrophotometers usually contain two sources of light: a deuterium lamp for UV 
light and tungsten halogen light for visible light region. The light passes through a 
monochromator and focused onto the cuvette containing the sample solution and 
the amount of light passing through the sample is detected by photomultiplier. In a 
double beam instrument a cuvette with only the solvent solution is placed in the 
reference beam and its absorbance is subtracted from measured absorbance of the 
sample. The wavelength of the beam sweeps over the UV-visible range and induces 
electron transition in the solvent and solute when passing through it. These 
transitions show characteristic peaks in the transmitted beam spectrum and can be 
used to measure the presence of a solute qualitatively or quantitatively. Figure  3.6 
shows the schematic diagram of a double beam spectrophotometer. 
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Figure  3.6: Schematic diagram of UV/Vis Spectrophotometer (UNICAM, 1995) 
 
The absorbance (A) is related to the intensity of light before (Io) and after (I) passage 
through the solution by Eq 4.7 and according to Beer-Lambert law, the absorbance 
depends linearly on concentration (Eq 4.8). 
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     Eq 4.7 
 
clA ε=       Eq 4.8 
Where in Eq 4.8 c is the molar concentration, l is the path length in cm and Ɛ (Lmol-1 
cm-1) is the molar absorption coefficient. Thus using Eq 4.8, the absorbance can be 
used directly to measure the concentration of a substance in a solution.  
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Method 
In this study UV-Vis spectrophotometry (ATI Unicam UV4, ATI Unicam, Cambridge, 
UK) was used to detect the amount of CHD released from drug-loaded materials 
into distilled water at 37°C. CHD absorbance was measured at 261nm wavelength. 
The instrument was set to record spectra between the wavelengths of 190 nm to 
600 nm, with a bandwidth of 2nm, scan speed of 600nm/min and data interval of 
1nm. The background of the instrument was set by placing fresh DW in both the 
reference and specimen cuvettes each time before taking the measurements. 10 
calibration liquids were prepared in the concentration range of 5x10-3 g/100mls to 
5x10-4 g/100mls by serial dilution of CHD in DW. Aliquots of 4ml were transferred to 
5ml quartz cuvettes (AC Unicam). A calibration curve was derived, which showed 
the relationship of absorbance at 261nm and the concentration of CHD (Figure  4.25; 
page 157).  
 
Aliquots were taken for analysis starting from 1 hour after initial immersion of 
specimens in water, then at each corresponding weight measurement interval, as 
mentioned in section  3.2.7. 5ml of solution was taken at each measurement and 
from this 5ml; 1ml was mixed with 9ml of DW to give a 10 times dilution. This diluted 
solution (4ml) was used to measure the absorbance of CHD against a DW (4ml) 
reference.    
 
3.2.12 The Fluoride Ion Electrode: 
For this study a fluoride ion electrode was used supplied by Orion Research Inc 
(USA), model 720A+. The schematic diagram is shown in Figure  3.7. 
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Figure  3.7: Schematic diagram of Flouride Ion Electrode (Scientific, 2007) 
 
The electrode is made up of a sensing element attached to an epoxy body. An 
electrode potential builds up in the sensing element when the electrode tip is place 
in a solution of fluoride ions. Depending on the amount of free fluoride in the solution 
a potential is formed which is measured against a constant reference potential with 
a digital pH/mV meter or specific ion meter. The potential measurement is equal to 
the level of fluoride ions in the solution. 
 
In order to get a high background ionic strength a ‘total ionic strength adjuster buffer’ 
(TISAB) is added to all fluoride calibrating standards and specimens. TISAB also 
works as a pH buffer and it also decomplexes any fluoride that might be bound to 
other polyvalent species like aluminium, iron and magnesium.  
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Method 
The fluoride electrode used was Orion model 720A+. The tip of the electrode was 
washed with DW before use. The electrode was then filled with the electrode filling 
solution (Optimum Result A 900061, Thermo Orion). The instrument was calibrated 
using fluoride standards prepared in DW.  
 
Standards in DW were prepared by serial dilution of 1000ppm aqueous sodium 
fluoride solution (Orion Sodium Fluoride Standard) to give concentrations of 10ppm, 
5ppm, 1ppm, 0.1ppm and 0.01ppm. The meter was first set to calibration mode. 
2.5ml TISAB III was mixed with 2.5ml of standard solution on the magnetic stirrer. 
The fluoride electrode was then immersed into the mix and the reading was 
recorded from the bench-top display once it reached stability. The tip was then 
washed with DW and shaken dry after every use. The calibration was performed in 
an descending order. After calibration measurement, the meter automatically 
calculates the slope of the linear relationship between concentration and output 
voltage, and then goes to the measurement mode for the test solutions to be 
analysed.  All standards and test solutions were measured at the same magnetic 
stirrer speed. 
 
Fluoride content of the aliquots taken at different time intervals as discussed in 
section  3.2.7 (page 118) was measured. Before fluoride measurements the aliquots 
were taken out of the fridge 1 hour before start of the testing to reach room 
temperature. 2.5 ml from the aliquot solution was mixed with 2.5ml of TISAB III 
solution on the magnetic stirrer. The measurements were performed using the same 
procedure as used for the calibration solutions.  
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3.2.13 Statistical Analysis 
IBM SPSS Statistics version 22 software was used for the statistical analysis of the 
results. One way analysis of variance (ANOVA) with a post hoc Tukey’s honest 
significant difference (HSD) test was performed to compare the means of the 
results. One way ANOVA compared the means of the groups to tell if there was any 
significant difference between the groups when p value was less than 0.05. If there 
were any differences among the means of the group a further post hoc Tukey’s HSD 
was performed (p≤0.05) that indicated which group or groups were significantly 
different from others. Univariate analysis of variance test was also performed to 
check the relationship between materials and the dependent factors. If the p value is 
less than 0.05 then then there is a positive relationship between the dependent 
factors. 
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4 Results  
The various results obtained are summarized in this chapter. The commercial 
materials Coe-comfort (CC), Viscogel (VG) and Viscogel Old (VG Old) were tested 
using the manufacturers recommended powder to liquid (P/L) ratio and a higher 1.8 
g/ml P/L ratio. Moreover, 1.8g/ml P/L ratio was used for the VG materials where 
chlorhexidine (CHD) was incorporated at 1% or 9% with and without the addition of 
0.5% NaF. For experimental powder liquid system (EPLS) a P/L ratio of 1.8 g/ml 
was used throughout. The experimental pre-gelled system (EPGS) was tested using 
a P/L ratio of 1.2 g/ml for all formulations, which was selected following initial 
screening as described in section  4.1  3.2.1. 
 
4.1   Development of Pre-Gelled System 
For the development of EPGS, Shore A hardness and subsequent creep 
compliance ratio (CCR) were used, to select the appropriate P/L ratio and the final 
formulation to be used for further testing.  
 
Figure  4.1 shows the mean Shore A hardness with standard deviations (SD) of 
different P/L ratios in the range 1.2 to 2.0 g/ml. Here the materials were tested 16 
hours after mixing, to allow the material to form a stable gel prior to the testing. The 
materials containing only acetyl tributyl citrate (ATBC) showed an increase in Shore 
A hardness with increasing the P/L ratio from 1.2 to 2.0. The materials prepared 
using a liquid mix of 70/30 and 50/50 by volume, of ATBC and n-butyrltri-n-hexyl 
citrate (BTHC), had statistically similar Shore A hardness values, but greater than 
the ATBC 1.2 counterpart. The formulations containing BTHC only and 30/70 
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ATBC+BTHC did not gel even after 24 hours as explained in section  0 3.2.1 (page 
108).  
 
Figure  4.1: Mean (±SD; n=6) Shore A hardness of pre-gelled formulations with 
different P/L ratios  
(No significant difference between groups with same letters; p≤0.05) 
 
Figure  4.2 shows the comparison of the effect on Shore A hardness of increasing 
dwell time from 1 to 30 sec for the different formulations. With increasing dwell time 
the measured Shore A hardness decreased in all the formulations. Generally, the 
Shore A hardness values decreased by ~5 units from 1 sec to 30 sec dwell time 
regardless of its value at 1 sec dwell time. From the measured Shore A hardness 
values CCR was calculated as described in section  3.2.6 (page 117) and the results 
using a 30 sec dwell time are summarized in Table  4.1. ATBC 1.2 showed the 
highest CCR of 2.56 and ATBC 2.0 showed the lowest CCR at 1.61.   
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Figure  4.2: Mean (n=6) Shore A hardness of pre-gelled formulations at 
different dwell times stored at 37°C  
 
Table  4.1: CCR of different pre-gelled formulations using 30 sec dwell time 
Pre-gelled formulation CCR at 30 sec dwell time 
ATBC 1.2 2.56 
ATBC 2.0 1.61 
ATBC+BTHC 1.2 2.14 
ATBC+BTHC 1.2 2.14 
 
Based on these results, ATBC 1.2 (now referred to as EPGS) was selected for 
further testing as a pre-gelled system as it had the lowest compliance combined with 
maximum flow (CCR). 
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4.1.1 Shelf Life of EPGS 
The selected EPGS formulation was tested for its stability over time (shelf life) by 
measuring the Shore A hardness over a period of 18 months at different times. 
 
EPGS was first stored at room temperature (23°C) and the results of mean Shore A 
hardness with standard deviation (SD) are shown in Figure  4.3. There were 6 
specimens to start with but two specimens were damaged during the experimental 
procedure so their data are not shown. The Shore A hardness of the material 
showed a constant increase from 0 day to 18 months however, this increase was 
more during the first 5 weeks.  
 
 
Figure  4.3: Mean (±SD; n=4) Shore A hardness of EPGS at different time 
periods when stored at 23°C 
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Figure  4.3 shows the Shore A hardness increased with time indicating that the gel 
was not stable at 23°C, so it was decided to evaluate the changes when stored at 
7°C, as many commercial materials and drugs are commonly stored in a 
refrigerator. Figure  4.4 shows the changes in Shore A hardness of EPGS over 18 
months when stored at 7°C. There was a significant increase in Shore A hardness 
from day 0 to 2. From day 2 till 18 month there were no further significant changes 
found in Shore A hardness at the different time periods, thus indicating a stable gel 
after ~2days.  
 
 
Figure  4.4: Mean (±SD; n=6) Shore A hardness of EPGS at different time 
periods when stored at 7°C 
(No significant difference between groups with same letters; p≤0.05) 
   
4.2 Particle Size Analysis 
Particle size analysis was carried out for VG, PEMA un-milled and PEMA 16 hours 
ball-milled powders (used for EPLS). Particle size is one of the important factors that 
affect the gelation process of the tissue conditioners and also affect other properties 
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e.g. Shore A hardness and creep etc. Table  4.2 shows the summary of results 
obtained. There was a decrease in Mean particle size D[v,0.5] of PEMA after 16 
hours ball-milling. D[v,0.5] of VG was smaller than PEMA powder.  
 
Table  4.2: Mean (± SD; n=5) of Mean particle size D[v,0.5 of different polymer 
powders 
Powder D[v,0.5] SD (±) 
VG 32.91 0.42 
PEMA 42.46 0.30 
PEMA 16 hrs 40.58 0.35 
 
4.3 Gelation Time 
Gelation time was determined for only the powder liquid (P/L) formulations at 37°C 
because these are chair side materials and so gelation time is important. The pre-
gelled system (EPGS) does not require mixing by the dentist who is only required to 
apply the material to the fitting surface of the denture.  
 
Figure  4.5 shows the gelation time of VG (1.5 and 1.8), CC (1.2 and 1.8) and EPLS. 
The gelation time decreased with increasing the P/L ratio of CC but no significant 
decrease was found in VG when P/L was increased. EPLS had a gelation time 
longer than all except CC 1.2 where there was no significant difference. 
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Figure  4.5: Mean gelation (± SD; n=5) time of CC, VG at different P/L ratio and 
EPLS at 37°C 
(No significant difference between groups with same letters; p≤0.05) 
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8; PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
CC 1.2: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.2g/ml 
CC 1.8: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
 
Figure  4.6 shows the effect of gelation time on VG when CHD was added at 1% or 
9% with and without 0.5% NaF. There was no significant difference in gelation time 
when CHD was added to VG 1.8, and when CHD was increased from 1% to 9%. 
Also there was no significant difference when NaF was added to 1% and 9% CHD 
formulations.  
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Figure  4.6: Mean gelation time (± SD; n=5) of VG with the addition of 1% or 9% 
CHD with and without 0.5% NaF at 37°C 
(No significant difference between groups with same letters; p≤0.05) 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
 
 
 
Figure  4.7 shows the effect of gelation time on EPLS when CHD was added at 1% 
or 9% with and without 0.5% NaF. Gelation time increased with the addition of CHD 
but no significant difference was found when CHD was increased from 1% to 9% or 
with the addition of NaF to them. 
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Figure  4.7: Mean gelation time (± SD; n=5) of EPLS with the addition of 1% or 
9% CHD with and without 0.5% NaF at 37°C  
(No significant difference between groups with same letters; p≤0.05) 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
 
4.4 Water Absorption 
The water absorption of different formulations of tissue conditioners was measured, 
as described in section  3.2.8 (page 119), for 12 weeks; the formulations with the 
additives were studied over a period of 4 weeks. Figure  4.8 is an example showing 
good reproducibility between the specimens of EPLS 1%CHD in DW at 37°C. 
Results are presented as plots of mean percentage (%) weight change with SD 
against square root of time. It should be noted that when immersed, materials not 
only gained weight by absorption of water but also lost weight by loss of ethanol and 
plasticiser etc. and the measured weight change reflects the combined effect. 
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Figure  4.8: Reproducibility of water absorption plots of EPLS 1%CHD in DW at 
37°C 
 
The water uptake study of VG and VG Old was carried for 12 weeks and the results 
are shown in Figure  4.9. Both VG Old 1.3 and 1.8 showed similar water uptake 
profiles of weight loss up to day ~5 (t1/2 =587.9) where they started to gain weight at 
different rates (i.e. VG Old 1.8 gained weight more rapidly than VG Old 1.3 until the 
end of the experimental period). VG Old 1.8 gained more weight (9.1%±0.9) 
compared to VG Old 1.3 (1.3%±0.2).  Both VG 1.5 and 1.8 lost weight rapidly up to 
~34 days (t1/2 =1610) followed by an increase in weight to a final negative weight 
change of -5.8%±0.6 and -1%±0.8 respectively. This initial part is indicative of loss 
of material being the predominant process. VG 1.5 and 1.8 results are discussed 
later in detail in Figure  4.10.  
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weight loss for the higher P/L ratios. On comparing the uptake profiles of VG Old 
versus VG, these reflect the roles of the different plasticisers in the two formulations 
(BPBG verses ATBC). This will be further discussed in section 5.4. 
 
Figure  4.9: Mean (±SD; n=5) % weight change of VG and VG Old formulations 
in DW at 37°C 
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
VG Old 1.3: PEMA powder & 93%BPBG+7%ethanol; P/L ratio 1.3g/ml 
VG Old 1.8: PEMA powder & 93%BPBG+7%ethanol; P/L ratio 1.8g/ml 
 
 
Figure  4.10 shows the % weight change of VG at two P/L ratios i.e. 1.5 and 1.8. 
Both VG 1.5 and 1.8 lost weight rapidly up to ~34 days (t1/2 =1610) followed by an 
increase in weight to a final weight change of -5.8%±0.6 and -1%±0.8 respectively. 
This initial part is indicative of loss of material. When looking at the weight change 
data for the first 24 hours (t1/2 =293.9) more closely, it can be seen that the initial 
rapid weight loss for both VG 1.5 and 1.8 followed a similar profile up to 24 hours 
(t1/2 =293.9). After this time point the weight change plots began to lose/gain weight 
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at different rates. VG liquid contains 6.2% w/v ethanol (see Appendix A1), so when 
the P/L ratio was increased from 1.5 to 1.8 the ethanol content in the formulation 
decreased; this resulted in a lower weight loss than VG 1.5 and highlights the role of 
ethanol.  
 
 
Figure  4.10: Mean (±SD; n=5) % weight change of VG at two P/L ratios: 1.5 and 
1.8 in DW at 37°C for 12 weeks  
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
 
 
Figure  4.11 shows the % weight change of EPLS in DW at 37°C. Note EPLS is the 
experimental powder liquid system with 5% ethanol compared to 10% ethanol in 
VG. EPLS showed a rapid weight gain in the first hour (t1/2 =60) followed by a very 
small loss in weight (0.8% to 0.5%), until 8 hours (t1/2 =169.7); this is shown more 
clearly in Figure 4.11 followed by a steady increase until the end of the experimental 
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time period of 12 weeks. Figure  4.11 clearly shows the effect of reducing ethanol in 
the formulation where there is a continuous increase in % weight change after 8 
hours, compared to continuous weight loss as shown with the VG specimens. 
 
 
Figure  4.11: Mean (±SD; n=5) % weight change of EPLS in DW at 37°C for 12 
weeks  
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
 
 
Figure  4.12 shows the % weight change of EPGS in DW at 37°C. EPGS specimens 
showed a rapid weight gain in the first eight hours (t1/2 =169.7), followed by a slower, 
steady increase until the end of the experimental time period of 12 weeks. Clearly 
the early weight losses observed with VG 1.5 and 1.8 and EPLS were not evident 
with EPGS. This could be attributed to the formulation containing no ethanol and this 
will be discussed further in the next chapter. 
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Figure  4.12: Mean (±SD; n=5) % weight change of EPGS in DW at 37°C for 12 
weeks  
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
 
Figure  4.13 shows the % weight change for VG, EPLS and EPGS. Here the effect of 
ethanol in tissue conditioner formulations is seen more clearly. Materials containing 
more ethanol (VG 1.5 and 1.8; see appendix A1 for ethanol content in VG) show 
weight loss. This weight loss is due to loss of ethanol and plasticiser from the 
material. Reducing ethanol in the experimental formulation (EPLS) resulted in 
weight gain which was further enhanced in the absence of ethanol (EPGS). Since 
these are polymer liquid gels, the initial weight change is driven by the ethanol 
(where present) and subsequently ethanol and citrate leaching out. Also note that 
the standard deviations were much smaller for experimental formulations compared 
to VG 1.5 and 1.8. 
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Figure  4.13: Mean (±SD; n=5) % weight change of commercial and 
experimental tissue conditioner formulations in DW at 37°C for 12 weeks  
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
 
VG 1.8 (commercial control) had the same P/L ratio as EPLS, so this formulation 
was further studied with respect to addition of CHD and NaF. Figure  4.14 shows the 
% weight change for VG1.8 containing 1% or 9% CHD with and without the addition 
of 0.5% NaF, VG 1.8 is included as the control whose results could be compared 
with the same formulations containing CHD with and without NaF. All formulations 
showed weight loss. The addition of 1% CHD to the VG 1.8 formulations resulted in 
increased weight loss; this increase in weight loss was further enhanced with an 
increase in CHD to 9%. Addition of NaF enhanced the weight loss at both levels of 
CHD. All formulations lost weight continuously with the exception of VG 1%CHD+F, 
which started to increase in weight at the end of experiment. Again weight loss is 
indicative of loss of components, in this case CHD together with the other 
components. 
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Figure  4.14: Mean (±SD; n=5) % weight change of VG with the addition of 1% 
or 9% CHD with and without 0.5% NaF, in DW at 37°C for 4 weeks  
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
 
Figure  4.15 shows the % weight change of EPLS formulations incorporating 1% or 
9% CHD, with and without 0.5% NaF; EPLS is also included as a control. All 
formulations gained weight throughout the experiment. Although the weight change 
increased in the 1% and 9% CHD materials compared to control, there was very 
little difference in weight change between the two (9.5%±0.4 and 8.8%±1.3 
respectively); the amount of CHD in EPLS did not appear to have an effect on the 
weight change. Incorporation of NaF further increased the weight gain of EPLS 
formulations where 9%CHD+F had a higher weight change (47.6%±0.4) compared 
to EPLS 1%CHD+F (42%±2.5) at 4 weeks. Hence the lower ethanol content in 
EPLS reduced the effect on the weight change of increasing CHD from 1% to 9% 
although inclusion of NaF increased weight change; it had a more significant effect 
on 9%CHD compared to VG. 
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Figure  4.15: Mean (±SD; n=5) % weight change of EPLS with the addition of 1% 
and 9% CHD with and without 0.5% NaF in DW at 37°C for 4 weeks  
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
 
Figure  4.16 shows the % weight change of EPGS incorporating 1% or 9% CHD with 
and without 0.5% NaF, and also EPGS as the control. The weight gain of all 
formulations appeared to be linear with the t1/2 axis, with the exception of EPGS 
1%CHD+F, which was concave to this axis. The data for 1% and 9% CHD+F were 
plotted against time (Figure  4.17) to determine whether the % weight change were 
following Case II diffusion; however, the plots proved not to be linear. Closer 
inspection of Figure  4.16, does show a small initial linear region. Therefore initial 
uptake kinetics were Fickian followed by anomalous behaviour. As before weight 
gain was enhanced when 1% CHD was added to the control and it was further 
increased with the 9% CHD addition. Incorporation of NaF led to a further increase 
in weight gain for both 1% and 9% CHD formulation.  
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Figure  4.16: Mean (±SD; n=5) % weight change of EPGS with the addition of 
1% and 9% CHD with and without 0.5% NaF in DW at 37°C for 4 week 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
 
 
Figure  4.17: Mean (n=5) % weight change data of EPGS 1% & 9% CHD+F 
plotted against time in sec x105  
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Figures  4.18 and  4.19 show the comparison of the % weight change of tissue 
conditioner formulations containing 1% CHD with or without 0.5% NaF and 9% CHD 
with or without 0.5% NaF respectively. In both figures the effect of additives can be 
clearly seen. When CHD is added to the controls the weight loss/gain was increased 
which was amplified when NaF was incorporated along with CHD. In most cases the 
addition of NaF enhanced the % weight change in formulations with 1% CHD to a 
greater extent than the 9% CHD formulations. 
 
 
Figure  4.18: Mean (±SD; n=5) % weight change of 1%CHD tissue conditioner 
formulations with and without 0.5% NaF in DW at 37°C for 4 weeks 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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Figure  4.19: Mean (±SD; n=5) % weight change of 1%CHD tissue conditioner 
formulations with and without 0.5% NaF in DW at 37°C for 4 weeks 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
 
4.5 Water Desorption 
Although all formulations did not reach equilibrium after water absorption for 12 
weeks (for formulations without additives) and 4 weeks (for formulations with 
additives), the specimens were desorbed at 37°C, as described in section  3.2.9 
(page 121), for a period of 1 week to allow equilibrium to be reached. The results 
are presented as graphs of % weight loss against square root of time. The results 
are usually presented in positive weight loss but here they are presented in negative 
weight loss because VG formulations showed a weight loss during the uptake 
experiment. Therefore for consistency purposes they are shown in negative values. 
All tissue conditioner formulations showed a similar trend of a rapid initial weight 
loss which then reached a state of equilibrium. Clearly, desorption was much faster 
than the absorption process, with all systems reaching equilibrium within a week. 
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Figure  4.20 shows the % weight loss of VG, VG Old, EPLS and EPGS tissue 
conditioner formulations. VG Old, EPGS and EPLS reached equilibrium after 8 
hours with weight losses of 9%±0.4 for VG Old 1.3, 4.3%±0.2 for VG Old 1.8, 
5.6%±0.2 for EPGS and 4.8%±0.2 for EPLS, whereas the VG 1.5 and VG 1.8 
reached equilibrium after 24 hours with an increased weight loss of 15.6%±0.7 and 
19.1±0.4 respectively. The latter reflects the higher weight change observed in the 
absorption process. 
 
 
 
Figure  4.20: Mean (±SD; n=5) % weight loss of tissue conditioner formulations  
 VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
VG Old 1.3: PEMA powder & 93%BPBG+7%ethanol; P/L ratio 1.3g/ml 
VG Old 1.8: PEMA powder & 93%BPBG+7%ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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Figure  4.21 shows the % weight loss of VG formulations incorporating 1% or 9% 
CHD, with and without 0.5% NaF. All formulations, with the exception of VG 
9%CHD, showed an initial rapid weight loss over 24 hours after which they reached 
equilibrium, whereas VG 9% CHD reached equilibrium after 8 hours (13.7%±0.3). 
The formulation with 1%CHD+F showed the greatest weight loss.   
 
 
 
Figure  4.21: Mean (±SD; n=5) % weight loss of VG with the addition of 1% and 
9% CHD with and without 0.5% NaF  
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
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Figure  4.22 shows the % weight loss of EPLS formulations incorporating 1% or 9% 
CHD, with and without 0.5% NaF. All formulations showed an initial rapid weight 
loss up to 24 hours and then they reached equilibrium. The formulations containing 
CHD and F showed the greatest weight loss (9%CHD+F = 37.3%±0.2; 1%CHD+F = 
35%±0.1). 
 
 
 
Figure  4.22: Mean (±SD; n=5) % weight loss of EPLS with the addition of 1% 
and 9% CHD with and without 0.5% NaF  
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
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Figure  4.23 shows the % weight loss of EPGS formulations incorporating 1% or 9% 
CHD, with and without 0.5% NaF. All formulations showed an initial rapid weight 
loss up to 24 hours and then they reached equilibrium, except for EPGS 1% CHD, 
which showed the least weight loss (10.2%±0.3) and reached equilibrium after only 
4 hours.  EPGS 9% CHD+F showed the greatest weight loss (39.3%±0.3) followed 
by EPGS 9% CHD (27.8%±0.8) and then EPGS 1% CHD+F (26.3%±1). It should be 
noted that desorption for all formulations followed Fickian diffusion. 
 
 
 
Figure  4.23: Mean (±SD; n=5) % weight loss of EPGS with the addition of 1% 
and 9% CHD with and without 0.5% NaF  
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
 
 
-40
-35
-30
-25
-20
-15
-10
-5
0
0 200 400 600 800 1000
%
 W
e
ig
h
t 
C
h
a
n
g
e
Time t1/2 (sec)1/2
EPGS 1%CHD EPGS 9% CHD EPGS 1%CHD+0.5%F EPGS 9% CHD+0.5%F
Results 
154 
 
4.6 Solubility & Diffusion Coefficient 
The diffusion coefficients for the water absorption process could not be calculated 
as none of the formulations reached a state of equilibrium, hence only desorption 
diffusion coefficients were calculated. Figure  4.24 shows an example of a typical 
graph used to calculate the diffusion coefficient. The slope of the plot was calculated 
where Mt/M∞≤0.5. The desorption diffusion coefficient (Ddes) was then calculated 
using equation 4.7 (Section  3.2.10; page 121). 
 
 
Figure  4.24: Mt/M∞ graph of EPGS desorption against square root of time 
 
 Table  4.3 shows the mean, % uptake weight change, % solubility, % real uptake 
and Ddes data for the different tissue conditioner formulations. These were calculated 
using equations 4.4 to 4.7 (Section  3.2.10; page 121). All the values increased when 
P/L ratio of VG was increased from 1.5 to 1.8, except % solubility where no 
significant difference (p≤0.05) was found, with the exception of VG Old. Interestingly 
VG Old 1.3 gave a negative solubility result. This will be discussed in section 5.4. 
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Higher % solubility and % real uptake values also indicated more loss of 
components from the material. The diffusion coefficients for VG were significantly 
lower compared to EPLS and EPGS formulations. It appears that a change in 
plasticiser decreased the Ddes from 10
-10 m2sec-1 for VG Old to 10-11 m2sec-1 for VG. 
 
 
Table  4.3: Mean (±SD; n=5), % uptake weight change, % solubility, % real 
uptake and desorption diffusion coefficient data of different tissue conditioner 
formulations for 12 weeks 
Formulation 
% uptake 
Weight 
Change 
% Solubility 
% Real 
Uptake 
Ddes (m
2sec-1) 
VG 1.5 -5.77 ± 0.6 19.7 ± 1.6a 14.0 ± 2.1 2.56 x 10-11 
VG 1.8 -0.99 ± 0.8 20.2 ± 2.1a 19.3 ± 2.6 1.96 x 10-11 
VG Old 1.3 9.13 ± 0.9 -4.5 ± 0.3 4.7 ± 0.4a 1.03 x 10-10 
VG Old 1.8 1.30 ± 0.2 3.0 ± 0.1b 4.3 ± 0.3a 1.40 x 10-10 
EPLS 3.11 ± 0.3 1.9 ± 0.4b 5.0 ± 0.6a 5.59 x 10-10 
EPGS 4.93 ± 0.3 1.0 ± 0.4b 5.9 ±  0.5a 3.14 x 10-10 
(No significant difference between groups with same letters; p≤0.05) 
 
Table  4.4 shows the mean % uptake weight change, % solubility, % real uptake and 
Ddes data of different tissue conditioner formulations incorporating 1% or 9% CHD, 
with and without 0.5% NaF. Generally, and as expected, the % solubility increased 
with the addition of CHD, and when this was increased from 1% to 9% in all 
formulations. The addition of NaF also significantly increased the % solubility in all 
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the formulations except EPLS 9%CHD. VG formulations had significantly higher % 
solubility values compared to EPGS and EPLS. The opposite effect of % solubility 
can be seen for Ddes where increasing the CHD percentage from 1% to 9% 
decreased Ddes. Addition of 0.5% NaF also led to lower Ddes values. 
Table  4.4 Mean (±SD; n=5), % uptake weight change, % solubility, % real 
uptake and desorption diffusion coefficient data of different tissue conditioner 
formulations incorporating 1% or 9% CHD, and with or without 0.5% NaF for 4 
weeks 
Formulation 
% Uptake 
Weight 
change 
% Solubility 
% Real 
Uptake 
Ddes (m
2sec-1) 
VG+1%CHD -10.15 ± 1.4 22.8 ± 1.1 12.7 ± 0.1+ 3.49 x 10-11 
VG+9%CHD -24.80 ± 0.9 35.1 ± 1.0 10.3 ± 0.2- 1.40 x 10-10 
VG+1%CHD+F -17.62 ± 1.3 38.2 ± 2.0 20.6 ± 0.9 1.55 x 10-11 
VG+9%CHD+F -29.21 ± 1.7 41.9 ± 2.8 12.7 ± 1.1+ 2.56 x 10-11 
EPLS+1%CHD 9.51 ± 0.4a 1.7 ± 0.2A 11.2 ± 0.4+- 2.56 x 10-11 
EPLS+9%CHD 8.78 ± 1.3a 7.0 ± 0.3BC 15.7 ± 1.4 5.03 x 10-11 
EPLS+1%CHD+F 41.99 ± 2.5b 7.7 ± 0.5C 49.7 ± 1.2 1.16 x 10-11 
EPLS+9%CHD+F 47.60 ± 0.4 7.4 ± 0.9BC 55.0 ± 1.4 1.26 x 10-11 
EPGS+1%CHD 9.79 ± 0.9a 1.5 ± 0.5A 11.3 ± 0.3+- 5.03 x 10-11 
EPGS+9%CHD 30.96 ± 1.6 5.5 ± 0.4B 36.4 ± 1.5 2.23 x 10-11 
EPGS+1%CHD+F 25.04 ± 1.0 7.8 ± 0.5C 32.8 ± 0.4 1.96 x 10-11 
EPGS+9%CHD+F 42.30 ± 0.3b 10.8 ± 0.9 53.1 ± 1.2 1.04 x 10-11 
(No significant difference between groups with same letters; p≤0.05) 
Univariate Analysis of Variance to check the relationship between materials (VG, 
EPLS & EPGS), CHD conc. (1% & 9%) with or without NaF showed highly 
significant (p≤0.05) among the groups. 
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4.7 Chlorhexidine Release 
Prior to measuring the amount of CHD released from specimens, first a calibration 
curve was plotted as shown in Figure  4.25. From the slope of the line (y = 42.97x - 
0.0157) the amount of CHD released at each time interval, as described in 
section  3.2.11 (page 122), was calculated. The results are shown as plots of % CHD 
release against time in seconds and/or square root of time to identify possible 
release mechanisms involved.  
 
Figure  4.25: Calibration curve for chlorhexidine measurement 
 
Figures  4.26 and  4.27 show the % CHD release from VG 1% and 9% CHD, with and 
without the addition of 0.5% NaF. The amount of CHD released was reduced 
(47.3%±0.9 to 8%±2.5) at the end of 4 weeks with increasing CHD in the formulation 
from 1% to 9%. Incorporation of NaF in the systems increased the % release of 
CHD in both 1% and 9% CHD formulations. NaF had a greater effect on the release 
of CHD in the 1% CHD formulation; it increased its release by ~30% at the end of 
the experimental time period. 
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Figure  4.26:Mean (±SD; n=5) % CHD release of VG 1% & 9% with and without 
the addition of 0.5% NaF in DW at 37ºC for 4 weeks plotted against time in sec  
 
 
 
Figure  4.27: Mean (±SD; n=5) % CHD release of VG 1% & 9% with and without 
the addition of 0.5% NaF in DW at 37ºC for 4 weeks plotted against square root 
of time in sec1/2 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
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Figures  4.28 and  4.29 show the release of CHD (%) from EPLS containing 1% and 
9%CHD, with and without 0.5% NaF. Here again EPLS containing 1% CHD 
released more CHD (50.3±0.1) compared with EPLS 9%CHD (20.2± 0.3). Addition 
of NaF enhanced the CHD release which was more significant in EPLS 1% CHD+ F 
(78.9±0.2) than in EPLS 9% CHD+F (27.2±0.3). Also there was an initial rapid 
release seen in both formulations with NaF followed by a slower release. From 
Figure  4.29 it can be seen that by incorporating NaF the release profiles/ 
mechanisms have been changed.  
 
 
Figure  4.28: Mean (±SD; n=5) % CHD release of EPLS 1% & 9% CHD with and 
without the addition of 0.5% NaF in DW at 37ºC for 4 weeks against time in sec 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
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Figure  4.29: Mean (±SD; n=5) % CHD release of EPLS 1% & 9% CHD with and 
without the addition of 0.5% NaF in DW at 37ºC for 4 weeks against square 
root of time in sec1/2 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
 
Figure  4.30 and  4.31 show the % release of EPGS formulations containing 1% and 
9% CHD with and without 0.5% NaF. Again EPGS 1% CHD showed more release 
(5.7%±0.6) compared to EPGS 9% (2.6%±0.1). When NaF was added the release 
of CHD was further increased from both formulations (21.7%±0.4 and 3.9%±0.3 in 
EPGS 1%CHD+F and EPGS 9% CHD+F respectively). NaF had a more substantial 
effect on the formulation with 1% CHD release than the 9% CHD. In EPGS 
1%CHD+F there was an initial rapid release of CHD in the first 8 hours 
(t=0.288x105; t1/2=169.71) followed by a slower steady release. EPGS 9%CHD+F 
showed a similar release to EPGS 9%CHD up to day 10 (t=8.64x105; t1/2=929.52) 
and from this point onwards the former started to show a higher % CHD release up 
to the end of experimental time period of 4 weeks. 
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Figure  4.30: Mean (±SD; n=5) % CHD release of EPGS 1% & 9% CHD with and 
without the addition of 0.5% NaF in DW at 37ºC for 4 weeks plotted against 
time in sec 
 
 
 
Figure  4.31: Mean (±SD; n=5) % CHD release of EPGS 1% & 9% CHD with and 
without the addition of 0.5% NaF in DW at 37ºC for 4 weeks plotted against 
square root of time in sec1/2 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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Figures  4.32 and  4.33 shows the comparison of % CHD release in formulations 
containing 1% CHD with and without NaF; Figures  4.34 and  4.35 shows the 
formulations with 9%CHD with and without NaF. Figures 4.32 to 4.35 clearly show 
that incorporation of NaF enhanced the % release of CHD in all formulations; 
however it is more noticeable in the 1%CHD formulations. It can also be seen that 
the EPLS formulations (containing 5% ethanol) showed the highest % release 
whereas VG formulations containing a higher ethanol content (Appendix A1) had a 
lower % release and the release was further reduced in EPGS where no ethanol 
was used, thus highlighting the effect of ethanol content. 
 
 
Figure  4.32: Mean (±SD; n=5) % CHD release of tissue conditioner 
formulations containing 1% CHD with and without the addition of 0.5% NaF in 
DW at 37ºC for 4 weeks plotted against time in sec 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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Figure  4.33: Mean (±SD; n=5) % CHD release of tissue conditioner 
formulations containing 1% CHD with and without the addition of 0.5% NaF in 
DW at 37ºC  for 4 weeks plotted against square root of time in sec1/2 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
 
Figure  4.34: Mean (±SD; n=5) % CHD release of tissue conditioner 
formulations containing 9% CHD with and without the addition of 0.5% NaF in 
DW at 37ºC for 4 weeks plotted against time in sec 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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Figure  4.35: Mean (±SD; n=5) % CHD release of tissue conditioner 
formulations containing 9% CHD with and without the addition of 0.5% NaF in 
DW at 37ºC for 4 weeks plotted against square root of time in sec1/2 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
 
Generally the CHD release was in three phases as shown in Figure  4.36. A rapid 
burst seen in the first 24 hours, then a constant steady release up to 1 week, 
followed by a slower release rate from weeks 2 to 4. These time periods were used 
to calculate (using the equation of slope of the line y=mx+b) the CHD release rate 
per hour in first 24 hours and then as per day in 1st week and the last 3 weeks. 
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Figure  4.36: CHD release in EPGS 9%CHD showing release in first 24 hours 
(blue), 1 week (red) and week 2-4 release (green) 
 
Table  4.5 summarizes the CHD release at 24 hours, 1 week and 4 week time. 
Generally the 1% CHD formulations showed more % release than the 9% CHD 
formulations but in terms of weight, 9% CHD formulations showed greater release. 
In all formulations more than 50% of CHD in total was released within the 1st week. 
Later in 2-4 weeks a smaller quantity of CHD was released, especially in 
formulations not containing NaF. 
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Table  4.5: Summary of CHD release in % and in mg in different formulations at 
different time periods 
Formulations CHD Release 1 Day  1 week  4 week  
VG 1%CHD 
in % 14.0A 46.5@  47.3  
in mg 0.690 2.286 2.326 
VG 9%CHD 
in % 3.1B,D,E  6.9+ 8.0a 
in mg 1.359 3.036  3.527 
VG 1%CHD+F 
in % 28.0  66.5 77.1b 
in mg 1.158 3.459 4.014 
VG 9%CHD+F 
in % 5.8C,E  8.7+ 11.8  
in mg 2.717 4.080 5.536 
EPLS 1%CHD 
in % 8.8C  35.1  50.3  
in mg 0.493 1.955 2.802 
EPLS 9%CHD 
in % 3.9B,D,E 18.9~  20.2c 
in mg 1.775 8.639 9.274 
EPLS 1%CHD+F 
in % 19.9  44.5@ 78.9b 
in mg 1.111 2.489 4.416 
EPLS 9%CHD+F 
in % 15.3A  20.7~ 27.2  
in mg 8.629 11.680 15.388 
EPGS 1%CHD 
in % 1.8B 3.2# 5.7a,d 
in mg 0.089 0.157 0.278 
EPGS 9%CHD 
in % 1.0B,D 2.0# 2.6e 
in mg 0.449 0.840 1.117 
EPGS 1%CHD+F 
in % 6.2C,D,E  11.4  21.7c 
in mg 0.396 0.730 1.387 
EPGS 9%CHD+F 
in % 1.2B  2.0# 3.9d,e 
in mg 0.651 1.130 2.151 
(No significant difference between groups with same letters; p≤0.05) 
Univariate Analysis of Variance to check the relationship between materials (VG, 
EPLS & EPGS), CHD conc. (1% & 9%) with or without NaF showed highly 
significant (p≤0.05) among the groups. 
 
From the graphs of %CHD release against t1/2 of the different tissue conditioner 
formulations the gradients, after 24 hours and associated intercepts of the y-axis 
were calculated and shown in Table  4.6. The gradients show the rate of diffusion 
controlled release while the intercepts are an indication of the surface burst release. 
Negative values of the intercept on y-axis show absence of burst release. Generally 
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the VG formulations had the highest release rates (gradients) followed by EPLS and 
then EPGS. 
Table  4.6: Gradients & intercepts of plots (%CHD release vs square root of 
time after 24 hours to 1 week) of % CHD release of tissue conditioner 
formulations containing 1% and 9% CHD with and without the addition of 0.5% 
NaF 
Formulation 
% CHD release 
gradients 
% CHD release 
intercept 
VG+1%CHD 0.0604 -1.2659 
VG+9%CHD 0.0055 2.6369 
VG+1%CHD+F 0.0678 8.8685 
VG+9%CHD+F 0.0048 4.618 
EPLS+1%CHD 0.043 -2.9589 
EPLS+9%CHD 0.0373 -7.991 
EPLS+1%CHD+F 0.048 2.1709 
EPLS+9%CHD+F 0.0097 12.708 
EPGS+1%CHD 0.0029 0.8023 
EPGS+9%CHD 0.0017 0.4556 
EPGS+1%CHD+F 0.0091 3.57 
EPGS+9%CHD+F 0.0015 0.7754 
 
Table  4.7 shows a summary of CHD release rate in the different formulations at time 
periods shown in Figure  4.36. Generally the CHD release up to 1 day was increased 
with an increase of CHD from 1% to 9% and, this was further enhanced when NaF 
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was added. From 1 day to 1 week CHD release decreased, even when CHD was 
increased from 1% to 9%, except for EPGS, where it increased. The addition of NaF 
enhanced CHD release in all formulations, except for VG 9%CHD. From week 1 to 
week 4 the CHD release rate was more when CHD was increased from 1% to 9%, 
except for EPLS and the addition of NaF showed a higher release rate in all 
formulations except VG 9%CHD to it. Also the release rate of CHD was higher up to 
1 week compared to the release rates up to 4 week except for VG 9%CHD.  
 
Table  4.7 Summary of CHD release rate in different formulations at different 
time periods 
Formulations 
CHD release rate 
1 Day (mg/day) 1 week (mg/day) 4 week (mg/day) 
VG 1%CHD 0.69  0.259  0.001  
VG 9%CHD 1.36  0.173  0.259  
VG 1%CHD+F 1.46  0.259  0.017  
VG 9%CHD+F 2.72  0.173  0.060  
EPLS 1%CHD 0.49  0.173  0.035  
EPLS 9%CHD 1.77  0.089  0.034  
EPLS 1%CHD+F 1.11  0.263  0.086  
EPLS 9%CHD+F 8.63  0.432  0.173  
EPGS 1%CHD 0.09 0.009 0.004 
EPGS 9%CHD 0.45  0.052  0.009  
EPGS 1%CHD+F 0.39  0.043  0.026  
EPGS 9%CHD+F 0.65  0.060  0.043  
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4.8 Fluoride Release 
Fluoride was added to the different formulations containing 1% and 9% CHD in the 
form of sodium fluoride (NaF). The release of F ions in DW at 37°C was then 
measured at the same time periods as the CHD release, as described in 
section  3.2.11 (page 122). The results were plotted as % release of F against time in 
seconds and square root of time, to study the amount released and identify possible 
release mechanisms involved. However plots against time were not very helpful so 
only square root of time plots are shown. 
 
 Figures  4.37 and  4.38 show the % F release from VG, EPLS and EPGS with 1% 
CHD and 9% CHD respectively. In 1% and 9% CHD formulations, VG (containing 
the highest ethanol content) showed the highest % F release followed by EPLS 
(containing 5% ethanol) while EPGS (containing no ethanol) showed the lowest 
release. From Figure  4.37 the effect of ethanol on the release profile is clearly seen, 
where in the absence of ethanol the release in EPGS is less. VG and EPLS have 
similar release profiles but different to EPGS, up to 2 weeks (t1/2=1099.8). The 
release slows after 2 weeks (t1/2=1099.8) for both EPLS and EPGS whereas little or 
no effect is seen in VG formulations (Figure  4.37). A similar effect was seen in 
formulations with 9% CHD (Figure  4.38), where the F release slowed in all 
formulations after 2 weeks (t1/2=1099.8), more noticeably for EPLS and EPGS than 
VG. Figure  4.38 shows that all three materials containing 9% CHD have similar 
release profiles up to 24 hours (t1/2=1099.8). Release then diverges with VG 
releasing the highest amount followed by EPLS and then EPGS, again showing the 
effect of ethanol. 
.   
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Figure  4.37: Mean (±SD; n=5) % fluoride release of 1% CHD formulations 
containing 0.5% NaF in DW at 37ºC for 4 weeks  
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
 
 
Figure  4.38: Mean (±SD; n=5) % fluoride release of 9% CHD formulations 
containing 0.5% NaF in DW at 37ºC for 4 weeks  
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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Table  4.8 summarizes the fluoride release as part per million (ppm) and % after 24 
hours, 1 week and after 4 week. Here it is clearly seen that all 1% CHD formulations 
released less fluoride (both ppm and %) compared to their 9% CHD counterparts at 
all time points. At all time points, for both 1% and 9% CHD formulations EPGS 
released less F than VG and EPLS (in ppm and %). 
 
 At 1 day there was no significant difference in the F release of VG and EPLS for 
both levels of CHD. Although the EPGS formulations showed the lowest F released, 
increasing the CHD incorporated from 1% to 9% increased the amount of F released 
more than fivefold; this was higher than for VG and EPLS. After 1 week EPLS 
1%CHD+F had released more F than either VG or EPGS, however for the 9%CHD 
formulations, VG had released the highest amount. Increasing the amount of CHD 
from 1% to 9% had more of an effect on release from EPGS and VG than EPLS. 
 
After 4 weeks VG had released significantly more F than either EPLS or EPGS, 
particularly for the 9% CHD formulations. Differences in release may be related to 
ethanol content and solubility (see Table  4.4; page 156) where VG has by far the 
highest solubility. 
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Table  4.8: Summary of fluoride release at different time periods 
Formulation 
Fluoride release  
1 Day 1 week 4 week 
ppm % ppm % ppm % 
VG 1%CHD+F 0.61 5.2a 1.43 12.2 3.86 32.8 
VG 9%CHD+F 0.85 7.3b 3.80 32.2 7.87 66.9 
EPLS 1%CHD+F 0.73 5.8a 1.84 14.6A 2.65 21.0 
EPLS 9%CHD+F 0.90 7.0b 2.72 21.3 4.46 34.9 
EPGS 1%CHD+F 0.12 0.9 0.66 4.6 2.36 16.4 
EPGS 9%CHD+F 0.71 5.1a 2.18 15.7A 3.23 23.3 
(No significant difference between groups with same letters; p≤0.05) 
 
From the graphs of %F release against t1/2 of the different tissue conditioner 
formulations the gradients, after 24 hours and associated intercepts of the y-axis 
were calculated and shown in Table  4.9. The gradients of the plots show the rate of 
diffusion controlled release while the intercepts are an indication of the surface burst 
release. Negative values of the intercept on y-axis show absence of burst release in 
all 9%CHD+F formulations. EPGS formulations had the lowest release rates 
(gradients) while VG 9%CHD+F showed the highest.  
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Table  4.9: Gradients & intercepts of plots (%F release vs square root of time 
after 24 hours to 1 week) of % F release of tissue conditioner formulations 
containing 1% and 9% CHD with and without the addition of 0.5% NaF 
Formulation 
% F release 
gradients 
% F release 
intercept 
VG+1%CHD+F 0.0138 0.9243 
VG+9%CHD+F 0.0492 -8.2664 
EPLS+1%CHD+F 0.0162 1.0255 
EPLS+9%CHD+F 0.0307 -3.224 
EPGS+1%CHD+F 0.0029 0.2337 
EPGS+9%CHD+F 0.02 -0.8912 
 
4.9 Shore A Hardness and Young’s Modulus 
Low hardness is an essential requirement for tissue conditioners to function 
effectively; the required level will depend on intended application (Table  2.2; page 
44). Shore A hardness values of all commercial and experimental materials were 
measured at 1 sec dwell time to minimize the effect of creep. The materials were 
stored at 37oC in different storage media i.e. Dry, distilled water (DW) and artificial 
saliva (AS) before testing.  
 
Effect of immersion on Shore A hardness varied between materials and storage 
conditions especially between dry and DW or AS. This reflects differences in 
gelation time, composition (e.g. ethanol content, which is highest in VG followed by 
EPLS and no ethanol in EPGS) and how the materials behave in the various 
environment (e.g. loss of ethanol, plasticiser etc).  
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4.9.1 Commercial and Experimental Materials 
Two commercial materials CC and VG were selected for use as commercial controls 
as they are recommended for the main three clinical applications of tissue 
conditioners as described in section  2.3 (page 38). All the commercial materials 
were mixed using the manufacturer’s recommended P/L ratio and an experimental 
P/L of 1.8 g/ml.  
 
Figures  4.39 to  4.41 show the mean Shore A hardness of VG1.5 and 1.8, CC 1.2 
and 1.8, EPLS and EPGS at different time periods when stored at 37°C in dry, DW 
and AS respectively. EPGS formulations were left to gel for 16 hours after mixing, so 
in all plots time of 1 hour is referred to as 16 hours after mixing. A similar pattern is 
seen for all formulations where the Shore A hardness increased with time in different 
media with the exception of dry (Figures  4.39 to  4.41). This increase in Shore A 
hardness was seen more in DW, followed by AS then dry. In CC and VG increasing 
the P/L ratio also increased the Shore A hardness.   
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When stored dry (Figure  4.39), Shore A hardness of all materials increased more 
over the first 24 hours and, then from 24 hours to 1 week, there was no significant 
difference except for CC 1.2. The increase in Shore A hardness from 1 hour to 24 
hours reflects the continuation of the gelation process, which is more noticeable in 
the P/L formulations. The continuing increase of Shore A hardness from 24 hours to 
1 week for CC 1.2 probably results from continuing gelation due to its lower P/L.  
 
 
Figure  4.39: Mean (±SD; n=6)  Shore A hardness values of CC and VG 
formulations at different P/L ratios, EPLS and EPGS stored dry at 37°C  
(No significant difference between groups with same letters; p≤0.05) 
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
CC 1.2: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.2g/ml 
CC 1.8: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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In DW (Figure  4.40) all formulations increased in Shore A hardness with time and 
with increasing P/L ratio for CC and VG. CC 1.2 showed a smaller increase in Shore 
A hardness from 1 hour to 24 hours and then a greater increase from 24 hours to 1 
week, whereas with all other formulations the increase in Shore A hardness was 
more from 1 hour to 24 hours than from 24 hours to 1 week. The Shore A hardness 
for each of the materials were significantly different at 1 week, except for VG 1.5 and 
VG 1.8; EPLS and CC 1.2, where there was no statistical difference.  
 
 
 
Figure  4.40 Mean (±SD; n=6)  Shore A hardness values of CC and VG 
formulations at different P/L ratios, EPLS and EPGS stored in DW at 37°C  
(No significant difference between groups with same letters; p≤0.05) 
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
CC 1.2: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.2g/ml 
CC 1.8: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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In AS (Figure  4.41) again Shore A hardness increased with time in all formulations 
with the exception of VG 1.5 where there was no significant difference found 
between 24 hours and 1 week, indicating difference in the balance between the 
effect on Shore A hardness of plasticiser loss (hardening) and fluid uptake 
(softening). CC 1.2 had a greater increase from 24 hours to 1 week than 1 hour to 
24 hours. At all time points the Shore A hardness of each of the materials were 
significantly different, except for VG 1.5 and EPLS at 1 week. 
  
 
 
 
Figure  4.41 Mean (±SD; n=6)  Shore A hardness values of CC and VG 
formulations at different P/L ratios, EPLS and EPGS stored in AS at 37°C 
(No significant difference between groups with same letters; p≤0.05) 
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
CC 1.2: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.2g/ml 
CC 1.8: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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Figure  4.42 shows the mean Young’s modulus (calculated as explained in 
section  3.2.5; page 117) for CC 1.2 & 1.8, VG 1.5 & 1.8, EPLS at 24 hours and 
EPGS in dry. CC 1.8 showed the highest value of Young’s modulus and CC 1.2 
showed the lowest value. In CC and VG increasing the P/L ratio also increased the 
Young’s modulus of the material. Note that the Young’s modulus of EPGS (16 hours 
after mixing) is very similar to VG 1.5 and EPLS (no significant difference in Shore A 
hardness as shown in Figure  4.39 to Figure  4.41). 
 
 
Figure  4.42: Mean (n=6) Young’s modulus of CC, VG, EPLS formulations 24 
hours after mixing and EPGS  
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
CC 1.2: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.2g/ml 
CC 1.8: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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4.9.2 Addition of CHD with and without 0.5% NaF 
This section of the results shows the effect of the addition of 1% or 9% CHD with 
and without 0.5% NaF, on the Shore A hardness and Young’s modulus of VG 1.8, 
EPLS and EPGS formulations. The results are displayed so that the effect of 
increase in CHD from 1% to 9%, and the effect of the addition of 0.5% NaF, can be 
compared in different storage media. Changes in Shore A hardness as well as being 
influenced by the factors noted at the start of this section will additionally be affected 
by the presence of additives. 
 
Figures  4.46 to  4.52 show the mean Shore A hardness of VG 1.8, EPLS and EPGS 
1% or 9% CHD formulations, with and without the addition of 0.5% NaF, stored at 
37°C in dry, DW and AS respectively. Generally, the Shore A hardness values 
increased with increasing time in all media, the increase being highest in DW 
followed by AS and then dry. When stored dry, there was little or no change in 
Shore A hardness between 24 hours and 1 week with some exceptions which are 
highlighted below. 
 
Figures  4.43 to  4.45 show the mean Shore A hardness of VG 1.8, 1% or 9% CHD 
formulations with and without the addition of 0.5% NaF, stored at 37°C in dry, DW 
and AS respectively. At 1 hour the addition of 1% CHD increased the Shore A 
hardness but there was no significant difference found when NaF was added. 
Increasing CHD from 1% to 9% decreased the Shore A hardness and the addition of 
NaF to 9%CHD increased the Shore A hardness significantly at 1 hour. Increase in 
Shore A hardness from 1 hour to 24 hours was more in 9%CHD than other 
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formulations. For VG stored dry (Figure  4.43), (except for 1%CHD), there was no 
significance difference found between Shore A hardness at 24 hours and 1 week.  
 
Figure  4.43: Mean (±SD; n=6) Shore A hardness values of VG, VG 1% and 9% 
CHD with and without 0.5% NaF stored dry at 37°C  
(No significant difference between groups with same letters; p≤0.05) 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
 
 
In DW (Figure  4.44) although the Shore A hardness of VG 1.8 increased with the 
addition of 1%CHD it was lower at 24 hours and, at 1week, there was no significant 
difference between the two. Increasing the CHD from 1% to 9%CHD decreased 
Shore A hardness at 1 hour but at 24 hours and 1 week the values were higher. 
Addition of NaF to 9%CHD increased the Shore A hardness which were significantly 
higher at each time point. A similar trend was also seen in AS (Figure  4.45). 
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Figure  4.44 Mean (±SD; n=6) Shore A hardness values of VG, VG 1% and 9% 
CHD with and without 0.5% NaF stored in DW at 37°C  
(No significant difference between groups with same letters; p≤0.05) 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
 
 
Figure  4.45 Mean (±SD; n=6) Shore A hardness values of VG, VG 1% and 9% 
CHD with and without 0.5% NaF stored in AS at 37°C 
(No significant difference between groups with same letters; p≤0.05) 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
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Figures  4.46 to  4.48 show the mean Shore A hardness of EPLS, 1% or 9% CHD 
formulations with and without the addition of 0.5% NaF, stored at 37°C in dry, DW 
and AS respectively. Addition of 1%CHD to EPLS resulted in an increase in Shore A 
hardness which was further increased in the 9%CHD specimens. Addition of NaF to 
both 1% and 9%CHD had no significant effect on the Shore A hardness at 1 hour. In 
all storage conditions addition of NaF to 1%CHD resulted in a further increase at 1 
week but this effect was not seen for 9%CHD.   
 
Stored dry (Figure  4.46), the Shore A hardness of EPLS increased significantly from 
24 hours to 1 week for 9%CHD+F; for all other formulations there was no significant 
difference between values after 24 hours and 1 week. 
 
 
 
Figure  4.46: Mean (±SD; n=6)  Shore A hardness values of EPLS 1% and 9% 
CHD with and without 0.5% NaF stored dry at 37°C  
(No significant difference between groups with same letters; p≤0.05) 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
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In DW (Figure  4.47) the Shore A hardness of EPLS showed no significant difference 
between 1%CHD and 1%CHD+F after 24 hours and between 1%CHD+F and 
9%CHD+F at both 24 hours and 1 week. 
 
 
 
 
 
Figure  4.47 Mean (±SD; n=6)  Shore A hardness values of EPLS 1% and 9% 
CHD with and without 0.5% NaF stored in DW at 37°C 
(No significant difference between groups with same letters; p≤0.05) 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
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In AS (Figure  4.48), addition of 1% CHD increased the Shore A hardness at all time 
points, which was further increased when CHD was increased to 9%. Addition of 
NaF increased the Shore A hardness in 1%CHD after 24 hours and 1week but 
reduced the Shore A hardness of 9%CHD at the same time points.  
 
 
Figure  4.48 Mean (±SD; n=6)  Shore A hardness values of EPLS 1% and 9% 
CHD with and without 0.5% NaF stored in AS at 37°C  
(No significant difference between groups with same letters; p≤0.05) 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
 
 
Figures  4.49 to  4.51 show the mean Shore A hardness of EPGS, 1% and 9% CHD 
formulations with and without addition of 0.5% NaF stored at 37°C dry, in DW and in 
AS respectively. In all media, at 1 hour the Shore A hardness of EPGS increased 
when 1%CHD was added but no significant difference was found when NaF was 
added to 1%CHD. Also Shore A hardness decreased when CHD was increased 
from 1% to 9% at the same time points.  
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Stored dry (Figure  4.49), all formulations of EPGS increased in Shore A hardness 
from 24 hours to 1 week except EPGS and 9%CHD+F. There was also no 
significant difference between 1% and 9% CHD after 1 week.  
 
 
Figure  4.49: Mean (±SD; n=6)  Shore A hardness values of EPGS 1% and 9% 
CHD with and without 0.5% NaF stored dry at 37°C 
(No significant difference between groups with same letters; p≤0.05) 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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In DW (Figure  4.50), Shore A hardness of EPGS showed no significant difference in 
1% and 9%CHD with and without NaF after 24 hours. However, Shore A hardness 
increased after 1 week when 1%CHD was added and further increased when CHD 
was increased to 9%, but addition of NaF decreased the Shore A hardness 
significantly for both.  
 
 
 
Figure  4.50: Mean (±SD; n=6)  Shore A hardness values of EPGS 1% and 9% 
CHD with and without 0.5% NaF stored in DW at 37°C 
(No significant difference between groups with same letters; p≤0.05) 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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Figure  4.51 showed that after 24 hours EPGS 9%CHD had a higher Shore A 
hardness than 1%CHD but when NaF was added there was no significant difference 
between the two. Also Shore A hardness showed a similar trend in AS after 1 week 
as seen in DW, but to a lesser extent.  
 
 
 
 
Figure  4.51: Mean (±SD; n=6)  Shore A hardness values of EPGS 1% and 9% 
CHD with and without 0.5% NaF stored in AS at 37°C 
(No significant difference between groups with same letters; p≤0.05) 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
 
 
Figure  4.52 shows a comparison of the mean Shore A hardness of VG 1.8, EPLS 
after 24 hours and EPGS with and without additives. Addition of CHD with or without 
NaF had more effect on EPLS and EPGS compared to VG 1.8. Effect of additives 
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EPGS. The addition of 1%CHD increased Shore A hardness except for VG1.8, VG 
1%CHD and EPLS 1%CHD having similar Shore A hardness. Increasing CHD to 
9% increased Shore A hardness for VG and EPLS but decreased Shore A hardness 
for EPGS, where there was no significant difference between VG 9%CHD and 
EPGS 9%CHD. For VG and EPGS adding NaF increased Shore A hardness for 1% 
and 9%CHD, but for EPLS there was no increase in 1%CHD and a decrease for 
9%CHD. 
 
 
 
Figure  4.52: Mean (±SD; n=6) Shore A hardness values of VG, EPLS (24 hour 
after mixing) and EPGS, 1% and 9% CHD with and without 0.5% NaF 
formulations in dry  
(No significant difference between groups with same letters; p≤0.05) 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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Figure  4.53 shows the mean Young’s modulus of VG, EPLS and EPGS formulations 
with and without the addition of the additives. The trends seen here are similar (as 
would be expected) to the ones seen in Figure  4.52. It should be noted that Young’s 
modulus was calculated for each materials at each time point, under each condition, 
and these are displayed in the Appendix. 
 
 
Figure  4.53: Mean Young’s modulus of VG, EPLS (24 hour after mixing) and 
EPGS, 1% and 9% CHD with and without 0.5% NaF formulations in dry oven 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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in determining suitability for tissue conditioner applications as detailed in 
section  2.6.3 (page 68). Here creep is used to measure the flow. The higher the 
creep in a material the greater will be the flow. 
4.10.1 Commercial and Experimental Materials 
The Shore A hardness of the different formulations decreased with increasing dwell 
time and this is seen in all the formulations at different time periods when stored in 
different media but to different extents. A typical plot of Shore A hardness at 
different dwell times is shown in Figure  4.54 which shows the results for CC1.2, CC 
1.8, VG 1.5, VG 1.8, EPLS and EPGS formulations stored dry for 24 hours at 37°C. 
The rest of the Shore A hardness data at 1 hour, 24 hours and 1 week when stored 
dry, DW and in AS with and without additives are given in the Appendix. 
 
 
Figure  4.54: Mean (n=6)  Shore A hardness values of VG, CC, EPLS and EPGS 
formulations at different dwell times stored at 37°C dry for 24 hours 
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
CC 1.2: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.2g/ml 
CC 1.8: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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Table  4.10 shows the mean CCR of CC (1.5 and 1.8), VG (1.5 and 1.8) and EPLS at 
1 hour and EPGS using a 30 sec dwell time for maximum effect of creep. EPLS 
showed the highest CCR followed by VG 1.8 whereas EPGS had the lowest CCR 
compared to all other formulations. A high CCR indicates more flow (creep) in the 
material. 
 
Table  4.10: Mean (±SD; n=6) CCR of different formulations using 30 sec dwell 
time after 1 hour 
Material 
CCR after 1 
hour 
CC 1.2 6.3 ± 0.4 
CC 1.8 5.1 ± 0.04 
VG 1.5 64.0 ± 6.4 
VG 1.8 31.4 ± 1.3 
EPLS 49.0 ± 5.5 
EPGS 2.6 ± 0.1 
 
Figures  4.55 to  4.60 shows the mean CCR of CC (1.2 and 1.8), VG (1.5 and 1.8) 
EPLS and EPGS formulations when stored at 37°C for a) 24 hours and b) 1week 
dry, in DW and in AS respectively. The CCR in general increased with increasing 
dwell time and decreased with the storage time, with a few exceptions which are 
discussed below. Interaction with the immersion fluids will effect CCR as well as 
differences in the materials composition. 
 
Figures  4.55 and 4.56 show the mean CCR of CC (1.2 and 1.8), VG (1.5 and 1.8) 
EPLS and EPGS formulations when stored at 37°C dry after 24 hours and 1 week 
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respectively. The CCR of all the formulations showed an increase from 24 hours to 1 
week except CC1.8 and VG1.8. This increase was more in CC1.2 than the other 
formulations (Table  4.11) which could be attributed to its low P/L ratio. 
 
 
Figure  4.55: Mean CCR of VG, CC, EPLS and EPGS at different dwell times 
when stored at 37°C in dry oven after 24 hours  
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
CC 1.2: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.2g/ml 
CC 1.8: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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Figure  4.56: Mean CCR of VG, CC, EPLS and EPGS at different dwell times 
when stored at 37°C in dry oven after 1 week 
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
CC 1.2: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.2g/ml 
CC 1.8: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
 
Figures  4.57 and 4.58 show the mean CCR of VG CC (1.5 and 1.8), VG (1.5 and 
1.8) EPLS and EPGS formulations when stored at 37°C in DW after 24 hours and 1 
week respectively. All formulations showed a reduction in CCR with time but to a 
different extent. EPLS showed the highest CCR, both after 24 hours and 1 week, 
and VG 1.8 showed the least change in CCR.  
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Figure  4.57: Mean CCR of VG, CC, EPLS and EPGS at different dwell times 
when stored at 37°C in DW after 24 hours 
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
CC 1.2: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.2g/ml 
CC 1.8: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
 
 
 
Figure  4.58: Mean CCR of VG, CC, EPLS and EPGS at different dwell times 
when stored at 37°C in DW after 1 week 
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
CC 1.2: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.2g/ml 
CC 1.8: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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Figures  4.59 and 4.60 show the mean CCR of VG CC (1.5 and 1.8), VG (1.5 and 
1.8) EPLS and EPGS formulations when stored at 37°C in AS after 24 hours and 1 
week respectively. EPLS and CC 1.2 showed the highest CCR after 24 hours 
whereas after 1 week VG 1.5 and EPLS showed the highest CCR.  CCR generally 
decreased from 24 hrs to 1 week, but there was little or no change for CC1.8, VG 
1.5 and VG 1.8. 
 
Figure  4.59: Mean CCR of VG, CC, EPLS and EPGS at different dwell times 
when stored at 37°C in AS after 24 hours 
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
CC 1.2: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.2g/ml 
CC 1.8: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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Figure  4.60: Mean CCR of VG, CC, EPLS and EPGS at different dwell times 
when stored at 37°C in AS after 1week 
VG 1.5: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.5g/ml 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
CC 1.2: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.2g/ml 
CC 1.8: PEMA powder & benzyl benzoate+ ester stearic acid+6.2% ethanol; P/L ratio 1.8g/ml 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
 
Table  4.11 summarises the mean CCR of different formulations using 30 sec dwell 
time after 24 hours and 1 week dry, in DW and in AS. Stored dry, CCR either 
increased or remained constant with time, whereas in DW and AS CCR either 
decreased or remained constant. When immersed in either DW or AS CC 1.2, EPLS 
and EPGS showed higher decreases after 1 week. 
 
 
 
 
1
1.5
2
2.5
3
3.5
0 5 10 15 20 25 30
C
re
e
p
 c
o
m
p
li
a
n
c
e
 r
a
ti
o
Dwell time (sec)
1 week AS
VG 1.5 VG 1.8 CC 1.2 CC 1.8 EPLS EPGS
Results 
197 
 
Table  4.11: Mean (±SD; n=6) CCR of different formulations using 30 sec dwell 
time after 24 hours and 1 week 
Material 
Dry  DW AS 
24 hour 1 week 24 hour 1 week 24 hour 1 week 
CC 1.2 4.9 ± 0.05 6.6 ± 0.03 
2.0A ± 
0.01 
1.7B ± 
0.07 
3.4- ± 
0.06 
1.8* ± 
0.04 
CC 1.8 
1.7a ± 
0.01 
1.7a ± 
0.03 
1.8C ± 
0.06 
1.3 ± 0.03 
1.6* ± 
0.04 
1.5* ± 
0.02 
VG 1.5 2.0b ± 0.2 
2.3c ± 
0.04 
2.1D ± 
0.04 
2.0A ± 
0.01 
2.5+ ± 
0.03 
2.5+ ± 
0.17 
VG 1.8 
1.9b ± 
0.02 
1.8a,b ± 
0.04 
1.8C ± 
0.01 
1.7B,C ± 
0.02 
1.7* ± 
0.002 
1.7* ± 
0.17 
EPLS 3.5 ± 0.2 3.9 ± 0.09 2.7 ± 0.01 
2.2D ± 
0.01 
3.5- ± 0.1 
2.5+ ± 
0.02 
EPGS 2.3c ± 0.1 
2.4c ± 
0.02 
2.6 ± 0.04 
1.8C ± 
0.01 
2.5+ ± 
0.01 
1.8* ± 
0.06 
(No significant difference between groups with same letters/symbols; p≤0.05) 
 
Table  4.12 shows the penetration ratio of different formulations of tissue 
conditioners after 24 hours and 1 week dry, in DW and in AS. When stored dry 
penetration ratio generally increased in all formulations except VG where it 
decreased particularly VG 1.5. When stored in DW and AS the ratio decreased in all 
formulations with the exception of VG when stored in AS where the ratio increased, 
particularly VG 1.5 and in DW where there was no change. 
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Table  4.12: Penetration ratio (R) of different formulations after 24 hours and 1 
week 
Material 
Dry  DW AS 
24 hour 1 week 24 hour 1 week 24 hour 1 week 
CC 1.2 1.47 1.55 1.3 1.19 1.46 1.18 
CC 1.8 1.2 1.23 1.25 1.11 1.21 1.17 
VG 1.5 1.42 1.15 1.26 1.26 1.37 1.45 
VG 1.8 1.27 1.2 1.22 1.2 1.19 1.2 
EPLS 1.52 1.58 1.41 1.32 1.65 1.42 
EPGS 1.36 1.37 1.4 1.26 1.44 1.26 
 
 
4.10.2 Addition of CHD with and without 0.5% NaF 
Table  4.13 shows the mean CCR of VG, EPLS and EPGS, 1% and 9% CHD 
formulations with and without the addition of 0.5% NaF at 30 sec dwell time. It 
should be noted that the CCR of VG and EPLS are at 1 hour after mixing whereas 
EPGS takes 16 hour to gel and the readings are after I hour i.e. 17 hours after 
mixing. EPLS formulations showed the highest CCR followed by VG formulations 
and EPGS showed the lowest CCR. Addition of 1% CHD to the controls decreased 
the CCR. Increasing the CHD from 1% to 9% increased the CCR and addition of 
NaF had a variable effect, increasing the CCR for VG 1%CHD and EPGS but 
decreasing for VG 9%CHD and EPLS formulations. EPGS had the lowest CCR but 
this was the least affected by the addition of CHD or NaF. CCR were also calculated 
for 5, 10, 15, 20 and 25 sec dwell time for each material when stored dry, in DW and 
in AS, 1 hour, 24 hours and 1 week after mixing. These data follow the trends in 
Table  4.13 and Figures 4.61 to 4.69, and are displayed in the Appendix. 
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Table  4.13: Mean (±SD; n=6) CCR of VG and EPLS after 1 hour and EPGS; 1 & 
9% CHD with or without 0.5% NaF using 30 sec dwell time  
Material 1 hour 
VG 1.8 31.4 ± 1.3 
VG 1%CHD 6.8 ± 0.2 
VG 9%CHD 23.2 ± 1.8 
VG 1%CHD+F 10.0 ± 0.3 
VG 9%CHD+F 9.1 ± 0.4 
EPLS 49.0 ± 5.5 
EPLS 1%CHD 16.6 ± 3.2 
EPLS 9%CHD 26.0 ± 4.8 
EPLS 1%CHD+F 10.3 ± 0.3 
EPLS 9%CHD+F 15.2 ± 0.6 
EPGS 2.6 ± 0.1 
EPGS 1%CHD 2.3 ± 0.1 
EPGS 9%CHD 2.6 ± 0.02 
EPGS 1%CHD+F 2.9 ± 0.05 
EPGS 9%CHD+F 2.7 ± 0.1 
 
 
Figures  4.61 to  4.63 show the mean CCR of VG 1.8, VG 1% and 9% CHD, with and 
without 0.5% NaF using 30 sec dwell time after 24 hours and 1 week when stored 
dry, in DW and in AS respectively at 37°C.  
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Dry (Figure  4.61), mean CCR values of VG 1.8 formulations decreased from 24 
hours to 1 week but for all except 9%CHD+F there was no statistical difference, also 
there were no statistical difference in CCR between 24 hours and 1 week for VG 1.8 
and VG 1%CHD+F formulations. Addition of NaF to 1%CHD increased CCR at both 
time points. Addition of 9%CHD increased the CCR at both time points, which was 
further increased when NaF was added.  
 
 
 
Figure  4.61: Mean (±SD; n=6) CCR of VG, VG 1% and 9% CHD with and without 
0.5% NaF using 30 sec dwell time stored dry at 37°C 
(No significant difference between groups with same letters; p≤0.05) 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
 
 
 
 
0
0.5
1
1.5
2
2.5
3
VG 1.8 1%CHD 9%CHD 1%CHD+F 9%CHD+F
C
re
e
p
 c
o
m
p
li
a
n
c
e
 r
a
ti
o
Dry
24 hour
1 week
a,b
a,b
a
b
c c,d
c,d
c
d
Results 
201 
 
In DW (Figure  4.62), there was no effect of immersion time on CCR of VG 1.8 
formulations except for 9%CHD, where it increased and 9 %CHD+F, where it 
decreased. At both time points addition of 1%CHD increased CCR which was 
further increased in 9% CHD. Addition of NaF had no effect on CCR for 1% CHD but 
decreased it for 9% CHD.  
 
 
 
 
 
Figure  4.62: Mean (±SD; n=6) CCR of VG, VG 1% and 9% CHD with and without 
0.5% NaF using 30 sec dwell time stored in DW at 37°C 
(No significant difference between groups with same letters; p≤0.05) 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
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In AS (Figure  4.63), there was no significance difference in CCR after 24 hours and 
1 week for VG 1.8, 9%CHD and 1%CHD+F whereas it decreased in the other 
formulations with time from 24 hours to 1 week. Addition of 1% and 9% CHD 
increased the CCR at both time points which was further increased when NaF was 
added to 1%CHD (no significant difference at 24 hours) but decreased for 9%CHD. 
 
 
 
 
 
 
Figure  4.63: Mean (±SD; n=6) CCR of VG, VG 1% and 9% CHD with and without 
0.5% NaF using 30 sec dwell time stored in AS at 37°C 
(No significant difference between groups with same letters; p≤0.05) 
VG 1.8: PEMA powder & 90%ATBC+10%ethanol; P/L ratio 1.8g/ml 
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Figures  4.64 to  4.66 shows the mean CCR of EPLS, EPLS 1% and 9% CHD, with 
and without 0.5% NaF using 30 sec dwell time at 24 hours and 1 week when stored 
dry, in DW and in AS respectively at 37°C.  
 
Dry (Figure  4.64), there was no statistical difference in CCR of EPLS after 24 hours 
and 1 week for all formulations. Addition of 1%CHD increased the CCR but was 
decreased when CHD was increased to 9% and further decreased when NaF was 
added to both 1% and 9% CHD formulations.  
 
 
 
Figure  4.64: Mean (±SD; n=6) CCR of EPLS, EPLS 1% and 9% CHD with and 
without 0.5% NaF using 30 sec dwell time stored dry at 37°C 
(No significant difference between groups with same letters; p≤0.05) 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
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In DW (Figure  4.65), CCR of EPLS decreased with time from 24 hours to 1 week in 
all formulations. Addition of 1%CHD increased the CCR but was decreased when 
CHD was increased  to 9% and addition of  NaF also decreased the CCR of both 
1% and 9%CHD at both time points. There was no statistical  difference between 
EPLS 24 hours and 1% CHD+F 24 hours, similarly 9% CHD 1week and 1% CHD+F 
1 week were statistically similar.   
 
 
 
 
Figure  4.65: Mean (±SD; n=6) CCR of EPLS, EPLS 1% and 9% CHD with and 
without 0.5% NaF using 30 sec dwell time stored in DW at 37°C 
(No significant difference between groups with same letters; p≤0.05) 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
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In AS (Figure  4.66), CCR decreased with time for EPLS and the two NaF containing 
formulations whereas it increased for  9%CHD but there was no significant 
difference for 1%CHD. Addition of 1%CHD had no effect on CCR at 24 hours but 
increased at 1 week. When CHD was increased to 9% CCR decreased and 
incorporating NaF also decreased CCR in both 1% and 9%CHD at both time points. 
 
 
 
 
 
Figure  4.66: Mean (±SD; n=6) CCR of EPLS, EPLS 1% and 9% CHD with and 
without 0.5% NaF using 30 sec dwell time stored in AS at 37°C  
(No significant difference between groups with same letters; p≤0.05) 
EPLS: PEMA powder & 95% ATBC+5%ethanol; P/L ratio 1.8g/ml 
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Figures  4.67 to  4.69 show the mean CCR of EPGS, EPGS 1% and 9% CHD, with 
and without 0.5% NaF using 30 sec dwell time after 24 hours and 1 week when 
stored dry, in DW and in AS respectively at 37°C.  
 
Dry (Figure  4.67), there was no significant difference in CCR of EPGS formulations 
from 24 hours to 1 week except EPGS 1%CHD and 9%CHD where it increased. 
Addition of 1%CHD increased the mean CCR (was not statistically significant) but 
decreased when NaF was added after 1 week. CCR was decreased when CHD was 
increased to 9% but increased when NaF was added after 24 hours but remained 
statistically constant after 1 week.  
 
 
 
Figure  4.67: Mean (±SD; n=6) CCR of EPGS, EPGS 1% and 9% CHD with and 
without 0.5% NaF using 30 sec dwell time stored dry at 37°C 
(No significant difference between groups with same letters; p≤0.05) 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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In DW (Figure  4.68), CCR of EPGS formulations decreased with time except for 1% 
CHD and 1% CHD+F where there was no statistical difference. Addition of 1%CHD 
decreased the CCR of EPGS after 24 hours only but had no effect after 1 week, 
similarly it was unchanged after 24 hours when CHD was increased to 9% but 
decreased after 1 week. Addition of NaF increased the CCR both in 1% and 
9%CHD, but after 1 week no significant difference was found in 9% CHD.  
 
 
 
 
 
 
 
 
Figure  4.68: Mean (±SD; n=6) CCR of EPGS, EPGS 1% and 9% CHD with and 
without 0.5% NaF using 30 sec dwell time stored in DW at 37°C  
(No significant difference between groups with same letters; p≤0.05) 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
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In AS (Figure  4.69), CCR of EPGS decreased with time in all formulations and after 
1 week there was no statistical difference between them. After 24 hours addition of 
1%CHD increased CCR but its value decreased when CHD was increased to 9% 
and with the addition of NaF to both. There was also no significant difference in 
CCR found between 1 %CHD+F and 9% CHD+F after both 24 hours and 1 week. 
 
 
Figure  4.69: Mean (±SD; n=6) CCR of EPGS, EPGS 1% and 9% CHD with and 
without 0.5% NaF using 30 sec dwell time stored in AS at 37°C  
(No significant difference between groups with same letters; p≤0.05) 
EPGS: PEMA powder & ATBC; P/L ratio 1.2g/ml 
 
Table  4.14 shows the penetration ratio of VG, EPLS and EPGS containing 1 and 9% 
CHD with or without 0.5% NaF when stored dry, in DW and in AS after 24 hours and 
1 week. At 24 hours the penetration ratio increased (or remained the same) for VG 
and EPLS when 1% and 9%CHD with or without 0.5% NaF was added, the effect on 
EPGS was more variable.  When stored dry the penetration ratio mainly increased 
with time, from 24 hours to 1 week, in all formulations except VG where it 
decreased. When stored in DW and AS the penetration ratio in general decreased 
with time in all formulations. This reduction was more in AS compared to DW. 
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Table  4.14: Penetration ratio (R) of VG, EPLS and EPGS; 1 & 9% CHD with or 
without 0.5% NaF after 24 hours and 1 week 
Material 
Dry  DW AS 
24 hour 1 week 24 hour 1 week 24 hour 1 week 
VG 1.8 1.27 1.2 1.22 1.2 1.19 1.2 
VG 1%CHD 1.33 1.22 1.30 1.27 1.31 1.25 
VG 9%CHD 1.40 1.34 1.40 1.38 1.28 1.33 
VG 1%CHD+F 1.41 1.34 1.42 1.27 1.36 1.34 
VG 9%CHD+F 1.42 1.42 1.24 1.21 1.29 1.24 
EPLS 1.52 1.58 1.41 1.32 1.65 1.42 
EPLS 1%CHD 1.74 1.70 1.48 1.48 1.47 1.51 
EPLS 9%CHD 1.60 1.62 1.34 1.26 1.46 1.55 
EPLS 1%CHD+F 1.55 1.60 1.43 1.25 1.40 1.26 
EPLS 9%CHD+F 1.50 1.62 1.30 1.21 1.31 1.16 
EPGS 1.36 1.37 1.40 1.26 1.44 1.26 
EPGS 1%CHD 1.42 1.49 1.27 1.24 1.51 1.26 
EPGS 9%CHD 1.27 1.34 1.25 1.15 1.30 1.22 
EPGS 1%CHD+F 1.34 1.36 1.33 1.33 1.25 1.25 
EPGS 9%CHD+F 1.40 1.34 1.28 1.20 1.26 1.23 
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5 Discussion 
Tissue conditioners have been used since the 1960’s (Chase, 1961) as chairside 
materials for application to the patient’s denture, cushioning the traumatised tissues, 
thus allowing them to recover. The P/L tissue conditioner systems contain ethanol 
as an essential component since it controls the gelation process. However, due to 
the problems associated with ethanol, as described in the Literature Survey, for 
example, leaching of ethanol causing irritation to the inflamed mucosa of patients 
and compromising the materials properties, it would be highly advantageous to 
develop a tissue conditioner with less or no ethanol. P/L systems also suffer from 
porosity which can lead to microbial ingress and subsequent fouling. Development 
of a pre-gelled tissue conditioner excluding ethanol would offer a solution to both 
problems.  Hence this was one of the aims of this project.  
 
There are pre-gelled materials currently available on the market but the majority are 
for home use, e.g. Snug and Dinabase 7, where they are more popular than the P/L 
versions. However the majority of them contain large amounts of solvents ( Murata 
et al. (2010) and, in the case of Dinabase 7, also require heating prior to application.  
The development of a pre-gelled tissue conditioner for clinical use, where they can 
be monitored, would be of obvious advantage. 
 
When developing a new tissue conditioner formulation it is important to have 
knowledge of its basic properties that make it appropriate for its use. These 
properties include gelation time, water uptake behaviour, hardness and creep 
compliance (flow properties). Gelation time is important as these materials are used 
at the chairside and therefore a short gelation time is desirable. However with a pre-
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gelled system this is not important. Due to these materials being used in an aqueous 
environment it is essential to study their water uptake behaviour and their interaction 
with the environment in which they are used. Similarly hardness and creep define 
the materials usage in a particular clinical situation. 
 
5.1 Development of Pre-gelled Systems 
The pre-gelled tissue conditioner system developed here did not contain ethanol; 
the final formulation selected for further investigation was PEMA+ATBC with P/L 1.2 
g/ml, referred to as experimental pre-gelled system (EPGS). It was selected based 
on its low Shore A hardness, high CCR (flow) values and the solubility parameter (δ) 
of the ATBC being similar to PEMA (the plasticiser is more compatible with the 
polymer powder). However, it should be noted that preparation of this final system 
took a considerable amount of time since several problems arose during its 
development. These are discussed below.   
 
Citrate based plasticisers, namely acetyltri-n-butyl citrate (ATBC) and butyryl tri-n-
hexyl citrate (BTHC) were selected for developing the experimental pre-gelled 
materials, since they are more biocompatible (Nishijima et al., 2002; Johnson, 2002) 
than some other commonly used plasticisers. Furthermore, Dhiman (2004) 
recommended the use of these two plasticisers in tissue conditioners. It was 
anticipated that these plasticisers would naturally gel with the PEMA powder. The 
weight average molecular weight (Mw) and molar volume of both citrate plasticisers 
(BTHC and ATBC: 514 g/mol and 504 cm3; 402 g/mol and 372.6 cm3 respectively) 
were compared with butyl phthalyl butyl glycollate (BPBG), a commonly used 
plasticiser in commercial tissue conditioners (Takamata et al., 2007); (336 g/ml and 
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300.7 cm3). The higher molecular weight and molar volume of BTHC and ATBC 
would mean that these plasticisers may experience more difficulty in penetrating the 
polymer chains so in turn they will slow the gelation process; however, leaching into 
the oral environment and subsequent hardening may be reduced.  
 
ATBC and BTHC were mixed with PEMA powder in different powder/liquid (P/L) 
ratios respectively; all ATBC formulations formed a coherent gel after 16 hours 
whereas BTHC failed to do so. Mixtures of ATBC and BTHC in three percentages 
(70:30, 50:50 and 30:70 v/v) were also tried. However, 30:70 ATBC and BTHC 
failed to form coherent gels after 16 hours at 37°C. To accelerate gel formation the 
temperature of BTHC based gels was raised to 75°C, which was above the Tg of 
PEMA. At high temperatures the intermolecular forces in the polymer chains reduce 
and they become more mobile. It was anticipated that this may facilitate plasticiser 
ingress and gel formation, but again no coherent gels were formed within 16 hours. 
This may be attributed to BTHC’s higher molecular weight and molar volume 
compared to ATBC and BPBG, as discussed subsequently. The addition of ethanol, 
or more time, may be required to facilitate the gelation process, both of which were 
thought as being not feasible for commercial production. However, further tests 
(hardness and creep) were carried out before selecting the appropriate final 
experimental formulation 
 
Dhiman (2004) investigated a range of citrate plasticisers in tissue conditioners 
formulations and reported that formulations containing BTHC had longer gelation 
times compared to the other citrate plasticisers used. Other authors have also 
reported that plasticisers with higher molecular weights /molar volume slowed the 
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gelation process (Parker and Braden, 1990; Li, 2007; Jones et al., 1988; Murata et 
al., 2005). 
 
Shore A hardness was used to screen the pre-gelled formulations in the pilot study. 
The Shore A hardness of the pre-gel systems, containing ATBC only, showed that 
increasing the P/L ratio increased the Shore A hardness, which is typical behaviour 
of tissue conditioners as seen in previous studies (Dhiman, 2004; Ali, 2010). Creep 
compliance ratio (CCR) of these formulations decreased with increasing P/L ratio. 
This enables tissue conditioners with a range of properties to be produced for use in 
different clinical situations such as temporary soft lining material and tissue 
conditioner.  Mixtures of ATBC and BTHC for the pre-gelled systems had a higher 
Shore A hardness and lower CCR compared to the counterpart containing ATBC 
only. There was no change in CCR in 30:70 and 50:50 ATBC and BPBG 
formulation. Based on these preliminary pilot studies, EPGS emerged as a suitable 
pre-gelled material and was investigated further with respect to other physico-
mechanical properties.  
 
For EPGS to be a viable commercial material it should have stable physical 
properties on storage (shelf life) and this was assessed based on the stability of the 
Shore A hardness results. When stored at 23°C (room temperature) there was a 
constant increase in the Shore A hardness up to 18 months. However when stored 
at 7°C (refrigerated) the materials stabilized after 2 days, and the hardness 
remained constant with no significant difference (p≤0.05) over 18 months. A 
possible explanation for this could be that at 23°C there is continuing entanglement 
of the polymer chains within the gel with time (Parker and Braden, 1990; Murata et 
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al., 2005), thus resulting in an increase in Shore A hardness. When stored at 7°C 
the mobility of the chains may be greatly decreased due to the lower temperature.  
 
5.2 Particle Size Analysis 
Particle size of the PEMA powder in tissue conditioners is important as it influences 
gelation time and thus handling characteristics. As can be seen from Table 4.2 the 
PEMA used in VG had a smaller average particle size D[v,0.5] than the PEMA 
powder used for EPLS (despite being ball milled) and for EPGS (un-milled). 
However ball milling has been shown not only to reduce particle size, as it did in this 
study, but also to change particle shape.  
 
Dhiman (2004) used scanning electron microscopy to investigate the effect of ball 
milling on PEMA powder.  He showed that after 16 hours ball milling the resulting 
powder had smaller, but also, more irregular shaped particles compared to un-
milled, which were spherical. He went on also to show that ball milling PEMA 
powder decreased gelation time of the resulting tissue conditioners, this effect was 
also demonstrated by other authors (Parker and Braden, 2001; Dhiman, 2004; Li, 
2007). Parker and Braden (2001) also attributed the decrease in gelation time to 
increased surface area of the ball milled PEMA in addition to the decrease in particle 
size.  They proposed that ball milling the polymer powder of a tissue conditioner can 
be used to enable ethanol content to be reduced while maintaining an adequate 
gelation time. Li (2007) demonstrated this where mixing a liquid containing ATBC 
with un-milled PEMA powder gave a gelation time of ~85 min but using PEMA 
powder ball milled for 16 hours decreased the gelation time to ~18 min. Thus EPLS 
was formulated using a ball milled PEMA powder. 
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5.3 Gelation Time 
Gelation time for the commercial materials (VG and CC) was measured using the 
recommended P/L ratio and a higher P/L ratio of 1.8g/ml. The latter was due to the 
manufacturers suggesting that increasing the P/L ratio of the mix will give a stiffer 
mix and will speed up the gelation process. The results from this study agreed with 
this suggestion where increasing the P/L ratio decreased the gelation times.        
                                                               
The gelation process begins when the powder and liquid are mixed together and the 
polymer beads start to swell in the presence of ethanol to allow the penetration of 
the plasticiser molecules resulting in gel formation. Thus the presence of ethanol 
acts as an accelerator to the gelation process (Parker and Braden, 1990). In a study 
by Parker and Braden (1996) ethanol content was found to have the most significant 
effect on gelation compared to molar volume of plasticiser, particle size and degree 
of ball milling the powder. Other factors that can affect gelation time are, for 
example, amount of ethanol, ball milling of polymer powder, P/L ratio and 
temperature.  
 
Gelation times (Figure 4.5) for VG and CC decreased with an increase in P/L ratio. 
The differences in gelation time between VG 1.8, CC 1.8 and EPLS (all with the 
same P/L ratio) were due to ethanol content (EPLS contained less ethanol) and 
different plasticiser in CC. The liquid of the latter contained a mixture of benzyl 
benzoate (plasticiser; Mw = 212.2 g/mol), ester stearic acid (Mw = 284.4 g/mol) and 
6.2% ethanol in the liquid (Takamata et al., 2007). 
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When comparing the gelation time results of VG and CC with other studies it was 
found that gelation time of CC ranged from ~46.1 min to ~16 min (Graham et al., 
1991a; Murata et al., 1997; Dhiman, 2004) and VG from ~6 min to ~16 min (Graham 
et al., 1991a; Murata et al., 1997; Parker and Braden, 2001; Murata et al., 2001a; 
Dhiman, 2004; Parker and Braden, 1996). The mean gelation times of CC and VG 
found in this study were 24.5 min and 11.8min respectively; these are within the 
range of the results obtained in other studies. The variation of results in different 
studies can be attributed to the variation in measuring techniques (weight versus 
volume to dispense powder and liquid), P/L ratio and temperature.  Also commercial 
materials are continuously been changed to improve their properties and it should 
be noted that VG in previously reported studies contained BPBG as the plasticiser. 
No other studies have been published which focused on VG formulations containing 
ATBC.  
 
The recommended composition by Li (2007; i.e. 16 hours ball milled PEMA powder 
with 95%ATBC and 5% ethanol) was used for EPLS. However the gelation time 
reported by Li was 15.5 min, whereas in this study the gelation time was found to be 
22.5. This is more likely to be due to the variation in molecular weight distribution of 
the polymer powder used in these studies. 
 
The gelation time of VG was not affected by the addition of CHD at either level, or 
when NaF was added. The gelation time of EPLS was increased significantly with 
the addition of 1%CHD, but further addition of CHD to 9%, or incorporation of NaF at 
both levels, had no further effect. Ethanol content is known to be a major factor in 
determining the gelation time (Parker and Braden, 1996; Murata et al., 1993). 
Therefore it can be assumed for VG, which has a higher ethanol content, gelation 
Discussion 
218 
 
will be less affected by other factors. EPLS, with a lower ethanol content, may be 
influenced more by other factors including addition of CHD and NaF.  
 
5.4 Water Uptake Study 
Tissue conditioners are used in the oral environment which can vary greatly in terms 
pH, temperature and with food and liquid intake. When developing new formulations, 
since it is difficult to mimic the oral environment in the laboratory, it is critical to 
understand the materials interaction with, for example, distilled water, and how this 
affect their physical properties. DW acts as a useful guide to study the diffusion 
processes without the complications of osmotic effects of the constituents of the 
immersion solutions as would be found in AS. 
 
In an aqueous environment water diffuses into the tissue conditioner and at the 
same time some components (plasticiser and ethanol, if present) leach out; the 
material will harden with time (Braden, 1970a; Jones et al., 1988; Parker and 
Braden, 1990). The leaching of these constituents is assumed to be the opposite of 
the gelation process where they penetrate the polymer chains during gel formation 
(Jones et al., 1988).  The change in weight of the tissue conditioner will indicate 
which process is predominant (Liao et al., 2012).  
 
The water uptake of VG, EPLS and EPGS formulations was measured in DW, at 
37°C, over 12 weeks (3 months), to cover the time they would function as temporary 
soft lining materials, and for 4 weeks (1 month) for those containing CHD and 
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with/without NaF, to behave as short term tissue conditioners (Graham et al., 
1991b).  
 
There was an early rapid weight loss seen only in VG in the first 24 hours, followed 
by a continued weight loss and a final weight change of ~-5.77% after 3 months. Its 
behaviour was not in line with previous studies where Addy and Handley (1981) 
reported ~2% uptake (at ~87 days which is a similar time period to the present 
study), Murata et al. (2001b) reported ~3.5% uptake after 21 days,  Sample (2001) 
reported ~3.4% in 140 days and Dhiman (2004) reported ~2.9% after 160 days 
immersion DW. The difference between previous studies and this present study is 
probably due to the change in composition of the VG liquid. Previously, the latter 
contained BPBG as a plasticiser but this has now been substituted by a citrate-
based plasticiser (Dentsply, 2014). Due to the latter, additional changes to the 
formulation may have been necessitated (e.g. ethanol content to maintain handling 
characteristics). Hence, change of plasticiser appears to have affected the water 
uptake characteristics. This is further supported by the percentage weight change 
results obtained in this project for VG Old (containing BPBG) and VG (containing a 
citrate plasticiser). The former presented with an uptake of ~1.2% for the 1.3 P/L 
ratio and ~ 9% for the 1.8P/L ratio compared with ~-5.7% for the VG 1.5 P/L ratio 
and ~-0.9% for the 1.8 P/L ratio.  
 
As mentioned earlier, ATBC has a higher molecular weight and molar volume 
compared to BPBG. Researchers have suggested that lower molecular weight 
plasticisers can leach out more easily compared to higher molecular weight 
plasticisers (Murata et al., 2001b; Sample, 2001; Dhiman, 2004; Hong et al., 2012). 
This was not the case for VG in this study as explained above. It could be argued 
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that ATBC is aliphatic and a linear molecule whereas BPBG is aromatic, containing 
a benzene ring. Therefore, it may have been easier for ATBC to penetrate the 
polymer chains, and its linear structure may have facilitated its leaching.  
 
The weight loss of VG was lower when the P/L ratio was increased from 1.5 g/ml to 
1.8 g/ml because increasing the P/L ratio reduced the amount of liquid present, thus 
the amount of ethanol and plasticiser present in the material. This therefore led to a 
lower weight loss at this ratio. On comparing the two experimental formulations 
EPLS (P/L) and EPGS (pre-gelled), the former initially gained weight and then lost 
weight in the first 24 hours, whereas the latter gained weight during this period. The 
differences in the initial uptake profiles can be attributed to the loss of ethanol and 
some plasticiser from EPLS. Hence, the effect of ethanol content has been 
confirmed by the varying weight change profiles in the first 24 hours for VG 
(containing the highest amount of ethanol), EPLS (containing 5% ethanol) and 
EPGS (containing no ethanol) (see appendix A1). Similar findings of ethanol being 
lost in the first 24 hours, have been reported by (Jones et al., 1988). In EPLS the 
ethanol loss facilitated plasticiser loss (Parker and Braden, 1990; Murata et al., 
1994). Some researchers have reported that materials containing more ethanol lost 
more weight due to it being more soluble in water and having a small molecular size 
compared to the plasticiser; therefore it will leach easily (Braden and Causton, 1971; 
Murata et al., 1996; Dhiman, 2004). 
 
When comparing the final weight change of VG with EPLS and EPGS, the former 
presented with negative weight loss whereas both EPLS and EPGS had a net 
weight gain. This can be attributed to the differences in compositions of the 
formulations of the three systems (e.g. ethanol content and P/L ratio) and the 
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differences in particle size of the polymer powders used. Overall, the weight 
changes seen are a combination of water being absorbed by the samples and 
simultaneously, ethanol and plasticiser leaching. The higher weight increase of 
EPGS could be due to a lower P/L ratio (1.2g/ml) and thus higher plasticiser content 
compared to EPLS. In addition there was no ethanol in EPGS so there was no early 
weight loss. Hence, ethanol and plasticiser leaching form VG is the predominant 
process whereas in EPLS and EPGS water uptake seems to be the predominant 
process.  
 
Addition of 1% CHD enhanced the weight changes in all formulations of tissue 
conditioners. VG showed an increased weight loss whereas EPLS and EPGS 
showed increased weight gains. On increasing the CHD content from 1% to 9% 
increased i) the weight loss in the case of VG, ii) the weight gain in the case of 
EPGS, and iii) no significant change (p≤0.05) for EPLS. The further addition of 0.5% 
NaF to both 1% and 9% CHD increased the weight loss in VG and weight gains in 
EPLS and EPGS. This is because CHD and NaF acted as water soluble impurities 
and hydrophilic sites and for droplet formation. The osmotic pressure of the solution 
in these internal droplets increased until they balanced the restraining force of the 
material, thus leading to higher water uptakes. Although the presence of CHD in the 
systems increased the water uptake, the further addition of NaF had a much greater 
effect due to its high solubility and low Mw (Sample, 2001). This means NaF 
solutions formed higher osmotic pressures than CHD (Patel et al., 1998) even 
though the incorporated weight (%) of the former was low.  
 
The results found here are in line with other studies where addition of CHD 
increased the water uptake of the materials, and this was further enhanced with the 
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addition of NaF. Parker et al. (1997a) reported the effect of CHD incorporation  on 
gels containing PEMA with 10% ethanol and BPBG immersed in DW for 4 weeks at 
37°C. Addition of 0.9% CHD gave a weight change of 2.5% and, when 9% CHD was 
added, this increased to 9.6% weight change. Sample (2001) reported that the % 
weight change for experimental tissue conditioners, with a similar composition to 
Parker et al. (1997), had 4.1% and 14.1% weight change for 0.9% and 9% CHD 
containing materials respectively. When 0.5% NaF was added to 0.9% CHD the 
weight change (%) increased to 36.1%. Similar trends were reported by Hassan 
(2007), where the weight change (%) after 2 weeks immersion in DW at 37°C, of 
PEMA mixed with 95% ATBC and 5% ethanol increased from 2.1% to 7.5% when 
1%CHD was added and, the uptake was further enhanced to 32.6%, when 0.5% 
NaF was added. In this study EPLS had the same composition as Hassan’s 
materials and its % weight changes after 2 weeks were at a similar level of 6.5% for 
1%CHD and 30.3% for 1%CHD+F. 
 
Generally all water uptakes plots against t½ appeared linear, with the exception 
EPGS 9%CHD+F and EPGS1%CHD+F, the latter material being concave to the t½ 
axis. To determine whether the weight changes (%) were following Case II diffusion 
in the latter material, the water absorption data were plotted against time. However, 
the plots proved not to be linear. Therefore it can be concluded that in the presence 
of sodium fluoride the water uptake process for EPGS became complex and was 
anomalous (i.e. non-Fickian).  
 
Due to the complex nature of the uptake profiles, in order to get a better 
understanding of the processes involved, the water absorption data for all systems 
was analysed further for evidence of Fickian diffusion as described subsequently. If 
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the data is plotted as log uptake against log time (Eq 6.1) and a linear relationship is 
presented, the gradient of the linear region will determine if the process is Fickian. 
Hence, if the gradient is ~0.5, then the uptake behaviour is classed as Fickian 
(Sample, 2001)  
2
1
ktuptake=      Eq 6.1 
then 
 logklogtuptakelog +=
2
1
   Eq 6.2 
Figure  5.1 shows a typical example of a log weight change (%) against log time (in 
seconds) plot; the rest of the plots are displayed in the Appendix.  EPLS, EPLS 
1%CHD, EPGS and EPGS1%CHD+F gave gradients less than 0.4 showing that 
diffusion behaviour was not Fickian in nature. All other formulations yielded a 
gradient between 0.4 and 0.6, and hence indicate that uptake behaviour was 
Fickian. It could be argued that because tissue conditioners are soft materials a 
typical swelling behaviour is seen during water uptake compared to crack formation 
in rigid polymers (Parker et al., 1997a; Patel and Braden, 1991; Parker and Braden, 
1989). Also, the crosslinks between the polymer chains are time dependent because 
there is no chemical reaction in the formation of the gel, compared to polymerised 
polymers. All these factors affect the diffusion behaviour. 
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Figure  5.1: log of % weight change of EPLS 1%CHD+F against log time (sec) 
 
After the water uptake studies the materials were desorbed at 37°C for 1 week. All 
formulations showed similar weight loss profiles presented as a rapid weight loss in 
the first 24 hours, followed by equilibrium within a period of 1 week, as reported in 
other studies (Hassan, 2007; Dhiman, 2004; Sample, 2001). All t½ plots showed an 
initial linear region thus indicating that water desorption was Fickian in nature  Also 
for diffusion to be Fickian, plots of Mt/M∞ (weight of sample at time, t, divided by 
equilibrium weight of sample) against the square root of time should yield a straight 
line (Patel and Braden, 1991). The data was re-plotted in this manner to obtain the 
slope, which was then used to calculate the diffusion coefficients for the desorption 
process (Ddes). Generally Ddes values increased when CHD amount was increased in 
the formulation from 1% to 9% (except for EPLS) and when NaF was added (except 
VG 9%CHD). Interestingly, it should be noted that Ddes was in the region of 10
-10sec-
1 for EPLS, EPGS and VG Old and slower for VG (10-11 m2sec-1). Again this is a 
reflection of the amount of ethanol in the latter.  
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This is further confirmed by the solubility results, which show that VG formulations 
had very high solubility values compared to VG Old, EPLS and EPGS. Similarly, 
solubility and real uptake (%) were increased when CHD was added and when the 
amount was increased from 1% to 9%; the effect was further enhanced when NaF 
was added. It is again assumed that is due to the higher ethanol content in VG and 
experimental formulations. All real uptake values were high for all formulations 
containing additives (CHD and NaF). This also suggests that as the water was 
drawn into the materials, the droplets around impurities/additives continued to grow, 
due to creep, until the restraining forces on the droplet by polymer matrix, equalled 
the osmotic pressure difference between the external solution and the droplet 
(Sample, 2001). It should be noted that VG old 1.3P/L presented with a negative 
solubility (-4.3 ± 0.3), indicating that the material gained weight after desorption. This 
could mean that the surfaces of the samples were weakly bonded with impurities. 
Although this finding has not been reported before in the literature for tissues 
conditioners; similar findings have been reported for water uptake of dental 
composites from AS (Mustaza et al., 2014).  
 
5.5 Chlorhexidine and Fluoride Release 
CHD was added to the formulations as 1% and 9% by weight of the total mix, where 
1% CHD showed a higher %CHD (but lower weight) release compared to the 
formulations containing 9% CHD; this release was further enhanced when 0.5% 
NaF was incorporated to both levels of CHD. Several factors affect the release of 
CHD from these materials. CHD is soluble in ethanol (1 part CHD is soluble in 15 
parts of 96% ethanol; MSDS-CHD, 2011; (Sigma, 2011)). Therefore the formulations 
containing more ethanol should release more CHD. This proved to be the case 
where VG formulations (containing the highest amount of ethanol) presented with 
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higher CHD release followed by EPLS (containing 5% ethanol) and then EPGS 
(containing no ethanol). Another possible mechanism by which ethanol may 
facilitate CHD release is by the formation of paths or other local structural changes 
that would facilitate leaching (Sample, 2001).  This theory seems unlikely, given the 
viscoelastic nature of these materials; even if paths were developed due to leaching 
of ethanol, they will not remain as permanent plastic deformations in the material. It 
is also logical to assume that a higher level of CHD will be released first from the 
surface and, subsequently to a lesser extent decreasing with time, from within the 
gel. This was evident from the amount of CHD released where more was released in 
the 1st week compared to the subsequent three weeks, both in terms of actual 
weight and percentage. 
 
Another factor that may affect CHD release is the pH of the immersion solution. It 
has been shown by different studies that more CHD is released in acidic solutions 
compared to neutral solutions, because the solubility of CHD at low pH is higher 
(10.4 g/L at pH 4) than at higher pH (3.6g/L at pH 6) (Shen et al., 2010; Anusavice 
et al., 2006). The normal pH of the oral cavity ranges between 6.2 to 7.5 (Aframian 
et al., 2006), which can vary according to food or drink intake, so more CHD would 
be released if the oral cavity was slightly acidic compared to a neutral pH. When 
fresh DW comes in contact with air, carbon dioxide dissolves in it forming carbonic 
acid that gives the DW a pH between 5 and 6. A study conducted by Uddin (2014) 
reported the pH of DW as 6.1±0.3; this same source of DW was used in this study, 
so this may result in higher release of CHD from the materials.  
 
Parker et al. (1997a) reported CHD release as 1.14mg and 10mg from 0.9% and 9% 
CHD by weight respectively from a tissue conditioner containing PEMA with 10% 
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ethanol and BPBG after 4 weeks in solution whereas EPLS 1%CHD and 9%CHD 
showed a release of 2.8mg and 9.27mg in 4 weeks, comparing both results a similar 
release is seen after 4 weeks although ATBC was used in the current studies with 
5% ethanol. Sample (2001) reported 0.82mg and 9.86 mg of CHD release 
respectively with the same composition used by Parker et al. (1997a) but over 120 
days. Sample (2001) also reported that tissue conditioners containing BMA/EMA 
with 2% ethanol and ATBC released 0.51mg and 6.98mg CHD when 0.9wt% and 
9wt% CHD were incorporated. The compositions containing more ethanol released 
more CHD, which is in agreement with the trends seen in this study. Furthermore, 
when NaF was added to 0.9% containing CHD, release was increased from 0.51mg 
to 2.94mg. Again the same effect of enhanced release with the addition of NaF was 
seen in this study. This might be attributed to the fact that CHD is positively charged 
and F is a negatively charged ion, so during water absorption chlorhexidine 
difluoride is formed (Shen et al., 2010). Also NaF increases the water uptake and 
swelling of the materials thus facilitating a higher amount of CHD release as 
indicated by the higher solubility values shown in Table 4.4. 
 
It was noted that initial %CHD release was rapid followed by a slower rate of 
release.  To investigate further the gradient of the %CHD release against t1/2 after 24 
hours to 1 week was calculated with the intercept with the y-axis taken as the initial 
burst release. Comparing gradients VG was higher than EPLS both much higher 
that EPGS, related to ethanol content as discussed earlier.  Averaging the gradients 
of VG, EPLS and EPGS formulations with the same additive to try and identify 
relative magnitudes of effects showed the same trends. For all materials 1%CHD 
showed faster release than 9%CHD however the weight of CHD released was 
higher. This means a higher concentration of CHD is present in immersion solution 
leading to lower concentration gradient resulting in less release. Although there is 
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more CHD in the 9% CHD material not all will be in the solution droplets formed at 
the CHD sites, which is limited by water solubility of CHD (MSDS-CHD, 2011; Sigma 
2011). Change in the immersion solutions at 1 week and 2 week does not seem to 
have an effect on the CHD release.  
 
When looking at the gradients and intercepts only trend seen is that higher release 
rates (gradients) show negative intercepts indicating no burst release. For early or 
burst release it may be better to look at Table 4.5 which shows the weight and 
%CHD released in the first 24 hours. In this case VG releases more than EPLS and 
much more than EPGS. This can be attributed to ethanol content which is said to 
leach out rapidly with some studies reporting all being lost with in the first 24 hours 
as reported by by Jones et al. (1988). Considering the percentage CHD release 
again 1% CHD materials are higher than the 9% materials but by weight it is the 
other way round. However the weight release is not proportionally higher than the 
1% CHD materials which may be related to the solubility in ethanol as previously 
noted in this section. 
 
The release of CHD from tissue conditioners is complicated owing to the 
simultaneous loss of ethanol, plasticiser and also high water uptake. This is 
particularly evident in VG formulations with overall loss in weight negative weight 
change and resulting in high solubility (Table 4.4). 
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To analyse the release mechanisms from these materials log of % CHD release was 
plotted against log of time (as explained earlier). The plots showed that CHD was 
released in two phases both with different mechanisms. The initial release phase 
was rapid followed by a slower release in the second phase, as shown in Figure  5.2, 
as a typical example (the remaining log/log release plots can be found in the 
Appendix). In the initial linear phase only VG 1%CHD, VG9%CHD, EPLS 1% CHD, 
EPLS 9%CHD+F had gradients between 0.4 and 0.6, thus indicating a Fickian 
release process. CHD released from the initial phase of all the other formulations, 
and the second phase of all formulations, was by non Fickian kinetics since the 
gradients were less than 0.4. 
 
Figure  5.2: Log % CHD release of EPLS 1%CHD against log of time (sec) 
 
NaF was added to the formulations to enhance release of CHD and not to provide a 
therapeutic effect, so only a small amount (0.5%) was used. The same percentage 
has previously been used in different studies which have been shown to have a 
similar effects (Patel et al., 1998; Sample, 2001; Hassan, 2007).  From the results 
summarized in Table 4.7 the amounts of F released were similar to the amounts 
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found by Sample (2001). After 4 weeks immersion in DW, Sample (2001) found that 
formulations based on BMA/EMA copolymer powder with 2% ethanol and ATBC 
showed a release of 2.21 ppm. Here VG 1%CHD+F showed a release of 3.86 ppm 
whereas EPLS and EPGS 1%CHD+F showed releases of 2.65 and 2.36 ppm 
respectively, which are similar to the findings of Sample (2001). The difference with 
VG is most probably due to the differences in polymer powder and the ethanol 
content.  
 
When the gradient of the %F release against t1/2 after 24 hours up to 1 week was 
calculated with the intercept with the y-axis taken as the initial burst release for 
further analysis, the %F release rate of 9%CHD was higher than 1%CHD for VG 
and EPLS but similar for EPGS. Again negative intercept for higher release rates 
indicates absence of burst release but again considering F release after 24 hours 
shown in Table 4.8 the 9% CHD+F materials all released more F than 1% CHD 
materials both measured as ppm and percentage. As was previously noted F is 
probably released as chlorhexidine difluoride and the 9% CHD materials release a 
higher weight of CHD (Shen et al., 2010).   
 
Generally, in all formulations, increasing the content of CHD increased the level of F 
released at 1 day, 1 week and 4 weeks. It proved difficult to analyse the process by 
which fluoride ions were released. Log F release against log time plots for all 
formulations are displayed in the Appendix, where none of the plots initially released 
fluoride by a diffusion controlled process. Therefore it can be concluded that fluoride 
was released by an anomalous process.   
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Comparing water uptake and %CHD release profiles, it was noted that there 
appears to be an arrest in both which occurs around 100 - 200 sec1/2. In the uptake 
profiles the weight change is due to a combination of inherent matrix uptake and 
also weight loss particularly due to ethanol loss (Braden and Causton, 1971; Murata 
et al., 1996; Dhiman, 2004). Afterwards the change is slope is due the water 
reaching CHD/F sites and formation of solution droplet (Dhiman, 2004). Then the 
uptake is driven by the osmotic gradient and droplet growth (Liao et al., 2012; 
Muniandy and Thomas, 1984). This will also influence the CHD/F release rates 
(Sample, 2001). Again due to the complex water uptake and loss of plasticiser and 
ethanol as well as CHD and F the release of later will affect the osmotic gradient. 
The change of immersion solutions at 1 week and 2 week, however, does not 
appear to have much of an effect on uptake or release except on formulations 
containing F where higher release is seen so saturation is more likely to occur.  
 
5.6 Shore A Hardness  
Shore A hardness is commonly used for elastomeric materials although ISO 10139-
1, ISO 10139-2 (2009) standards for soft lining materials recommend IRHD. The 
main differences between Shore A testing and IRHD are that Shore A uses variable 
(spring load) force and is used for sample thickness of 6 mm or more of whereas 
IRHD uses a constant (dead load) force and is used for sample thicknesses of 4mm 
or above. Additionally, the dwell time in IRHD is an initial minor load for 5 sec and 
then a secondary load for 30 sec, a total time of 35 sec (Hertz and Farinella, 1998) 
whereas for Shore A hardness, the standard dwell time is 1 sec (ASTM D 2240-05; 
2005). Thus, IRHD hardness measurements can be effected by creep due to the 
extended dwell time, whereas this effect will be minimised using a dwell time of 1 
sec. 
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ASTM D2240 (Testing and Materials, 2005) standard for Shore A hardness 
recommends a minimum thickness of 6mm, however this is not practical  in clinical 
situations.  According to Murata et al (2009), tissue conditioners are optimally 
compliant when used in a thickness of 1.5-2 mm, a more clinically appropriate 
thickness. The thickness used in this study was 10mm and, although it may not be 
relevant clinically, a lower thickness is not suitable for materials with very low Shore 
A hardness values (<20). In studies by Siddiqui et al. (2010) and Ali (2010) the 
effect of increasing the thickness resulted in decreasing hardness. It was found that 
when thickness was increased from 1 to 6mm there was a decrease in Shore A 
hardness and then the values remained almost constant when the thickness was 
increased from 6mm upwards. Ali (2010) showed that the Shore A hardness of a 
experimental tissue conditioner formulations containing PEMA+BPBG or 
PEMA+ATBC decreased more than 10 fold when thickness was increased from 1 
mm to 6 mm. Additionally Siddiqi et al (2010) found that for materials with lower 
Shore A hardness the decrease showed more dependence on thickness. So to 
evaluate the true Shore A hardness of tissue conditioners it was considered that a 
10mm thickness is more suitable to ensure there is no effect of thickness. 
 
The commercial materials, VG and CC, were tested using two different P/L ratios. 
One was the manufacturer’s recommended P/L ratio and a higher P/L ratio 
(1.8g/ml), which was suggested by the manufacturer if a stiffer gel was required, as 
explained in section 5.3. When VG was developed the original P/L ratio used was 
1.8g/ml (Jones et al., 1986); this was also used by Dhiman (2004) in his studies. 
Additionally, a study was conducted by Yahaya (2003) in the Dental Institute of 
Barts and London School of Medicine and Dentistry, in which 8 clinicians were 
asked to mix a tissue conditioner to their preferred consistency. The results varied 
from 1.1g/ml to 1.8g/ml so, a P/L ratio of 1.8g/ml was also used in this study.  
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Figure  4.39 shows the Shore A hardness values of all the materials measured 1 
hour after mixing. Differences in Shore A hardness between the materials as may be 
due to many factors as detailed in section 2.6.2. EPGS has the highest Shore A 
hardness despite a low P/L ratio (Figure  4.39). This is because EPGS, at the time of 
measurement which, as explained earlier in section 4.9.1, is actually 16 hours after 
mixing will be in the post gelation phase.  
 
When the P/L ratios of VG and CC were increased the Shore A hardness of the 
materials also increased. This increase in powder content will reduce the overall 
level of plasticiser/ethanol in the material and reduce polymer chain mobility. Thus 
the material will resist penetration of indenter leading to higher Shore A hardness. 
VG 1.8, CC 1.8 and EPLS have the same P/L ratios but different Shore A hardness 
values. In this case differences may be due to gelation time where VG 1.8 has the 
shortest gelation time and EPLS the longest. Thus after 1 hour VG 1.8  is most likely 
to be in the post gelation stage (Murata et al., 2005) and CC 1.8 and EPLS are still 
in sol-gel stage (Murata et al., 2005) so gelation may not be complete.  Additionally, 
VG and CC both contain ATBC but VG contains more ethanol.  A study by Jones et 
al (1991b) reported that a high ethanol content produced stronger gels which would 
resist penetration by the indenter and give a higher Shore A hardness value. A 
number of studies have shown the lower Shore A hardness of CC compared to VG.  
Dhiman (2004) attributed this to the lower Mw plasticisers in CC. 
 
The Young’s modulus was calculated from Shore A hardness, 1 hour after mixing, 
as explained in section 2.6.2 According to Murata et al. (2009) the physical 
properties of soft lining materials should ideally be equal to the oral/basal mucosa 
and for tissue conditioners Young’s modulus should be less. This is so that when 
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loaded, e.g. during mastication, the tissue conditioner will deform more than the 
mucosa so acting as a cushion (Braden et al., 1995). Inoue et al. (1985) reported 
that Young’s modulus of oral mucosa ranges between 0.4 – 4.4 MPa. The results in 
Figure  4.42, show that the Young’s modulus of EPLS and EPGS were 0.22 and 0.24 
respectively and lower than that of oral mucosa as proposed by Murata et al. (2009).  
 
As well as continuing gelation/maturation, storage in different media will also affect 
Shore A hardness with time. The different formulations were stored dry, in DW and 
in AS at 37°C in order to study and compare the effects of different conditions. 
When stored dry, the materials will only be influenced by temperature. In DW and 
AS, where Shore A hardness will be influenced additionally by ethanol/plasticiser 
leaching and water uptake, AS will also simulate the oral environment. 
 
When stored dry at 37°C (Figure 4.39), Shore A hardness for the different P/L 
formulations increased over the first 24 hours after which there was only a minimal 
increase up to the end of experiment (1 week). This suggests that up to 24 hours 
there is continuing gelation (sol-gel stage) or continuing chain entanglement in the 
post-gel phase as described by Murata et al. (2005). From 24 hours to 1 week the 
formulations will be mature gels and so only minimal changes in Shore A hardness 
will occur. EPGS showed the lowest changes over time as it was already a mature 
gel at the start of the experiment, as previously noted. 
 
When immersed in DW and AS at 37°C (Figures 4.40 and 4.41), an increase in 
Shore A hardness with time was seen in all formulations, including EPGS. 
Plasticisers and ethanol will leach out over time resulting in hardening of the 
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materials,(Ali, 2010). The increase in Shore A hardness with time was higher in DW 
compared to in AS. AS is an aqueous solution and contains a number of different 
components that may affect the uptake/leaching processes. Several studies have 
shown that water uptake is less from solutions than water because of the reduction 
in osmotic gradient, the driving force for uptake (Dhiman, 2004; Liao et al., 2012). A 
study by Kazanji and Watkinson (1988) showed that in artificial saliva tissue 
conditioners have a lower weight change, which then proposed that it was due to 
less plasticiser loss compared to DW. Yahaya (2003) also showed that when tissue 
conditioners are immersed in AS, they had lower change in Shore A hardness with 
time, which again was attributed to less plasticiser loss.  
 
After one week storage in all media EPLS had the lowest Shore A hardness 
compared to VG 1.8 and CC 1.8 (with the same P/L). EPGS showed the least 
change over time in all media indicating the stability of the material.  Both reflect the 
differences in ethanol content between the materials where VG has the highest and 
EPGS the lowest. 
 
In the literature, either Shore A hardness or compliance (which is inverse of 
hardness) was used to measure the softness of these materials. Murata et al. (1996) 
studied the changes in compliance in different tissue conditioners namely CC, CS, 
GC and VG, in DW over a period of 28 days at 37°C. They reported that biggest 
change in compliance was seen during first few days, which agrees with the findings 
of this study where for VG and EPLS the major changes in Shore A hardness were 
seen during the first 24 hours.  
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Yahaya (2003) reported the effect of storage in DW and AS on Shore A hardness of 
VG and an experimental tissue conditioner containing 50/50 BMA/EMA copolymer 
with 2% ethanol and ATBC. The Shore A hardness of VG increased more in DW 
than in AS, however the experimental tissue conditioner showed an increase in 
Shore A hardness in DW but decrease in AS. This is contrary to the results found in 
the present study where Shore A hardness increased in both DW and to a lesser 
extent in AS for both VG and EPLS. This may be attributed to the difference in 
composition where Yahaya’s experimental material had lower ethanol content at 
2%, compared to VG and EPLS leading to lower plasticiser loss (Jones et al, 1988), 
as shown by the higher solubility in DW compared to AS, so reducing the hardening 
effect  Additionally the study was carried out over 5 weeks where the resulting 
higher water uptake may have a plasticising effect which can partially compensate 
for plasticiser loss (Murata et al., 2009).  
 
Ali (2010) investigated the effect of immersion on two experimental tissue 
conditioners containing PEMA powder with 5% ethanol and BPBG or ATBC, the 
latter being similar in composition to EPLS. The results showed that Shore A 
hardness increased with time in DW and AS, and increase was higher in DW than in 
AS. There were also rapid changes in hardness during the first week followed by a 
gradual increase, supporting the findings from this study  
 
One of the aims of the study was to investigate the effect of incorporation of CHD 
with and without NaF for VG, EPLS and EPGS on Shore A hardness. In general 
when CHD and NaF were added to VG, EPLS and EPGS, Shore A hardness was 
increased. When CHD and NaF were added they would be dispersed within the gel 
matrix where, as they are particulate, they may act as fillers and increase the 
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resistance to penetration of the indenter into the material and thus increasing the 
Shore A hardness (Schneid, 1992).   
 
Shore A hardness measured at 1 hour after mixing generally increased for all 
formulations when CHD with and without NaF were added with only slight variations. 
Changes in Shore A hardness over time for the materials containing additives 
followed similar trends as seen in the original materials but the final values were 
higher (Figures 4.43 – 4.51). These higher values result from higher solubility values 
(Table 4.4) for these materials indicating greater plasticiser loss. As for the materials 
without additives, EPLS formulations had the lowest Shore A hardness after 1 week 
and EPGS formulations showed the least change. Additionally, EPLS was the only 
formulation (except 9%CHD) and VG 1%CHD had Young’s modulus values at 24 
hours (Figure  4.53) below the range for the mucosa (0.4 – 4.0 MPa) found by Inoue 
et al (1985).  
 
There are few studies that have been carried out on the effect of addition of 
antifungal drugs on Shore A hardness. However, the increase in Shore A hardness 
when CHD was added into the soft lining materials has been reported by some 
authors. Urban et al. (2014) investigated the effect of incorporation of antifungal 
drugs into Softone, a tissue conditioner and Truesoft, a resilient liner, on Shore A 
hardness when immersed in DW at 37°C. The Shore A hardness of both materials 
increased with time and when the amount of antifungal drugs was increased thus 
showing the same trends found for EPLS in DW in this study. Similarly Bertolini et 
al. (2014) also investigated the effect of incorporation of CHD into Coe-soft and 
Truesoft when stored in DW, as found in this study, the Shore A hardness increased 
with time for both materials. They also found that increase in the amount of CHD did 
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not have an effect on Coe-soft however, it did increase Shore A hardness of 
Truesoft. The authors proposed that this is due to the difference in composition 
between the materials e.g. plasticisers. Similarly in this study, increase in 1%CHD to 
9% increased the Shore A hardness for EPLS but decreased it for VG where the 
main difference is ethanol content.  
 
5.7 Creep Compliance Ratio 
Viscoelastic materials show a relationship between stress and strain which depends 
on time. If the stress is held constant, the strain increases with time (viscoelastic 
creep); and if the strain is held constant, the stress decreases with time (viscoelastic 
relaxation). In this study the ratio of compliance at time t (dwell time) to the 
compliance at 1 sec dwell time is used to calculate the creep compliance ratio 
(CCR). CCR is a measure of flow in the material and is an important property of a 
tissue conditioner where it can determine the appropriate clinical application of the 
material. When used as a tissue conditioner the material should have a high flow 
(high CCR) so that it can adapt to the underlying tissue and it should maintain its 
flow so as to allow the tissues to heal. When used as a temporary soft liner they 
should have relatively low flow (low CCR) maintained throughout the time required 
in the mouth (Murata et al., 1996). In functional impression material a very high flow 
(very high CCR) is required at the time of placement so it can record the details 
accurately but the flow should then reduce quickly so as to maintain the record of 
the anatomy for a maximum of 24 hours in the mouth (Shylesh et al., 2013).  
 
Shore A hardness was measured using dwell times from 1 sec to 30 sec. All the 
formulations showed that by increasing the dwell time Shore A hardness decreased 
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indicating the occurrence of creep. Penetration of the indenter using a dwell time of 
1 sec will result in a mainly elastic strain whereas for longer dwell times plastic strain 
will also occur thus resulting in lowering the Shore A hardness. 
 
As can be seen from Table  4.10, at 1 hour after mixing increasing the P/L of both 
VG and CC (to a lesser extent) decreased CCR reflecting the decrease in ethanol/ 
plasticiser content.  The CCR for VG and EPLS I hour after mixing (Table  4.10) were 
much lower than CC which is due to the difference in plasticiser.  CC contains lower 
molecular weight plasticisers which will lead to less polymer chain mobility 
compared to those with higher molecular weights (Jones et al., 1986; Jones et al., 
1988). The very high CCR of EPLS may also be due to continuing gelation at 1 hour 
time thus resulting in higher flow (high CCR). The high CCR found for VG at 1 hour 
may result from higher ethanol content so facilitating polymer chain mobility (Murata 
et al., 2001a). However, both VG and EPLS showed a dramatic decrease in CCR at 
24 hours in all storage media when they would have reached the post gelation 
stage. After 24 hours there was minimal change in CCR for all materials in all 
storage media up to 1 week (Table  4.11). EPGS had the lowest CCR of all 
formulations as it was measured 16 hours after mixing as previously discussed so 
was a mature gel. This is further evident by the fact that there was no statistically 
significant (p≤0.05) change in CCR throughout the 1 week of the study, when stored 
dry (Table  4.11).  
 
Considering the ATBC containing materials, the order of decrease in CCR was 
VG<EPLS<EPGS which equates inversely with ethanol content which is in the order 
VG>EPLS>EPGS. 
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According to ISO 10139-2 the penetration ratio (R) of 30 sec and 5 sec dwell time 
after 24 hours of mixing can be classified into two classes based on the resistance 
to the flow. Class I materials are high resistant to flow when R≤1.1 and class II 
materials are low resistance to flow when 1.1<R<1.75. Increasing the P/L ratio 
decreased R in both CC and VG resulting from the decreased ethanol content. 
When stored dry only VG showed a decrease in R with time (more notable in VG1.5) 
which might be due to higher amount of ethanol evaporating from the material 
whereas all other materials had less or no ethanol so leading to increase in R. When 
stored in DW and AS all materials showed a decrease in flow because of leaching of 
plasticiser and uptake of water. The trends seen in R of materials in different 
immersion solutions are similar to the ones seen in CCR. 
 
Ethanol content has been found to be one of the major factors that influence flow of 
tissue conditioners in a number of studies. Jepson et al. (2000) studied the 
viscoelastic properties of different commercial tissue conditioners including VG and 
CC in different immersion solutions including DW. There was a reduction in creep 
compliance in all materials with time although to different degrees depending on 
immersion solution. However it was noted that the formulations with higher ethanol 
content had higher reductions. This result agrees with the findings of the present 
study where VG and EPLS having higher ethanol content showed decrease in CCR. 
Murata et al. (2010) investigated the viscoelastic behaviour of various commercial 
home reliners (containing polyvinyl acetate and ethanol) for 7 days and found that 
these have no elastic component and behaved only in a viscous manner i.e. very 
high flow (CCR). The authors attributed the higher ethanol content of 20-30% in 
these material as the leading factor of this finding compared to the tissue 
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conditioner’s (where the ethanol content is much less) in their earlier study which 
also showed elastic response (Murata et al., 2001b; Murata et al., 2010). It is 
believed that more ethanol will result in greater plasticiser loss (Jones et al., 1988; 
Liao et al., 2012), as explained in section 5.4, resulting in reduced flow due to 
reduced polymer chain mobility and so reducing CCR. 
 
For the P/L materials, the addition of CHD and NaF decreased CCR at 1 hour 
(Table  4.13), the additives acting as filler particles to reduce flow. However, their 
addition had little effect on the CCR of EPGS throughout the 1 week study when 
stored dry.  When stored dry, the additives generally increased the CCR of VG and 
EPLS at 24 hours and 1 week with the exception of the NaF containing EPLS 
formulations where there was a slight decrease, it is not clear what the cause of this 
effect was.  Stored in DW and AS the additives had a variable effect depending on 
the material, however changes were low. 
 
At the end of the 1 week study VG and EPLS formulations in all storage conditions 
had similar CCR values whereas those for EPGS were slightly lower but were more 
stable throughout the 1 week study. 
 
For all materials, addition of CHD and NaF had a variable effect on R (Table 4.14) 
whereas in CCR addition of additives had little or no effect. When stored dry again 
with exception VG, which has the highest ethanol content, R generally increased 
with time from 24 hrs to 1 week. When stored in DW and in AS all materials showed 
a decrease (or remained unchanged) in R which, as explained earlier is because of 
the leaching of the plasticiser and water uptake by the material. In DW the decrease 
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in R was more than in AS owing to the fact that AS contains more variables and with 
the addition of additives makes the whole water uptake and leaching of constituents 
more complex (Ali, 2010). In general the CCR and R in DW follows the same trends 
but the CCR had more variable effects in AS.  
 
Variabilities in hardness, penetration ratio and CCR measurements of formulations 
containing additives may have been affected by their distribution in the matrix. 
Differences could have been caused by composition, especially ethanol content 
where the solubility of CHD could improve homogeneity in the higher ethanol 
materials. 
 
It was not possible to compare the effect of additives on flow (CCR) with other 
studies as none were available in current literature. 
 
5.8 Summary 
When developing a new tissue conditioner formulations it is important to know basic 
properties that define its use. These include gelation time, water uptake behaviour, 
hardness and creep compliance (flow properties). Gelation time is important to know 
as they are chairside materials and it is desirable to have a short gelation time 
however with a pre-gelled system this is not important. Tissue conditioners are used 
in an aqueous environment so it is essential to study their water uptake behaviour. 
Similarly hardness and creep are important to know as they define the materials 
usage in a particular clinical situation. 
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As discussed above the gelation time for pre-gelled system is not important but for 
P/L systems the gelation time with and without the additives were not ideal but 
acceptable.  
 
When studying the water uptake behaviour of these materials % weight changes are 
measured which also reflects the dimensional changes occurring in them. So weight 
change of ~8.8% in EPLS 9%CHD (lowest among all formulations) and ~47.6% in 
EPLS 9%CHD (highest among all formulations) after 4 weeks mighty be problematic 
in its use in mouth. Higher the % weight change reflects higher dimensional change 
so the fitting of the denture might be compromised if it is used for periods of 4 weeks 
even after 1 week the % weight changes range from ~4% to ~25% which is still too 
high to be acceptable for clinical use. So they must be replaced after every 2-3 days 
to have optimum properties (Braden et al., 1997).  
 
CHD is a good anti-microbial and anti-fungal agent to be added in these materials 
as they can also be used in denture wearers to improve the general oral health 
(Petersen and Yamamoto, 2005; Sloane et al., 2013), rather than only in patients 
with candidal infections. As discussed above the amount of CHD in the formulation 
affects the % weight change. Increasing the % of CHD increases the water uptake 
and addition of NaF further enhances the % weight change which will all contribute 
to the problems of the fitting of the denture over period of 1 week and more.  
 
Hardness and CCR values are important for the functional classification of the 
materials in its intended use. There are no ideal values found in the literature for the 
hardness of tissue conditioners, however Craig (1997) suggested that Shore A 
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hardness of 13 to 49 in 24 hours will not interfere with the use of tissue conditioners 
in mouth. According to Gonzalez (1977) the ideal Shore A hardness for temporary 
denture liners should be between 20 and 25 without changes during use. The 
results in this study seem to satisfy both the author’s criteria. Similarly the 
penetration ratios (R) of the materials were in the range of class II low resistance to 
flow which also satisfies the ISO 10139-2 standards. The additives did not have a 
sufficient effect on the hardness and CCR values that would hinder function, 
however the EPGS formulations had the most stable CCR values over the period of 
1 week.  
 
EPLS formulations are best used as vehicle of delivery of CHD as the increase in 
amount from 1% to 9% did not effected the % weight change of the materials but the 
addition of NaF increased the release and % weight change. Considering hardness 
and CCR, the NaF containing EPLS formulations had higher hardiness and lower 
CCR than the formulations without them. These formulations might be more useful 
as tissue conditioners rather than temporary lining material or functional impression 
material. 
 
Based on all above properties EPGS would be best used as a tissue conditioner or 
as a temporary lining material although when additives are added the CHD release 
is not as high as compared to the other formulations. 
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6 Conclusions 
• An ethanol-free, citrate-based, pre-gelled material, EPGS, has been developed 
with suitable physical properties to function as a tissue conditioner.  It has been 
shown to have stable Shore A hardness values over 18 months storage, if 
refrigerated. Based on Shore A hardness and flow (CCR) EPGS is best suited to 
be used as temporary soft lining materials or as tissue conditioner. 
• The P/L citrate-based material, EPLS had comparative or improved properties 
compared to the commercial P/L tissue conditioners. Based on the Shore A 
hardness and CCR. EPLS is best suited as a tissue conditioner. 
• The ethanol content of tissue conditioners was found to play a key role affecting 
all properties. 
• Addition of CHD and NaF affected the properties of both commercial and 
experimental tissue conditioners; these effects varied with composition. Their 
addition increased both water uptake and solubility which in turn may affect their 
dimensional stability. However they did not have sufficient effect on the Shore A 
hardness and CCR values to affect the function of the materials; EPGS 
formulations presented with more stable values. 
• All materials, both commercial and experimental, released CHD, but at different 
levels. Addition of NaF further increased the amount of CHD released. 
• Generally all water uptakes plots against t½ appeared linear (Fickian uptake 
kinetics). It can be concluded that in the presence of sodium fluoride, the water 
uptake process of EPGS became complex and was anomalous.  
• Water desorption was rapid and Fickian in nature for all systems. Ddes values 
increased with increasing CHD content in formulations from 1% to 9% (except 
for EPLS), and when NaF was added (except VG 9%CHD). Ddes was slower for 
VG (10-11 m2sec-1) reflecting the higher ethanol content in this formulation. 
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• CHD was released in two phases. Initially, it was released by a Fickian process 
from VG 1%CHD, VG9%CHD, EPLS 1% CHD, EPLS 9%CHD+F. For all other 
formulations, the initial and second phases of release were by non Fickian 
kinetics. 
• It proved difficult to analyse the process by which fluoride ions were released. 
Therefore it can be concluded that fluoride was released by an anomalous 
process.   
• The replacement of BPBG (VG old) with a citrate-based plasticiser in VG has 
changed its water uptake profile dramatically, with the current VG showing 
continued weight loss on storage in DW. Thus it can be assumed that the citrate-
based plasticiser leaches out more readily than BPBG. This highlights the 
importance of reducing the ethanol content in the experimental ATBC-based 
materials to reduce plasticiser leaching, as was shown in this study for EPLS 
and EPGS. 
• Use of Shore A hardness measurements using different dwell times has proved 
a useful method for assessing CCR (flow properties) of tissue conditioners, 
particularly change over time when stored in various conditions. As noted in the 
discussion section, findings from this study were in general agreement with other 
studies where different methods were used. 
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7 Future Work 
• Further development of EPGS is required in terms of its clinical chairside 
delivery. Home use materials are usually in the form of a thin sheet or 
contained in a tube, so these formats should be initially studied. 
• Water uptake behaviour in other liquids such as artificial saliva and food 
simulating liquids should be studied to help evaluate in vivo performance. 
Additionally interaction with commonly used denture cleansers needs to be 
assessed. 
• Plasticiser and ethanol leaching needs to be quantified using such methods 
as UV/Vis spectroscopy or high performance liquid chromatography (HPLC). 
• Although all the materials did release CHD, microbiological studies should be 
carried out to assess whether they are effective against Candida albicans. 
• The amount of CHD used in the formulations needs to be optimized by using 
different concentrations so that maximum percentage release can be 
obtained. 
• Release of other drugs from this material should be studied to investigate 
their potential for use in the treatment of other oral infections e.g. topical 
delivery of steroids for the treatment of lichen planus. 
• CCR results should be compared with other testing methods for 
viscoelasticity like creep test or stress relaxation test so that a better 
understanding could be obtained about the accuracy of results obtained by 
the methodology used in this study. 
• Release of F from the materials and its role in drug release needs to be 
further explored.  
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Appendix 
A1. Ethanol Content 
To measure the ethanol content of Visco-gel (VG) liquid a glass jar of 100ml 
capacity was weighed using an AE Mettler balance (Metler – Toledo Ltd, Leicester, 
UK) accurate to four decimal places. 10 g of the VG liquid was weighed in the jar 
and the jar was left on a bench top for 24 hours so that the ethanol in the liquid 
could evaporate in air. After 24 hours the jar was reweighed and the difference of 
weight was found to be 6.2% w/v.  
As a control the liquid used in experimental powder liquid system (EPLS) was used. 
This liquid contained 5ml ethanol and 95ml of Acetyl tributyl citrate (ATBC). When 
10g of this liquid was weighed after 24 hours the difference between the two 
readings were 3.5% w/v.  
From these two readings it can be concluded that the VG liquid contains almost the 
double the amount of ethanol compared to the control liquid in EPLS. 
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A2. Difference between VG new and VG old 
The manufacturers of VG changed the plasticiser used in its liquid from BPBG to a 
citrate based one. To investigate the effect of this plasticiser change on the 
properties of VG a study was conducted measuring particle size of the powders 
used, water uptake and desorption, Shore A hardness and creep compliance ratio 
(CCR) of both VG old and VG new were compared using the same techniques as 
mentioned in section 3.2.  
 
Table 15 shows no significant difference was found between VG and VG Old 
polymer powder in terms of Mean particle size (D[v,0.5]), surface/volume mean 
diameter (D[3,2]) and volume mean diameter (D[4,3]). 
 
Table 15 Mean of Mean particle size D[v,0.5], surface/volume mean diameter 
D[3,2] and volume mean diameter D[4,3] with SD of different polymer powders 
(n=5) 
Powder D[v,0.5] SD (±) D[3,2] SD (±) D[4,3] SD (±) 
VG old 32.54a 0.17 13.70a 0.54 34.16a 0.17 
VG new 32.91a 0.42 14.31ab 0.28 34.67a 0.34 
No significant difference (p≤0.05) between groups with same letters 
 
The water uptake study of VG New and VG Old was carried for 12 weeks and the 
results are shown in Figure  4.9. Both VG Old 1.3 and 1.8 showed a similar water 
uptake profile of weight loss till day ~5 (t1/2 =587.9) where they started to gain weight 
at different rates i.e. VG Old 1.8 gained weight more rapidly than VG Old 1.3 up to 
the end of experimental time period. VG Old 1.8 gained more weight (9.1%±0.9) 
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compared to VG Old 1.3 (1.3%±0.2).  Both VG New 1.5 and 1.8 lost weight rapidly 
up to ~34 days (t1/2 =1610) followed by an increase in weight to a final weight 
change of -5.8%±0.6 and -1%±0.8 respectively. This initial part is indicative of loss 
of material.  
The changes seen in both VG old and VG when the P/L ratio was increased is due 
to decreased ethanol content in the formulation thus resulting in a lower weight loss 
with the lower P/L ratios. The weight changes seen in uptake profiles of VG Old 
verses VG reflect the roles of the different plasticisers in the two formulations (BPBG 
verses ATBC). This will be further discussed in the discussion. 
 
 
 
Figure 3: Mean (±SD; n=5) % weight change of VG New and VG Old 
formulations in DW at 37°C 
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Figure  4.20 showed the % weight loss of VG Old 1.3 and 1.8; VG New 1.5 and 1.8,  
on desorption where all reached equilibrium after 24 hours. The final weight loss for 
VG Old 1.3 was 9%±0.4 and fro VG Old 1.8 was 4.3%±0.2.  VG New 1.8 and 1.8 
reached equilibrium % weight loss of 15.6%±0.7 and 19.1±0.4 respectively. 
 
 
 
Figure 4: Mean (±SD; n=5) % weight loss of VG New and Old formulations in 
drying oven at 37°C 
  
 
Table  4.3 showed the mean % weight change, % solubility, % real uptake and 
desorbed diffusion coefficient (Ddes) data for the different tissue conditioner 
formulations. % weight change and % solubility increased when P/L ratio of VG New 
and Old was increased however % real uptake and Ddes increased w=hen P/L ratio 
was increased in VG New and decreased in VG Old. 
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Table 16: Mean (±SD; n=5) % weight change, % solubility, % real uptake and 
Ddes of VG New and Old formulations  
Formulation 
% Weight 
Change 
% Solubility 
% Real 
Uptake 
Ddes (m
2sec-1) 
VG New 1.5 -5.7703 24.6 ± 1.6 18.8 ± 2.1 2.56 x 10-11 
VG New 1.8 -0.9896 25.4 ± 2.1 24.4 ± 2.6 1.96 x 10-11 
VG Old 1.3 9.1340 -4.3 ± 0.3 4.8 ± 0.4 1.03 x 10-10 
VG Old 1.8 1.2964 3.1 ± 0.1 4.4 ± 0.3 1.40 x 10-10 
 
 
 
Figure 5 shows the Shore A hardness of VG New and VG Old formulations at 
manufacturer’s recommended and a higher P/L ratio 1 hour after mixing. Increasing 
the P/L ratio increased the hardness of the material. The Shore A hardness of VG 
was increased when the plasticiser was changed from BPBG to citrate based 
plasticiser. 
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Figure 5: Mean (±SD; n=6) Shore A hardness of VG New and VG Old 
formulations at different P/L ratios, 1 hour after mixing  
 
 
The Shore A hardness of the different VG formulations decreased with increasing 
dwell time at 1 hour after mixing (Figure 6). CCR of VG old increased with 
increasing the P/L ratio whereas it decreased in VG New as shown in Figure 7.  
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Figure 6: Mean Shore A hardness at different dwell times of VG New and VG 
Old formulations at different P/L ratios, 1 hour after mixing 
 
 
 
Figure 7: Mean CCR of VG New and VG Old formulations 1 hour after mixing 
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A3. Log-log graphs for water uptake studies 
 
log of % weight change of EPLS against log time 
 
 
log of % weight change of EPGS against log time 
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log of % weight change of EPLS 1%CHD against log time 
 
 
 
log of % weight change of EPLS 9%CHD against log time 
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log of % weight change of EPLS 1%CHD+F against log time 
 
 
 
log of % weight change of EPLS 9%CHD+F against log time 
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log of % weight change of EPGS 1%CHD against log time 
 
 
 
log of % weight change of EPGS 9%CHD against log time 
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log of % weight change of EPGS 1%CHD+F against log time 
 
 
 
log of % weight change of EPGS 9%CHD+F against log time 
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Chlorhexidine Release for 4 weeks 
 
Log % CHD release of VG 1%CHD against log of time (sec) 
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Log % CHD release of VG 9%CHD against log of time (sec) 
 
Log % CHD release of VG 1%CHD+F against log of time (sec) 
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Log % CHD release of VG 9%CHD+F against log of time (sec) 
 
 
 
 
Log % CHD release of EPGS 1%CHD against log of time (sec) 
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Log % CHD release of EPGS 9%CHD against log of time (sec) 
 
Log % CHD release of EPGS 1%CHD+F against log of time (sec) 
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Log % CHD release of EPGS 9%CHD+F against log of time (sec) 
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Log % CHD release of EPLS 1%CHD against log of time (sec) 
 
 
Log % CHD release of EPLS 9%CHD against log of time (sec) 
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Log % CHD release of EPLS 1%CHD+F against log of time (sec) 
 
 
Log % CHD release of EPLS 9%CHD+F against log of time (sec) 
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Fluoride Release for 4 weeks 
 
 
Log % F release of VG 1%CHD+F against log of time (sec) 
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Log % F release of VG 9%CHD+F against log of time (sec) 
 
Log % F release of EPLS 1%CHD+F against log of time (sec) 
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Log % F release of EPLS 9%CHD+F against log of time (sec) 
 
Log % F release of EPGS 1%CHD+F against log of time (sec) 
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Log % F release of EPGS 9%CHD+F against log of time (sec) 
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A3. Shore A hardness  
 
Mean (n=6) shore A hardness of CC 1.2 at different dwell times stored at 37°C 
in dry, DW and AS 
 
 
Mean (n=6) shore A hardness of CC 1.8 at different dwell times stored at 37°C 
in dry, DW and AS  
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Mean (n=6) shore A hardness of VG 1.5 at different dwell times stored at 37°C 
in dry, DW and AS  
 
 
Mean (n=6) shore A hardness of VG 1.8 at different dwell times stored at 37°C 
in dry, DW and AS  
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Mean (n=6) shore A hardness of EPLS at different dwell times stored at 37°C 
in dry, DW and AS  
 
Mean (n=6) shore A hardness of EPGS at different dwell times stored at 37°C 
in dry, DW and AS  
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Mean (n=6) shore A hardness of VG 1%CHD at different dwell times stored at 
37°C in dry, DW and AS  
 
 
Mean (n=6) shore A hardness of VG 9%CHD at different dwell times stored at 
37°C in dry, DW and AS  
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Mean (n=6) shore A hardness of VG 1%CHD+F at different dwell times stored 
at 37°C in dry, DW and AS  
 
 
Mean (n=6) shore A hardness of VG 9%CHD+F at different dwell times stored 
at 37°C in dry, DW and AS  
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Mean (n=6) shore A hardness of EPLS 1%CHD at different dwell times stored 
at 37°C in dry, DW and AS  
 
 
Mean (n=6) shore A hardness of EPLS 9%CHD at different dwell times stored 
at 37°C in dry, DW and AS  
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Mean (n=6) shore A hardness of EPLS 1%CHD+F at different dwell times 
stored at 37°C in dry, DW and AS  
 
 
Mean (n=6) shore A hardness of EPLS 9%CHD+F at different dwell times 
stored at 37°C in dry, DW and AS  
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Mean (n=6) shore A hardness of EPGS 1%CHD at different dwell times stored 
at 37°C in dry, DW and AS  
 
 
Mean (n=6) shore A hardness of EPGS 9%CHD at different dwell times stored 
at 37°C in dry, DW and AS  
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Mean (n=6) shore A hardness of EPGS 1%CHD+F at different dwell times 
stored at 37°C in dry, DW and AS  
 
 
Mean (n=6) shore A hardness of EPGS 9%CHD+F at different dwell times 
stored at 37°C in dry, DW and AS  
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A4. Creep compliance ratio 
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Creep compliance ratio of VG, VG 1% and 9% CHD with and without 0.5% NaF 
stored dry, in DW and in AS at 37°C 
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Creep compliance ratio of EPLS, EPLS 1% and 9% CHD with and without 0.5% NaF 
stored dry, in DW and in AS at 37°C 
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stored dry, in DW and in AS at 37°C 
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